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The objective of the present study was to examine the ways that the T. evansi components
interact with the host by investigating the components of tire parasite which acted as antigens during
infection and to study the dynamics of some of these antigens during infection. Results from this study
could help in identifying new diagnostic reagents, a better understanding of existing diagnostic
methods and target antigen for production ofvaccines.
The antigenic components of intact and trypsin-treated T. evansi were identified. Thirty nine
protein bands were detected in the trypanosomal preparations using sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE). Twenty seven of these components were identified as
antigens using immunoblotting against sera from infected rabbits and rabbits immunised with a range
of soluble parasite materials. The solubilisation procedure and immunisation method affected the
number of antigens recognised by these sera. The trypsin-treated parasites failed to produce any
antibody response as measured by immunoblotting and ELISA.
Two soluble antigens identified by immunoblotting were selected for further study, a trypsin
sensitive component of ~ 52 k.Da which was cleaved from the parasite by the process of trypsinisation
and a non-surface component of~ 42 k.Da which was recognised strongly by sera from infected rabbits
and rabbits immunised with the parasite soluble materials. Both antigens were also immunogens as
soluble extract. A third antigen of molecular weight of ~72 k.Da recognised by monoclonal antibodies
raised to the intact living trypanosomes was also included in the study.
Polyclonal monospecific antibodies were produced to both the 52 k.Da and 42 k.Da antigens.
The 72 k.Da monoclonal antibody and both polyclonal antibodies were labelled separately with biotin
and horseradish peroxidase. These labelled antibodies were used to develop an enzyme-linked
immunosorbent assay (antigon ELISA) to dctoct their corresponding antigens in the blood and tissue
extracts of infected animals, and in immunohistochemical tests on cryostat sections to localise the
antigens in the tissues.
The three antigens were detected in the blood of infected animals at different times. The 52
k.Da antigen was first detected in the blood 6 days after infection, followed by the 42 k.Da antigen 7
days post-infection and the 72 k.Da antigen 8 days after infection. Following the administration of
Berenil, the 72 k.Da was cleared from the circulation the following day. The two other antigens were
cleared from the circulation 2 days after treatment. In the tissue extracts, the 42 k.Da antigen was
detected extravascularly from the spleen, brain and kidneys. In case of the 52 k.Da, it was also detected
from the heart and lungs in addition to the above organs. The 72 k.Da antigen was, however, not
detected in any of the tissue extracts. On cryostat sections prepared from the above organs however,
none of the antigens was detectable.
The 52 k.Da antigen identified as an invariant antigen is a possible candidate for the
diagnosis of infection but only in areas where T. evansi is the only trypanosome species present due to
cross reaction.
The difference in the dynamics and localisation of the trypanosomes antigens warrants further
investigation and provides a better understanding of the host-parasite interaction.
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Trypanosomes are uniflagellated parasitic protozoa, the majority of
which live and divide extracellularly in the blood and tissues of infected hosts.
Most of the parasites in the Genus Trypanosoma are of veterinaiy and
medical importance causing widespread disease throughout many tropical and
subtropical countries.
Trypanosoma evansi, the causative agent of the disease most commonly
referred to as Surra was the first pathogenic trypanosome described (Evans,
1881-1882). Infection with T. evansi has an extremely wide geographical range
in countries with hot and warm-temperate climates (Hoare, 1972) and infects a
range of economically important livestock. Equids, camels, cattle, buffaloes,
goats, sheep and pigs can all become infected (Luckins, 1988), but the principal
affected hosts are equines, dromedaries and dogs (Hoare, 1972). A wide range
of wild animals from wild rats to tigers and jaguars have been reported as
naturally or experimentally susceptible to infection with T. evansi (Choudhury
and Misra, 1972; Marinkelle, 1976; Sinha et al, 1971; Stephen, 1986). Usually
T. evansi has a lethal effect upon most of these wild animals which are not
regarded as sources of infection for domestic animals (Hoare, 1972). Successful
transmission of T. evansi depends on factors such as vector preferences and
closeness of donor to recipient host (Payne, 1988) which are not likely to be
satisfied with these wild animals under normal livestock management practices.
Hoare (1972) considered these wild animals as much victims of the infection as
the livestock and they probably acquire the infection secondarily from the
domestic animals.
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The other major trypanosome antigens are invariant and common between
stocks of the same species and between different species of trypanosomes (De
Raadt, 1974, Burgess and Jerrells, 1985, Muller at al, 1992).
1. 2. 1. Variant surface antigens:-
Trypanosome infections are classically characterised by successive waves
of parasitaemia each consisting of immunologically distinct parasite populations
(Turner, 1982). This works in the parasites5 favour as by the time that antibodies
capable of clearing the circulation of the trypanosomes are produced by the
host's immune system, other populations of parasites bearing different antigens
on their surface emerge, evade the hosts immune system and proliferate to
continue the infection (Seed, 1972; Campbell and Phillips, 1976; Murray and
Urquhart, 1977; Wellde et al, 1981). This cycle can continue, apparently
indefinitely, usually leading to the death of the host if chemotherapy is not
instituted (Gray, 1965; Turner, 1982; Donelson and Turner, 1985). Each
antigenically distinct trypanosome population is commonly referred to as a
variable antigen type (VAT). The variable antigen itself is a surface
glycoprotein usually referred to as variant-surface glycoprotein (VSG) (Cioss,
1975).
Ritz (1916) demonstrated that infections initiated with a single
trypanosome can produce multiple variants. Although the total number of
variant-surface antigens in the repertoire of a single infection is not known a
single trypanosome of Trypanosoma equiperdum has been shown to give rise to
over one hundred distinct antigenic types, with no indication that the repertoire
had been exhausted (Capbern et al, 1977). Furthermore, genetic studies of
Trypanosoma brncei VSG genes suggest that the genome has the potential to
encode about one thousand VSG (Van der Ploeg et al, 1982).
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The first indication that the variable antigen was located on the surface of
the trypanosome came from the observation of Vickerman (1969) that the
bloodstream and metacyclic stages of trypanosomes differed from other tsetse
developmental stages in possessing a 12-15 nm thick surface coat. This coat
corresponded to the variable antigen, and adapted the trypanosomes to life in a
mammalian host by providing a replaceable surface which enabled the
trypanosomes to evade immunological attack by the host. This role of surface
coat in protection in the mammalian stages of the trypanosome life cycle has
been confirmed and substantiated by subsequent workers (Vickerman and
Luckins, 1969; Cross, 1975; Taylor and Cross, 1977; Fruit et al, 1977; Barry
and Vickerman, 1979) who have demonstrated the presence of the variable
antigen on the surface coat of the trypanosomes using a range of techniques.
Although chemically variable the surface coat of living trypanosomes is a
stable structure and is attached to the cell membrane through a glycosyl-
phosphatidylinositol (GPI) membrane anchor (Ferguson et al, 1988). GPI-
anchored surface proteins are commonly found in other protozoa, in metazoa
and in higher eukaryotes (Ferguson, 1994). GPI anchors act to insulate the
intracellular components from external physicochemical attack as the GPI-
anchored proteins do not possess cytoplasmic domains and therefore do not
interact directly with intracellular components (Ferguson, 1994).
The trypanosome surface coat is susceptible to enzymatic digestion and is
removed by the proteolytic enzyme trypsin (Wright and Hales, 1970; Cross,
1975; Frommel et al, 1988). Electron microscopy studies carried out by Cross
(1975) showed that the surface coat could be unifoimly removed from the
trypanosomes by trypsin treatment without causing any other gross changes in
morphology or affecting trypanosome motility. Trypsin only cleaves peptide
bonds on the carboxyl side of arginine and lysine residues (Stryer, 1988). The
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trypsin-sensitive region of the VSG molecule is the hinge region between the bl¬
and C-terminal domains as shown in the following diagram adapted from
Ferguson and Homans (1989).
domain domain anchor
Schematic representation of Variant Specific Surface Glycoprotein (VSG)
The susceptibility of different trypanosome species and variants to
trypsin digestion is not uniform. In their study on the organisation of variant-
specific surface antigens of Trypanosoma brucei, Cross and Johnson (1976)
found that radiolabeled Concanavalin A (Con A) could bind to the trypanosome
surface after brief trypsinisation. Under the conditions used, binding was
optimal after 12 minutes trypsinisation, when the surface coat was no longer
visible by electron microscopy. After 30 minutes, binding of Con A was
negligible, trypanosome viability was poor and lysis was occurring. However,
Frommel et al (1988) stressed that trypanosomes exposed to trypsin for 60
minutes were still motile and viable, and more than 90% of the variant-specific
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glycoprotein was removed from the surface of all clones of Trypanosoma brucei
brucei, T. b. rhodesiense and T. b. gambiense studied. This could be due to a
difference in the accessibility of trypsin to the target amino acids and to
differences in the density of the surface coat.
Removal of the surface coat of the trypanosomes by protease treatment
was found to abolish the trypanosome infectivity (Cross, 1975). The exposure of
the plasma membrane following removal of the surface coat by trypsin provides
sites for activation of complement by the alternative pathway (Ferrante and
Allison, 1983); when the trypanosomes are covered with C3b, they are
phagocytosed by macrophages (Newton, 1981). The behaviour of trypsin-treated
trypanosomes is similar to uncoated T. congolense culture forms trypanosomes
and procyclic forms of T. congolense and T. brucei which are lysed by normal
human serum while coated blood forms are resistant to serum lysis (Ferrante and
Allison, 1983).
The molecular weight of VSG of most tsetse-transmitted trypanosome
species ranges from 50 to 65 k.Da (Cross, 1975; Cross, 1977; Johnson and
Cross, 1977; Hoeijmakers et al, 1980; Reinwald et al, 1978; Rovis et al, 1978;
Richard et al, 1981; Ross et al, 1987). T. vivax has a reported VSG molecular
weight between 46 and 50 k.Da (de Gee and Rovis, 1981; Gardiner et al, 1987).
The VSG molecular weight of T. evansi clones studied ranged from 45 to 67
k.Da (Cross, 1979; Vervoort et al, 1981; Richards, 1984; Uche, 1989). There
are thus very wide variations in the VSG molecular weight not only between
different trypanosome species, but also between different stocks of the same
species possibly due to different degrees of glycosylation of the different VSG
molecules.
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1. 2. 2. Invariant Surface Antigens:
Although the variant antigens of Salivarian trypanosomes constitute the
major part of the surface, invariant surface antigens have also been reported.
Infected mammalian hosts produce antibodies against minor and invariant
surface antigens (Burgess and Jerrells, 1985; Frommel and Balber, 1987). These
invariant surface antigens, reported mainly in T. brucei, are glycoprotein and
referred to as invariant surface glycoproteins (ISGs); their abundance is said to
be > 100-fold lower than the VSG (Overath et al, 1994). These antigens are
considered to be arranged in between the VSG molecules on the surface of the
parasite. The 145 k.Da and 140 k.Da molecules are invariant surface
glycoproteins which act as receptors for low-density lipoprotein (LDL) which is
required for trypanosome growth (Hide et al, 1989; Coppens et al, 1988;
Coppens et al, 1992; Rolin et al, 1990). Other ISG's function as glucose
transporters (Parsons and Nielsen, 1990; Bringaud and Baltz, 1992). ISGs with
as yet unknown function have been identified and include a 77 k.Da protein
isolated from coated endocytotic vesicles of Trypanosoma brucei (Webster and
Shapiro, 1990). Two invariant surface glycoproteins of 65 and 75 k.Da have
been identified by Ziegelbauer and Overath (1992) in the bloodstream stage of
T. brucei . These particular ISG's having large extracellular domains were
initially thought to be the most abundant surface proteins with the exception of
VSG (Overath et al, 1994). However, with the exception of a weak reaction
with anti-ISG 75 antibodies, in live trypanosomes these ISGs were not
considered to be accessible to antibodies (Ziegelbauer et al, 1992) and are not
involved in protection against reinfection.
1. 2. 3. Non-surface antigens:-
The inherent variability of the trypanosome surface antigens and their
poor potential for diagnosis of trypanosome infection has stimulated a search for
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alternative parasite materials for diagnostic tests. However, little have been done
on the role of internal trypanosome antigens in protection and control of the
disease.
The way in which the host deals with the release of internal antigens after
VSG-specific lysis is not fully examined, but could form an important part of
the response to infection. Once the host has initiated immune-mediated parasite
destruction, a range of non-surface parasite components will be exposed to the
host. It is possible that the type of host response to such individual components
might be important in influencing the final outcome of an infection. Evidence of
the involvement of non-variant immunity comes from studies on T. brucei
infected N'dama and Zebu cattle. Three internal antigens were found to play an
important role in control of the infection by these animals (Shapiro and Murray,
1982). These antigens, with molecular weights of 300, 150 and 110 k.Da, were
recognised more frequently than other antigens. Animals with the capacity to
recognise one or more of these antigens appeared to control parasitaemia better
than those which did not recognise these antigens. Two antigens, a 69 k.Da and
a 33 k.Da proteins from T. congolense have been associated with increased
resistance to infection and elicited an IgGl response in N'dama but not in Zebu
cattle (Authie et al, 1993). Uche (1989) studied antibody response to a number
of non-surface antigens of T. evansi. He showed that the number of
trypanosome antigens recognised by IgG antibodies in rabbits during the period
of primary infection ranged from 16 to 25 components and were dominated by
the response to six major proteins with molecular weights of 94, 85, 75.5, 43,
32.4 and 28.6 k.Da. Animals that responded to a high proportion of these non-
surface antigens during early infection were found to be more resistant to
infection than those which responded to fewer antigenic components of the
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parasite. He concluded that the immune response to non-surface antigens could
be important in determining the outcome of T. evansi infection.
The internal components of the trypanosomes are estimated to constitute
about 90% of the total protein of the bloodstream forms of T. brucei, with the
remaining 10% attributed to the surface coat (Cross, 1990). Roelants and Pinder
(1984) suggested that the internal antigens of tiypanosomes could play an
important role in the pathogenesis of the disease not only by triggering an
immune response after the destruction of the parasite by VSG specific
antibodies but also by the consequential formation of immune complexes . The
deposition in the kidneys of immune complexes formed by the interaction of
internal trypanosome antigens and antibodies, was found to be responsible for
nephritis in infected animals (Boreham and Kimber, 1970; Nagle et al, 1974).
Free internal antigens were also found to contribute to the pathology of the
disease. The highly antigenic enzyme cysteine proteinase of T. cruzi has been
found to contribute to the pathology of the disease by degrading proteins across
a wide range of pH's and by stimulating immune T cells from chronic chagasic
patients resulting in inflammation (Murta et al, 1990).
Many of the non-surface antigens of trypanosomes are non-variable and
stable components across trypanosomes species (De Raadt, 1974). This stability
makes them better prospects as antigens for diagnostic tests than the parasite
VSG. Two T. brucei non-variable antigens recognised early during infection by
different mammalian hosts have been identified and characterised as
microtubule proteins, designated GM6 and MARP1, (Muller et al, 1992). Both
antigens were present in bloodstream and procyclic forms of the parasite.
Moreover probing whole cell extracts of T. evansi, T. congolense, T. rangeli and
T. cruzi with hyperimmune sera raised against these antigens indicated their
presence in all these parasites. This makes them candidates for
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immunodiagnosis of trypanosomal infections at an early stage irrespective of
trypanosome species or serodeme particularly in areas where only one species of
trypanosomes is present.
1. 3. EXTRAVASCULAR TRYPANOSOMES:-
Trypanosomes of the subgenus Trypanozoon are known to inhabit both
vascular and extravascular sites throughout the host (Seed and Effron, 1973;
Seed et al, 1984; Tanner et al, 1980; Turner et al, 1986; Sudarto et al, 1990).
These extravascular trypanosomes were suggested as the source of relapse
populations following remission of the parasitaemic wave (Jennings et al, 1979).
Their presence in tissues also contribute to the pathology of infection due to
local tissue damage (Losos and Ikede, 1972). The presence of degenerated
trypanosomes in the internal organs of infected host (Ormerod and Venkatesan,
1971a; Ormerod and Venkatesan, 1971b, Schmidt and Bafort, 1987) and the
sequential release of the parasite antigens in these tissue may, however, play an
important role in the defence against the infection by forming a continuous
source of stimulation of the immune system.
1. 4. DETECTION OF TRYPANOSOME ANTIGENS:-
Most of the diagnostic assays are directed at detecting trypanosomal
antibodies and are dependent on the availability of specific parasite antigens.
Antigen-trapping assays for the diagnosis of trypanosomal infections have
recently been developed and are dependent on the availability of specific
antibodies. Two types of materials can be used in these assays, blood which
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contains whole trypanosomes, products of lysis, degenerating trypanosomes and
immune complexes. Tissues containing extravascular trypanosomes,
degenerating parasites and depots of immune complexes.
1. 4. 1. Sources Of Antibodies:-
Different types of antibody sources can be utilised for identification and
detection of parasite antigens.
Trypanosomes, being extracellular blood parasites provoke primarily an
antibody response (Urquhart and Holmes, 1987). Infected animals produce
antibodies against both surface and non-surface antigens (Musoke et al, 1981;
Shapiro and Murray, 1982; Uche, 1989). This type of antiserum is a useful
indicator of the parasite antigens that are exposed to the animal during infection.
Antibodies in this type of serum are, however polyspecific, with different levels
of affinity and do not discriminate between individual trypanosome antigens.
Another disadvantage of infection serum is that the response to trypanosome
infection varies not only between different species of animals but also between
animals of the same breed. Some animals respond to a large number of
trypanosome components while others respond to only a few components
(Shapiro and Murray, 1982, Uche, 1989).
Hyperimmune serum to crude extracts of trypanosomes is another type of
antibody source for use in immunoassays. (Tijssen, 1985). This type of sera
often contains high levels of high affinity antibodies (Harlow and Lane, 1988).
Hyperimmune serum contains polyspecific antibodies that do not discriminate
between individual antigens. Moreover, immunising with crude extracts of
trypanosomes may expose parasite components that are not usually antigenic
during the course of infection and do not reflect the parasite components that are
accessible to the immune system during infection.
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Hyperimmune serum to single parasite antigens is a third type of
antibody source for use in immunoassays. Antibodies in this type of serum
contain high proportions of high affinity antibodies. The monospecificity of
these antibodies makes them better reagents for use in immunoassays than those
raised to crude trypanosomes extracts. The high affinity and high detectability
of these polyclonal monospecific antibodies also makes them better reagents in
immunoassays compared to monoclonal antibodies (Tijssen, 1985). However,
there are a number of factors that determine a successful antibody response to
single antigens, these include the nature of the antigen, the degree of purity, its
relative immunogenicity, its physical form and the method and amount of
administration (Tijssen, 1985). Large molecules such as proteins and
polysaccharides are strongly immunogenic, while lipids, steroids and nucleic
acids are weak immunogens (Barriga, 1981, Tijssen, 1985). A high degree of
purity of the antigen is important when highly specific antiserum is required as
in case of immunoassays since the sensitivity of these assays is dependent on the
specific activity of the antibody. Small amounts of an immunodominant
contaminant in the antigen sample may overwhelm the response to the principal
antigen due to antigenic competition (Tijssen, 1985). The physical form of the
antigen is also known to affect the host response; soluble antigens in their native
form are usually poor immunogens while aggregated, polymeric, antigens are
good immunogens (Dresser, 1962).
The fourth type of antibody source for immunoassays is the production of
monoclonal antibodies. Monoclonal antibodies are highly selective reagents that
can be used to identify individual antigens in complex mixtures such as
trypanosomes. Unlike polyclonal mono-specific antibodies, a pure antigen is not
required for immunisation of animals for monoclonal antibody production.
Another advantage of this type of antibody over the polyclonal sera is that the
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hybridoma cells secreting the desired antibody can produce unlimited quantities
of antibodies with defined specificity thus representing a continuous source of
antibody. A disadvantage of the monoclonal antibodies is their lower
detectability in immunoassays compared to polyclonal antibodies due to their
low avidity and the small fraction of high-affinity antibodies among them
(Tijssen, 1985).
1. 4. 2. Separation and purification of antigens:-
Trypanosomes are easily separated from host blood cells by ion-
exchange chromatography (Lanham and Godfrey, 1970) using DE52 cellulose.
Extracts of trypanosomes, for production of antibodies to different components
of the parasite or for identification of the parasite antigens, are usually obtained
by disruption of the parasites by treatment with ultrasound (Brown and
Williamson, 1962), by freezing and thawing (Hughes, 1951; Weitz, 1960;
Johnson et al, 1963) or by ionic and non-ionic detergent lysis (Cardoso de
Almeida and Turner, 1983, Frommel et al, 1988). Protease inhibitors are usually
included in the solublisation medium to block the activation of the endogenous
proteases present in the trypanosomes such as lysosomal cysteine proteinases,
cytosolic alkaline peptidases, acidic proteinases, amino-peptidases and
metalloproteinases (North et al, 1983, Lonsdale-Eccles and Mpimbaza, 1986,
Lonsdale-Eccles and Grant, 1987) released by these solublisation methods.
Trypanosomes consist of a complex mixture of chemical components,
and purification of individual trypanosome antigens from such materials is
usually based on their physicochemical properties. Most of the trypanosomes
antigens described so far are either proteins (Shapiro and Murray, 1982, Muller
et al, 1992, Authie et al, 1993) or glycoproteins (Cross, 1975, Frommel and
Balber, 1987). Most of the work carried out on the purification of trypanosome
antigens has been directed to the variant specific glycoprotein. This is possibly
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due to its high degree of immunogenicity, its role in protecting animals against
reinfection (Wellde et al, 1981, Hall and Esser, 1984) its abundance (it
constitutes 10% of the total trypanosome materials. Cross, 1990) and the relative
ease with which it can be separated from other trypanosome materials.
Purification methods used to purify the VSG molecules involve
chromatographic separation including high performance ion-exchange
chromatography (Clarke et al, 1984) using a packed column of particulate
material consisting of a rigid, polymeric substrate to which charged groups are
bound (fixed charges). Proteins and peptides (mobile ions) will attach to the
fixed charges via ionic interactions. The fractionation is then achieved by
altering the pH or increasing the ionic strength of the medium (Henry, 1989).
Size exclusion chromatography has also been used to purify the VSG (Down et
al, 1991). In this method, molecules in solution are separated according to
differences in their molecular sizes as they pass through a column packed with a
chromatographic medium which is a gel. Large molecules are usually separated
first followed by smaller ones whose passage is delayed by their diffusion into
and out of the gel matrix. Affinity chromatography using lectins (Johnson and
Cross, 1977, Strickler et al, 1978, Reinwald et al, 1979) or antibodies (Pearson
and Anderson, 1980) have also been used in purification methods, however,
different VSG molecules have different affinity for lectins (Johnson and Cross,
1977; Turner, 1982) and antibody-affinity chromatography requires specific
antisera or monoclonal antibodies.
The number and heterogeneity of the non-variant protein antigens of
trypanosomes necessitates the application of different purification methods both
separately and in combination. A relatively simple method for the separation
and purification of protein antigens is by sodium dodecyl sulphate -
polyacrylamide gel electrophoresis (SDS-PAGE) (Harlow and Lane, 1988).
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Although this method involves denaturation and may lead to changes in epitope
conformation, SDS-denatured antigens usually retain their antigenicity and elicit
strong antibody responses (Lazarides and Weber, 1974, Stumph et al, 1974).
This method of purification of antigens has been used to analyse the response to
antigens from a wide range of organisms (Strauss et al, 1975, Carrol et al, 1978,
Boulard and Lecroisey, 1982). An important part of using SDS-PAGE
purification of antigens is the efficient localisation of the target antigen in the
gel therefore avoiding extensive fixation and denaturation of the antigen that can
be caused by the staining procedure. Localisation methods include the use of a
stained reference lane to localise the band of interest in the rest of the gel.
Misalignment of the reference lane and the rest of the gel can, however, result in
contamination of the chosen antigen Alternatively the whole gel can be stained
with a light stain such as Coomassie blue, sodium acetate or copper chloride to
locate the target antigen. This method permits the separation of a single protein
band with a minimum risk of contamination by nearby protein bands. The
excised gel slice containing the target antigen can then be fragmented by
repeated passage through a syringe and injected into animals for production of
antibodies (Strauss et al, 1975, Boulard and Lecroisey, 1982). Fragmentation,
however, depends on the concentration of acrylamide and thickness of the gel as
thick gels are difficult to fragment. Alternatively, proteins trapped in
polyacrylamide gel can be electro-eluted from the polyacrylamide and used for
immunisations (Harlow and Lane, 1988). An advantage of this method is that,
the concentration of the eluted protein can be measured and the antigen can be
incorporated with an adjuvant before injection into animals.
1. 4. 3. Identification of antigenic components of trypanosomes:-
The development of SDS-PAGE, (Laemmli, 1970) provided a powerful
method of resolving and analysing protein mixtures such as trypanosomal
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material. Shapiro and Murray used SDS-PAGE in combination with immuno-
precipitation to assess the humoral response to T. brucei infection in cattle. The
fractionation of proteins by SDS-PAGE is based on the molecular size of the
polypeptide chain of each component. The treatment of the parasite materials
with an ionic detergent such as SDS will lead to the binding of large amounts of
this highly charged detergent molecule (Reynolds and Tanford, 1970) which is
sufficient to effectively overwhelm the intrinsic charges on the polypeptide
chain so that the net charge per unit mass becomes approximately constant. The
migration of proteins is therefore proportional to their molecular weight. The
separated constituents can be visualised easily with protein stains such as
Coomassie Blue. The antigenic identification of components with specific
antibodies, however, is not easy to perform directly on the polyacrylamide gel,
since macromolecules buried within the gel matrix have different accessibility to
reagents. This is particularly important when gradient gels are used, since
different parts of the gel have different porosities (Andrews, 1988). These
problems are overcome by transfering the separated proteins to a solid matrix
such as nitrocellulose (NC) to which they bind and are immobilised before they
can be probed for antigenicity. The process of transferring separated proteins
and nucleic acids from gels to a solid matrix is referred to as "blotting". The
most widely used transfer method is the one employing electrophoretic transfer
of proteins to NC which is commonly referred to as "western blotting" (Towbiri
et al, 1979; Burnette, 1981) or electroblotting.
There are several different types of immobilising matrix used for blotting
such as diazobenzyloxymethyl paper(DBM), diazophenylthioether (DPT),
nylon-based membranes and NC. The activated papers (diazo groups) covalently
bind proteins and have good mechanical strength, but the coupling method is
incompatible with many gel electrophoresis systems since the linkage is through
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primary amine groupings. They are also expensive and the reactive groups have
a limited half-life. Nylon has excellent mechanical strength and does not shrink
by washing or drying, but it can only bind to a small amount of protein and is
therefore not suitable for most applications (Harlow and Lane, 1988). The most
commonly used material is NC which has a protein binding capacity of 80 - 100
fig/cm^. Although the mechanism of protein binding to NC is not well
understood, it is thought to involve hydrophobic interactions (Andrews, 1988)
Western blotting has been used extensively for the study of parasite
systems including several species of trypanosomes. Cardoso de Almeida and
Turner (1983) used the technique to investigate the properties of the membrane
form variant surface glycoprotein of T. brucei, while Gardiner el al (1987) used
it for the identification and isolation of T. vivax VSG. The technique was also
used to determine the molecular nature of invariant antigens in T. brucei
rhodesiense (Burgess and Jerrells, 1985) and the presence of glycoproteins in T.
brucei using lectin blotting (Frommel and Balber, 1987). Uche (1989) used the
technique to study antibody responses to T. evansi antigens in experimentally
infected rabbits.
1. 4. 4. Assay for antigens in the host:-
Soluble trypanosome antigens circulating in body fluids of infected
animals have been detected using enzyme linked immunosorbent assay, ELISA,
(Rae and Luckins, 1984; Nantulya et al, 1989, Olaho-Mukani et al, 1989;
Masake and Nantulya, 1991, El Amin et al, 1993, Olaho-Mukani et al, 1993,
Sinyangwe and Munyama, 1993). The assay offers many advantages over other
immunoassays in terms of speed, sensitivity, convenience, simplicity and
reliability. The test is based essentially on two fundamental steps, the
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immunological reaction between the antibody and antigen and the enzymatic
indicator reaction to demonstrate the presence or absence of antibody-antigen
reactions (Kurstak, 1985).
Competitive and non-competitive assays can be used to detect the soluble
antigens in the test sample. Competitive assays are based on the competition of
the test antigen with a standard amount of enzyme-labelled antigen for the
immobilised antibody (WHO, 1976). The decrease in staining indicates the
presence of antigen in the test sample. The non-competitive assay or double
antibody sandwich method is the most popular method, however, it depends on
the antigen having at least two epitopes (Tijssen, 1985). In this method the
antibody is immobilised on the solid matrix followed by incubation with the test
sample containing the antigen and the reaction is then detected by the addition
of the primary antibody labelled to an enzyme. The detectability of this method
for the detection of antigen or antibody can be improved by use of bridge
methods, in which the captured antigen or antibody is detected by
nonimmunologic methods such as linked avidin-biotin system (LAB) (Kurstak,
1985). In this modification the bound antigen or antibody is reacted with a
biotinylated secondaiy antibody directed against the bound molecule and the
complex is then detected by the addition of avidin-enzyme conjugate (Figure
1.1).
Of the factors influencing the performance of solid-phase enzyme
immunoassays, the solid matrix, the quality of antibodies and antibody-
conjugate are the most important (Tijssen, 1985, Kemeny, 1992). The choice of
the solid matrix or carrier depends on the purity of the coating material, the
presence or absence of non-specific binding and the sample concentrations
which have to be assayed (Kemeny, 1992). Two types of carriers can be used
based on their capacity to bind proteins. High capacity carriers such as cellulose
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Figure 1.1.









and nitrocellulose are stable and can be stored for long periods after being
coated. They are particularly suitable for impure coating materials such as crude
extracts. However, they are difficult to wash and give higher background
binding compared to low capacity carriers. Low capacity earners such as plastic
are most commonly used in ELISA, they are easy to wash and produce low
background binding (Kemeny, 1992). 96-well polystyrene microtitre plates
(Voller and Bidwell, 1975) are the most commonly used plastic carriers in
ELISA. They are easy to handle and multiple samples can be tested per plate.
High affinity antibodies are usually required in immunoassays because they bind
large amounts of antigen and consequently produce a strong signal in a short
period of time (Harlow and Lane, 1988). Low affinity-antibodies bind only a
small proportion of the antigen and therefore require a proportionately longer
period of time to develop a detectable signal. The affinity of the antibody also
has an effect on the avidity of the antigen-antibody complex because antibodies
with a high affinity increase the stability of the antigen-antibody complex during
washing steps (Tijssen, 1985), therefore increasing the final signal strength. As
in the case of unlabelled antibody, the specificity of the labelled preparation is
also important.
The development of immunohistochemical techniques has facilitated the
identification and localisation of the antigens in the tissues.
Immunofluorescence as a method of detecting antigens in tissues has
increasingly been replaced by enzyme immunoassays (Tijssen, 1985). The
properties of the enzymes made much more sensitive modifications possible,
such as the peroxidase-anti-peroxidase (PAP) method and avidin-biotin-
peroxidase complex. Enzyme immunoassays have been successfully applied for
the detection and localisation of antigens in cells or tissues (Naritoku and
Taylor, 1982, Mwangi et al, 1990, Sudarto, et al, 1990). Paraffin sections from
21
fixed tissues or cryostat sections of frozen, fresh or fixed tissues are usually
used in such tests (Tijssen, 1985, Harlow and lane, 1988). Although both
sections have been successfully used, paraffin sections did not preserve many
antigens (Tijssen, 1985). While cryostat sections are reputed to preserve
antigens and cell structures (Harlow and Lane, 1988) the diffusion of soluble
antigens will decrease their detectability. The tissues are usually fixed to avoid
structural decomposition and to reduce the diffusion of soluble antigens
However, depending on their chemical composition antigens may be extracted
or denatured by fixative agents such as methanol or acetone which are suitable
for large proteins (Tijssen, 1985).
1. 5. ANTIGEN DYNAMICS DURING INFECTION:-
Typically the recognition of any antigenic substance, either free m
solution or constituting part of a more complex structure begins with its
phagocytosis and processing by antigen-presenting cells (Barriga, 1981). In
trypanosomes, however, phagocytosis is antibody-dependent as revealed by both
in vitro and in vivo studies. T. brucei and T. gambiense were found to attach and
be ingested by macrophages in vitro in the presence of immune serum (Lumsden
and Herbert, 1967; Takayanagi et al, 1987). MacAskill et al (1980) evaluated
the process of phagocytosis in the absence of antibody and found that,
suppression of antibody production by prior irradiation, at a level which did not
impair phagocytic function, abolished the ability of infected and treated mice to
remove high levels of radiolabeled T. brucei. In vivo studies using 75Se-labelled
T. brucei also showed that, while labelled parasites remained in the blood of
normal mice, they were rapidly removed from the circulation of immune mice
mainly through hepatic uptake (Holmes et al, 1979). Moreover the antigen-
presenting cells particularly macrophages have been shown to play no role in the
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response to trypanosomiasis. Paulnock et al (1988) observed a significant
reduction in the proliferative response by T cells when macrophages from T.
rhodesiense infected mice were used as antigen-presenting cells, although these
cells were capable of processing and presenting heterologous antigen.
The initial response in trypanosome-infected animals involves IgM
antibodies specific to variant surface antigens (VSG), this response is later
dominated by an IgG response. The protective immunity to trypanosomes is
mainly antibody-mediated rather than cell-mediated immunity. Protection
against homologous T. brucei infection in mice can be achieved through transfer
of immune serum or by transfer of B lymphocyte enriched fractions of spleen
cells (Takayanagi and Enriquez, 1973; Takayanagi and Nakatake, 1975;
Campbell and Phillips, 1976; Seed, 1977). A strong correlation between
protection and the level of neutralising antibodies has been demonstrated in
cattle immunised with irradiated whole T. brucei trypanosomes (Morrison et al,
1982) or with T. brucei purified VSG (Wells et al, 1982). In vitro studies
showed that VSG-specific antibodies -are capable of causing various forms of
damage to trypanosomes including trypanolysis (Shakibaei and Frevert, 1992),
decrease in respiratory rate (Desowitz, 1956), agglutination (Cunningham and
Vickerman, 1962; Takayanagi et al, 1991a; Takayanagi et al, 1991b;
Takayanagi et al, 1992a; Takayanagi et al, 1992b), and opsonisation (Lumsden
and Herbert, 1967).
Most of the information on the host-parasite interaction is based only on
the behaviour of the whole parasites. The dynamic aspects and the fate of
individual trypanosome components during infection are, however, not well
understood. Information on these aspects might provide better insight into host-
parasite interaction acting as indicators of infection, progress of the disease and
effectiveness of chemotherapy. Most of the information on the dynamics of
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trypanosome antigens during infection has come from studies designed to
produce diagnostic tests based on antigen detection. In developing an antigen-
ELISA for the diagnosis of bovine trypanosomiasis using monoclonal antibodies
specific to the plasma membrane antigen of procyclic trypanosomes, Nantulya
and Lindqvist (1989) reported variations in the antigen dynamics of different
trypanosomes species. T. vivax and T. congolense antigens were detected as
early as 10 to 12 days following tsetse challenge, while T. brucei antigens were
detectable between 8 and 14 days post-infection. Following treatment, T. vivax
and T. congolense antigens disappeared from circulation within two weeks but
the rate of T. brucei antigens was slower compared to that of the other two
species. The appearance of these antigens and their rate of clearance from blood
is also influenced by the species of infected host. Using the above brucei-group-
specific monoclonal antibody El Amin et al (1993) in evaluating antigen-ELISA
for the diagnosis of T. evansi infections in camels and goats detected the antigen
as early as 2 - 4 days post-infection in camels. In goats the antigenaemia was
detectable 7 days after infection. Following treatment of camels with Trypacide
the antigenaemia dropped within two weeks of treatment until disappeared from
circulation 35 days later.
Investigations in this study were aimed at the identification and antigenic
characterisation of individual components of T. evansi which acted as antigens
during infection. The dynamics of some of these antigens was studied during the
course of infections in mice and rats.
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CHAPTER TWO
GENERAL MATERIALS AND METHODS
This chapter includes methods used in more than one area of the study.
2. 1. TRYPANOSOMAS
Two stocks of Trypanosoma evansi originally isolated from naturally
infected buffaloes from Indonesia were used - one population of BAKIT 374
and two variants of BAKIT 259A. The passage and isolation history of these
populations is presented in Figure 2. 1.
2.2 EXPERIMENTAL ANIMALS
2. 2. 1. Mice:
The mice used for expansion of trypanosomes were female random bred
albino white mice "TO" (A. Tuck & sons, England) weighing 20-30 g.
2. 2. 2. Rabbits:
The rabbits used for the production of infection serum and polyclonal
antibodies against T. evansi materials were female adult New Zealand White
rabbits (Hyline Commercial Rabbits, England) weighing between 2 - 2.5 Kg.
2. 3. SEPARATION OF TRYPANOSOMES FROM HOST BLOOD:
Cryopreserved trypanosomes were grown in mice until fulminating
infection developed. The mice were exsanguinated by cardiac puncture under
general anaesthesia and blood collected into a 1 ml syringe containing 10 i.u. of
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heparin in 0.1 ml of phosphate buffered saline ( PBS ) ( Appendix 1 ).
Trypanosomes were then separated from host blood cells by ion-exchange
chromatography on DEAE cellulose ( DE52, Whatman Biochemical UK.) as
described by Lanham and Godfrey (1970). The separated trypanosomes were
washed three times in phosphate buffered saline glucose (PSG) pH 8.0
(Appendix 2 ) by centrifugation at 2650g for 20 minutes at 4°C.
2. 4. ESTIMATION OF TRYPANOSOMES CONCENTRATION:.
The concentration of the trypanosomes used for infection was determined
by counting the parasites in a haemocytometer slide (Neubauer, Improved
Double Ruling Weber, UK). Five p.1 of a trypanosome suspension diluted to
1/1000 in PSG was carefully transferred to the haemocytometer slide by
touching a pipette tip onto the coverslip edge. Using a microscope (x 400
magnification, Leitz Wetzlar Laber-Lux, Germany) the number of trypanosomes
in 16 small squares (one large square) were counted. All trypanosomes touching
the left and upper borders were included. The total number of trypanosomes in
the four large corner squares was determined and the mean calculated. The
number of trypanosomes per ml was determined using the following
formula:Trypanosomes / ml = mean no. of trypanosomes in the 4 squares x 10^ x dilution
factor
2. 5. ROUTINE MONITORING FOR TRYPANOSOMES:
Tail blood from mice or blood from rabbit ear vein was examined to
monitor the progress of infection in infected animals. The blood was examined
microscopically (20 microscopic fields at x 400 magnification) either as a wet
blood smear on a slide (Baker, 1970) or using the microhaematocrit
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centrifugation technique (MHCT) (Woo, 1970). For the MHCT the heparinised
glass capillary tubes containing the centrifuged blood were cut at the buffy coat
area using a diamond pencil. The cut ends of the capillary tube were then
touched on a microscope slide to expel the contents of the buffy coat as well as
the plasma and erythrocyte areas adjacent to the buffy coat.
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Figure 2. 1
The history of T. evansi trypanosomes stocks
T. evansi stock Bakit 259A
trypanosomes isolated from a buffalo
from RIVS in Bogor, Indonesia, 1985
3Z
3 days passage through mice
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T. evansi stock Bakit 374
trypanosomes isolated from
a buffalo in Semarang, Central
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conducted in a vertical gel tank apparatus containing electrode buffer, pH 8.3
(25 mM tris, 0.192 M glycine, 0.1% SDS, Appendix 4) in both top and bottom
reservoirs. 50 pi of sample per well and one well of 20 pi of proteins of known
molecular weights (Low molecular weight markers , Pharmacia) were loaded
onto each gel. The sample separation was carried out at room temperature,
initially with a constant voltage of 150V for one hour, then at constant 100V
overnight. After electrophoresis gels were removed for protein detection from
the glass plates and stained with Coomassie Brilliant Blue R-250 (Sigma Ltd.,
UK.) by immersing the gels in 0. l%(w/v) Coomassie Brilliant Blue in destain
solution (Appendix 5) at room temperature with gentle shaking for 60 minutes.
The gels were then destained with destain solution up to 2 hours or until the
background cleared. A calibration curve based on the molecular weight markers
was constructed and used to calculate the molecular weight of individual
trypanosome proteins. For permanent records the gels were rinsed in distilled
water and photographed on a Polaroid film (Type 55; 4x5 inches; Sigma Ltd.
UK.) with Polaroid camera (MP.4 Land camera) using a 35 Kodak Wratten
gelatin filter.
2. 7. 1. Electrophoretic transfer of T. evansi proteins to nitrocellulose membrane:
The unstained gel containing T. evansi proteins separated by SDS-PAGE
was soaked in transfer buffer (Appendix 6) and laid on two pieces of filter paper
(6 gin pore size, Whatman) pre-soaked in the transfer buffer and laid on top of
the anode plate of a Sartoblot^- II-S semi-diy electroblotter (Sartorius Ltd.,
Germany). A nitrocellulose membrane (0.45 pm pore size, Sartorius Ltd.,
Germany) previously cut to the size of the gel and soaked in transfer buffer was
then laid on top of the gel and again covered by two soaked filter paper at the
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cathode side. Electrophoretic transfer to nitrocellulose membrane was conducted
for 90 minutes at room temperature with a constant current of 0.8 mA per cm^
of gel.
Detection of the antigenic components of T. evansi on nitrocellulose membrane:
Following the transfer of T. evansi proteins onto nitrocellulose
membrane, the membrane was transferred into a sandwich box and the excess
protein binding sites blocked in 5% dried milk (Marvel, Premier beverages,
Stafford, UK) in blocking buffer, pH 7.4 (Appendix 7) overnight with gentle
shaking. The blocked membrane was rinsed with PBS and incubated overnight
with the appropriate dilution of T. evansi antibodies in blocking buffer at room
temperature. The unbound antibodies were then removed by washing the
membrane with 7 changes of PBS over a period of 2 hours, before a peroxidase-
labelled, donkey anti-rabbit IgG (Scottish Antibody Production Unit, Carluke,
Lanarkshire) diluted to 1/500 in blocking buffer or goat anti-mouse IgG (Pierce,
USA) diluted to 1/2500 was added and incubated for 2 hours. After washing the
membrane in PBS as above to remove excess conjugates, the labelled
antigen/antibody complexes were visualised by incubation in 4-chloro-l-a-
naphthol substrate solution, pH 7.5 (Sigma Ltd., UK.) (Appendix 8). Colour
development was allowed to occur over 20 - 30 minutes, and the reaction was
stopped by washing in distilled water and permanent records made by
photography.
2. 7. 2. Elution of proteins from polyacrylamide gels:
T. evansi proteins were eluted from Coomassie stained SDS-PAGE gels
using an electro-eluter (Model 422 Electro-Eluter, Bio-Rad, USA) according to
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the manufacturers instructions. Dialysis membrane caps, molecular weight cut
off of 3,500 daltons, were soaked at 60°C in elution buffer (Appendix 4) for one
hour. Glass tubes with frits in their bottom were placed into the electro-eluter
module. The pre-wetted membrane caps were placed in bottom of silicone
adapters. The adapters were then filled with elution buffer and slid onto the
bottom of the glass tubes. Each tube was then filled with elution buffer and the
gel slice containing an appropriate protein component was placed in each tube.
The entire module was then placed in the buffer chamber of the equipment
which was then filled with elution buffer, the level of which covers the silicone
adapters. The upper buffer chamber was also filled with elution buffer and a stir
bar was placed in the bottom buffer tank to prevent bubbles from sticking to the
bottom of the dialysis membranes. Elution was performed at 10 mA per glass
tube for 5 hours. For recovery of the eluted protein, the glass tubes were
removed from the apparatus and the elution buffer in the tubes removed to the
level of the frit using a plastic pipette and the liquid was discarded. The silicone
adaptor together with the membrane cap containing approximately 400 pi of the
eluted protein were then removed from the bottom of the glass tube and the
protein was collected into a microcentrifuge tube using a plastic pipette. The
membrane was rinsed with a further 200 pi of fresh elution buffer and added to
the content in the microcentrifuge tube and stored at -20°C until needed.
2. 8. ENZYME-LINKED IMMUNOSORBENT ASSAY
(ANTIBODY-ELISA) FOR T. EVANSI ANTIBODIES:
This assay was used to monitor T. evansi antibodies in rabbits and to test
the reaction with monoclonal antibodies to the soluble materials of the parasite.
ELISA microtitre plates (Immulon 1, Dynatech, USA) were coated with T.
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evansi soluble materials diluted in carbonate / bicarbonate buffer, pH 9.6
(ELISA coating buffer, Appendix 9). 100 pi of the diluted T. evansi antigen was
dispensed into each well and the plates were then incubated overnight at 4°C.
Unadsorbed antigen was washed out of the wells with 3x1 minute washing
cycles with PBS/Tween, pH 7.4 (Appendix 10) using an automatic ELISA
washing machine (Dynatech). Antibody samples were diluted in PBS/Tween to
the required range and 100 pi aliquots dispensed into the appropriate wells of
the antigen coated plates. The plates were incubated at 37°C in a Varishaker-
Incubator (Dynatech) for 30 minutes and the unbound antibodies removed by
washing in PBS/Tween as described above. A peroxidase-labelled donkey anti-
rabbit IgG (Scottish Antibody Production Unit) or goat anti-mouse IgG (Pierce,
USA) was diluted in PBS/Tween to the appropriate concentration and 100 pi
aliquots dispensed into each well of the microtitre plates. The plates were
incubated at 37°C for 30 minutes and the unbound conjugate removed by
washing in PBS/Tween as above. The enzyme labelled immunoglobulin
complexes were then visualised by adding 100 pi / well of 3,3',5,5-
Tetramethylbenzidine dihydrochloride (TMB substrate, Sigma Ltd. UK.) in 0.05
M phosphate-citrate buffer, pH 5.0, containing 0.03% (w/v) sodium perborate
and the plates incubated at 37°C for 15 minutes. The reaction was stopped by
adding 50 pi 2M sulphuric acid to each well and the absorbance of each well
was then measured photometrically at 450 nm using an ELISA plate reading
photometer (MultiskanR Plus, Labsystems, Finland).
2. 9. AGGLUTINATION TEST:
This test was used to examine the agglutinating ability of the T. evansi
polyclonal monospecific antibodies and monoclonal antibodies. Terasaki pattern
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microplates (Nunc HLA plates, 60x10 PS SH, Inter Med, Denmark) were
flooded with approximately 5 ml of mineral oil (light white oil, Sigma chemical
company, St. Louis, USA). A 2-fold dilution range from 1/2 to 1/1024 of serum
in borate buffer, pH 8.0 (Appendix 11) were made in a 96-well microtitre plate
and 2 pi were dispensed into the appropriate wells of the Terasaki microplates.
2 pi of borate buffer were also added to one of the wells as negative control, and
the plates were incubated overnight at 4°C. Using a repeating dispenser, PB-
600-1, (Hamilton Company, Reno, Nevada, USA) 2 pi of cryopreserved
trypanosome population diluted 1/5 in borate buffer were added to each well
and incubated for 30 minutes at 37°C. The plates were examined for
agglutination by dark illumination with xlO objective and xlO Periplan
eyepiece.
2. 10. INDIRECT FLUORESCENT ANTIBODY TEST:
2. 10. 1. Formalin-fixed trypanosomes:
The method of Nantulya and Doyle (1977) was used in which 0.1 ml of
freshly collected parasitaemic blood in microcentrifuge tubes was added to 0.9
ml of 1% formalin in PBS, and then incubated for 3 hours at 4°C with
occasional agitation. The fixed tiypanosomes were then centrifuged at 350 g for
10 minutes at 4°C. The supernatant discarded and pelleted trypanosomes were
resuspended and washed twice in PBS by centrifugation at 350 g for 10 minutes
at 4°C. Finally the trypanosomes were resuspended in 50 pi of heat inactivated
foetal calf serum and thin smears were made on microscopic slides, air dried at
room temperature for 10 to 15 minutes and reaction zones were made on the
slides by a ball point paint marker (TEXPEN^-, Mark Tex Corp. USA). The
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slides were wrapped in tissue papers, sealed in plastic bags and stored at 4°C in
the presence of silica gel, as a desicating agent, until needed.
2. 10. 2. Acetone-fixed trypanosomes:
The method of Masterson et al (1988) was used in which thin smears of
T. evansi infected blood on microscopic slides were air dried and fixed first by
immersion in methanol for 6 minutes at - 20°C and then in acetone for 30
seconds at - 20°C. They were then washed by immersion in PBS for 5 minutes
at room temperature, air dried and stored as above until needed.
2. 10. 3. Immunofluorescent Antibody Staining Procedure:
The stored slides were left to warm up at room temperature for 15
minutes before undiluted hybridoma culture supernatants or test sera at the
appropriate dilution in PBS were added to the reaction zones. Positive and
negative control serum and PBS were also included in each slide. 50 pi of each
antibody solution were added to each reaction zone and the slides were
incubated for 20 minutes at room temperature in a humid chamber. The
unbound test reagents were washed off with a stream of PBS and the slides were
immersed in PBS for 5 minutes and then in fresh PBS for a further 20 minutes.
The slide edges were dried with tissue paper before 50 pi of fluorescein
isothiocyanate (FITC)-labelled sheep anti-mouse IgG (The Binding Site Ltd,
Birmingham, UK.) or FITC-labelled donkey anti-rabbit IgG (Scottish Antibody
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Production Unit) was added to each reaction zone and allowed to react for
another 20 minutes. The slides were washed as before and mounted in 50%
glycerol in tris-saline, pH 9.0 for microscopy. The preparations were examined
using a Diaplan fluorescence microscope with the x40 NPL fluorescence phase
contrast oil objective and xlO Periplan GF eyepiece. The filter combinations
used were a (2 x KP490 and 1 mm GG 455) excitation filter, a TK510 dichroic




OF TRYPANOSOMA EVANSI (TREU 2165)
COMPONENTS RELEASED DURING THE
COURSE OF INFECTION AND PHYSICAL
DISRUPTION
3. 1. INTRODUCTION:
Experiments in this Chapter were aimed at identifying suitable methods
for the separation of the individual Trypanosoma evansi components and their
antigenic characterisation as a preliminary step in identifying candidates for
studies on the dynamics of these components during infection.
Most of the studies carried out on trypanosomal antigens ( reviewed in
Turner, 1982, Cross, 1990) have concentrated on the variable glycoprotein
coat of the parasites probably due to its high degree of immunogenicity
(Urquhart and Holmes, 1987), its role in protecting animals against reinfection
(Wellde et al, 1981, Hall and Esser, 1984), its abundance (Cross, 1990) and
the ease with which it can be purified from other parasite components (Cross,
1975, Strickler, et al, 1978, Reinwald et al, 1979, Clarke et al, 1984, Down et
al, 1991).
To date little attention had been paid to the identification and
characterisation of the non-surface antigens in the Trypanozoon, particularly in
T. evansi. Uche (1989) studied antibody responses to both surface and non-
surface antigens of T. evansi using a combination of SDS-PAGE and
immunoblotting with serum from experimentally infected rabbits. He reported
thirty soluble protein components as visualised by Coomassie Blue staining, of
which 25 components were recognised as antigens by IgG antibodies in serum
collected from infected rabbits. An association between trypanotolerance and
invariant antigens was investigated by Shapiro and Murray (1982) who studied
the immune response to T. bracei non-surface antigens in trypanotolerant
N'dama and susceptible Zebu cattle during the course of infection using
immuno-precipitation and SDS-PAGE. Eight antigens with molecular weights
ranging from 300 k.Da to 20 k.Da were identified using these techniques.
Animals that exhibited a capacity to control the disease responded to at least
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one of three specific antigens of molecular weight of 110, 150, and 300 k.Da;
the N'dama responded to more of these three antigens than did the Zebu.
Animals that died of infection did not respond to any of the three specific
antigens.
Results of previous studies indicate that the antigenic components of
trypanosomes consist of a complex mixture of substances, with those
identified so far being proteins or glycoprotein (Cross, 1975, Frommel and
Balber, 1987, Muller et al, 1992, Authie et al, 1993). Most membranes
including those of trypanosomes contain glycosylated molecules in which the
carbohydrate is bound to protein (glycoprotein) or lipid (glycolipid). These
glycoproteins and glycolipids often function as surface receptors or antigens.
The trypanosomatidae contain a surface layer outside the cell membrane
composed entirely of glycosylphosphatidylinositols (GPI) (Low, 1989, Cross,
1990b). These GPI molecules function as membrane anchors for a diverse
group of proteins including the variant surface antigen of the trypanosomes
(Ferguson et al, 1988). They probably comprise the major glycolipid class in
the Trypanosomatidae and the molecules associated with them are involved in
parasite infectivity and survival. In order to study the individual parasite
components it is necessary to break the whole organism down into individual
components. Numerous solubilisation methods have been used to break down
complex biological stinctures into simpler components that might be studied
more easily. Techniques include freeze-thawing, sonication, freeze-fracture,
ionic and non-ionic detergent lysis with one of several detergents such as tritori
X-100, triton X-l 14, nonidet and sodium dodecyl sulphate.
All these solubilisation methods will result in the release or activation
of the endogenous proteases present in the Trypanosomatidae which include
lysosomal cysteine proteinases, cytosolic alkaline peptidases, acidic
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proteinases, amino-peptidases and metalloproteinases ( Lonsdale-Eccles and
Grant, 1987; North et al., 1983; Lonsdale-Eccles and Mpimbaza, 1986). The
presence of these proteinases in lysates or extracts of trypanosomatidae can be
controlled by including one or a number of inhibitors in the solubilisation
medium. Solubilising intact trypanosomes can be effectively accomplished by
boiling a suspension of trypanosomes in the presence of a reducing agent such
as dithiothreitol or mercaptoethanol, and a 1% solution of SDS. This
effectively solubilises both amphiphylic and hydrophylic molecules and
boiling destroys protease activity. Proteins solubilised by this technique
remain antigenic when tested by immunoblotting (Cardoso de Almeida and
Turner, 1983, Frommel et al, 1988).
Experiments in this chapter were designed to compare two ways of
extracting trypanosomal molecules, soluble materials produced by freeze-
thawing trypanosomes and materials produced by boiling trypanosomes in the
presence of SDS, which were evaluated by electrophoresis on polyacrylamide
gels and also to examine the proteins in the trypanosomes after in situ
trypsinisation to characterise their surface proteins as trypsin has been shown
to remove the major surface VSG. The antigenicity of the parasite components
was investigated against a range of serum from infected animals and animals
immunised with T.evansi crude soluble materials.
3. 2. MATERIALS AND METIIODS:-
3. 2. 1. Trypanosomes:
The history of the trypanosome TREU 2165 used in this study has been
described in section 2.1.
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3. 2. 2. Trypsinisation of Trypanosoma evansi:
Optimisation.
The effect of trypsinisation on T. evansi was investigated over a series
of incubation periods of 15, 30, 45, 60, 75, 90, 105 and 120 minutes. To each
of 8 samples containing 1x10** trypanosomes in 1 ml PSG 20 pi of trypsin at a
concentration of 5 mg/ml (Sigma Ltd., U.K.) was added and the tubes mixed
by vortexing. Each tube was then incubated at 37°C for the appropriate time
period. At the end of the incubation period a drop was removed from each tube
and examined microscopically (x400 magnification) for trypanosome motility.
To all tubes containing viable trypanosomes after trypsin treatment, 20 pi of
trypsin inhibitor at a concentration of 5 mg/ml in distilled water (Sigma Ltd.,
U.K.) was added and the mixture incubated for a further 5 minutes at 37°C.
The trypanosomes in each tube were then washed by centrifugation at 5000 g
for 5 minutes in PSG. For each tube, the pellet of trypanosomes was
resuspended in 0.5 ml PSG and inoculated each into a single mouse.
Parasitaemia was monitored daily for up to 40 days using wet film
preparations as described in section 2.5. The microhaematocrit centrifugation
technique was also used to monitor the parasitaemia eveiy three days.
Electron microscopy of trypsinised trypanosomes:
Intact trypanosomes and trypanosomes after being incubated with
trypsin for 75 minutes and the trypsin neutralised with trypsin inhibitor, were
fixed for 2.5 hours using 3% gluteraldehyde in 0.1M sodium cacodylate buffer
pH 7.3 (Appendix 13). The trypanosomes were then washed in 0.1M sodium
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cacodylate buffer by centrifugation at 2500 r.p.m. over 20 minutes with the
buffer changed 3 times. They were then post-fixed in 1% osmium tetroxide in
0.1M cacodylate buffer for 45 minutes and washed in distilled water by
centrifugation at 2500 r.p.m. over 20 minutes with the water changed 3 times.
The trypanosomes were then dehydrated 1x10 minutes each in 50%, 70% and
90% acetone and 3 times 10 minutes in 100% acetone. They were then
infiltrated with a 50:50 (v/v) araldite mix : Analar acetone (BDH,
Leicestershire, U.K) for 30 minutes at room temperature, centrifuged at 2500
r.p.m. for 4 minutes and then infiltrated with the same mixture overnight at
60°C and centrifuged as before. Further infiltration was carried out 3x1 hour
with araldite mix alone followed by two changes of araldite mix and
accelerator ( 19:1, v/v) for one hour per infiltration. Finally trypanosomes
were embedded in a 19:1 (v/v) araldite mix : accelerator for 48 hours at 60°C.
Sixty nm thick sections of trypanosomes were cut on a diamond knife
with a Reichert OMU4 Ultramicrotome and mounted on 200 mesh copper
grids. The sections were stained for 30 minutes in saturated uranyl acetate in
50% ethanol and then for 5 minutes in 2.76% lead citrate, pH 12.0 (Reynolds,
1963). Stained sections were viewed and photographed using a Philip 400
transmission electron microscope (x 100000 magnification) at 100 KV.
3. 2. 3. T. evansi Soluble extract:
2.2 x lO^ DEAE column separated tiypanosomes of TREU 2165 were
prepared as described in section 2.3. The separated trypanosomes were washed
three times by centrifugation at 2650g for 20 minutes at 4°C with phosphate
buffered saline glucose (PSG) pH 8.0 ( Appendix 2 ). After the final wash the
trypanosome pellet was resuspended in an equal volume of PSG and then
subjected to three cycles of freezing to -80°C for 10 minutes followed by
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thawing to room temperature for 10 minutes. The lysate was then centrifuged
at lOOOOg for 45 minutes at 4°C using a Biofuge 17 RS centrifuge (Heraeus
Sepatech, Essex, UK). The supernatant was removed and the protein
concentration determined using the BCA^ technique according to
manufacturer's instructions (Pierce Chemical Company, USA). The
trypanosome soluble extract was aliquoted into 100 pi volumes and stored at -
20°C until needed.
The trypanosome soluble extract prepared as described above was
diluted 1:3 with SDS-sample buffer (Appendix 12) and heated to 100°C for 5
minutes. After cooling and centrifugation at 10000 g for 5 minutes, the sample
was aliquoted into 200 pi volumes and stored at -20°C until required.
Immediately before use the samples were heated again to 100°C for 3 minutes
to redissolve any crystallised SDS and centrifuged as described above.
3. 2. 4. Whole trypanosome extract:
2.2x10^ of washed trypanosomes collected from the DE52 column as
above were diluted with an equal volume of SDS-sample buffer and heated to
100°C for 5 minutes. After cooling to room temperature and centrifugation at
10000 g for 5 minutes, the materials were aliquoted into 200 pi volumes and
stored at -20°C until required. Immediately before use the samples were
heated to 100°C for 3 minutes to redissolve any crystallised SDS.
3. 2. 5. Whole cell extract of trypsinised trypanosomes:
2.2x10^ trypanosomes after being incubated with trypsin for 75 minutes
and the trypsin neutralised with trypsin inhibitor were diluted with an equal
volume of SDS-sample buffer and heated to 100°C for 5 minutes. After
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cooling to room temperature and centrifugation at 10000 g for 5 minutes, they
were aliquoted into 200 pi volumes and stored at -20°C until required.
3. 2. 6. Production of antibodies to T. evansi:
Antibodies to intact living trypanosomes (Infection serum):
Washed, column separated TREU 2165 trypanosomes were used to
infect a rabbit by injection with lxlO5 trypanosomes in 1 ml PSG through the
marginal ear vein. Prior to infection 2 ml of blood were collected from the
rabbit for production of pre-infection serum. Parasitaemia was monitored daily
using wet film preparations from the marginal ear vein until the experiment
was finished 21 days post-infection.
Ten ml of blood was collected from the marginal ear vein of the rabbit
on days 2, 5, 9, 14 and 21 after infection. Serum was obtained from the blood
as described in section 2.6. The experiment was terminated 21 days after
infection, by treating the rabbit with a single i.m. injection of diaminazine
aceturate ( BerenilR, Hoechst Lab., Germany ) at dose rate of 7 mg / Kg body
weight.
Antibodies to trypsin-treated trypanosomes
lxlO7 trypanosomes treated with trypsin (20pl @ 5mg/ml) for 75
minutes were suspended in 1 ml PSG and inoculated intravenously (i.v.) into
one rabbit. The inoculation was repeated on days 28 and 57 with lxlO7 freshly
prepared trypsinised trypanosomes. On each occasion two mice were also
inoculated intraperitoneally with lxlO7 trypsinised trypanosomes in 0.5 ml
PSG to serve as infection controls. The mice were monitored for parasitaemia
daily using wet blood films of tail blood. The microhaematocrit centrifugation
technique was used to monitor parasitaemia in the rabbit at time of collection
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of blood for serum and in mice at the end of the experiment on day 63 after
injection.
Blood was collected from the rabbit on days -1, 7, 9, 21, 35, 40, 50 and
63 after injection. Serum was prepared as described in section 2.6.
Antibodies to T. evansi soluble extract:
A rabbit was immunised with T. evansi soluble extract, prepared as
described in section 3.2.3, using an immunisation regime adapted from Harlow
and Lane (1988). The rabbit was first injected subcutaneously at eight
different sites along its back with a total of 200 pg (800 pi) of the freeze-
thawed T. evansi soluble extract emulsified in Freund's Complete adjuvant
(FCA). The emulsion was prepared at a ratio of antigen to adjuvant of 1:2
using 5 ml glass syringes connected through a luer fitting. The antigen was
first injected into the adjuvant and the mixture was then passed repeatedly
between the syringes until the emulsion became thick and creamy. The rabbit
was then boosted by s/c injection with a further 100 pg (400 pi) of the same
materials in incomplete Freund's adjuvant ( FIA ) at 28 and 56 days post-
immunisation. A final boost of 100 pg soluble extract in PSG was
administered intravenously to the rabbit 68 days after the first immunisation.
The rabbit was bled for production of serum on days -1, 7, 10, 21, 34,
39, 49, 61, 67 and 75. The serum was prepared as described in section 2.6.
3. 2. 7. SDS-PAGE electrophoresis of T. evansi extracts:
Fifty microlitre of T. evansi freeze-thawed soluble extract containing
45pg protein, 50pl SDS-solublised whole trypanosome extract equivalent to
o
...
1.1x10 trypanosomes and 50pl SDS-solublised trypsinised trypanosomes
• o
extract equivalent to 1.1x10 trypanosomes were subjected separately to SDS-
PAGE gradient gel electrophoresis as described in section 2.7. Visualisation of
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the gel protein banding pattern was by Coomassie Blue stain as described in
section 2.7.
3. 2. 8. Detection of antigenic components of T. evansi
T. evansi soluble extract (50 pi, 45 pg), whole trypanosome extract (50
pi, 1.1x10^ trypanosomes) and trypsinised tiypanosomes extract (50 pi,
1.1x10^ trypanosomes) were subjected to SDS-PAGE. Proteins from the gel
were then transferred to a nitrocellulose membrane as described in section
2.7.1. The reactivity of the separated proteins was examined by incubation of
the membrane with antisera from the two rabbits inoculated with intact or
trypsinised trypanosomes and from the rabbit immunised with soluble extract
of the intact trypanosomes. The serum samples collected from each rabbit
were pooled equally and then diluted to 1/50 in blocking buffer, pH 7.4
(Appendix 7) before used in the assay. The assay was performed as described
in section 2.7.1.
3. 2. 9. Enzyme-linked immunosorbent assay (antibody-ELISA) for
trypanosome antibodies:
Serum samples from the two rabbits inoculated with intact or
trypsinised trypanosomes and from the rabbit immunised with soluble extract
of the intact trypanosomes were assayed for T. evansi antibodies by ELISA.
Each serum sample was tested at a dilution of 1/50 against soluble extracts
prepared by freeze-thawing from trypsin-treated and untreated T. evansi
tiypanosomes at a coating dilution of 1/80. Pre-immunisation serum from each
rabbit at a dilution of 1/50 was included in the assay as negative controls. All
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serum samples were tested in duplicate and the antibody-ELISA was
performed as described in section 2.8.
3. 3. RESULTS:
3. 3. 1. Trypsinisation of T. evansi :
Trypanosomes remained intact and motile after incubation with trypsin
for periods of up to two hours. The incubation of the trypanosomes with
trypsin for up to 45 minutes did not affect their infectivity as parasites were
found in mouse blood three days following i.p. inoculation (Table 3. 1).
Incubation for one hour, however, reduced the infectivity of the parasite as
pre-patent period was extended to ten days (Table 3. 1). While incubation of
trypanosomes with trypsin for periods of 75, 90, 105 and 120 minutes
completely abolished their infectivity to mice as trypanosomes were not
detected by 40 days after inoculation.
Electron microscope sections prepared from untreated trypanosomes
were seen to possess a thick (20 nm), compact and dense surface coat
overlying the plasma membrane. In the sections prepared from trypanosomes
incubated with trypsin for 75 minutes, the surface coat was removed, leaving
behind the plasma membrane which was sometimes difficult to resolve but the
microtubules appeared normal. Representative photograph of these sections
shown in Figure 3.1a and Figure 3. lb.
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Table 3. 1
Parasitaemia in mice inoculated with tiypanosomes incubated with trypsin for
periods ranging from 15 to 120 minutes
Number of trypanosomes per 20 microscopic fields at x400 magnification.
Days 15 minutes 30 minutes 45 minutes 60 minutes 75-120min
incubation incubation incubation incubation incubation
1 0 0 0 0 0
2 0 0 0 0 0
3 1 1 1 0 0
4 N N N N 0
5 N N N N 0
6 4 9 3 0 0
7 59 100 6 0 0
8 120 64 1 0 0
9 200 0 0 0 0
10 D 5 2 1 0
11-40 _ N N N 0




Transmission electron micrograph of section through surface of body of T.
<?ram/(TREU 2165). 1 mm =10 nm.
a- 75 minutes trypsin-treated trypanosomes lacking a surface coat,
b- Intact non-treated trypanosomes possessing a surface coat.
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3. 3. 2. Parasitaemia In Inoculated Rabbits:
The parasites were first detected on day 5 following injection of rabbit
with the living tiypanosomes. Parasitaemia fluctuated, with parasites detected
only on days, 12, 13, 14, 15, 16 and 21 post-infection.
Trypanosomes were not detected by the microhaematocrit technique
during the 63 days of immunisation regime in the rabbit inoculated with the
trypsin-treated trypanosomes. Control mice inoculated with these
tiypanosomes also did not show parasites in their circulation.
3. 3. 3. SDS-PAGE separation of T. evansi materials:
Slight difference was seen in the number of the protein bands resolved
by Coomassie blue stain of the whole trypanosome extract and the soluble
extract. The highest number of individual proteins were seen in the whole
trypanosome extract with a total of 39 individual protein bands with molecular
weight ranging from 158.6 k.Da to about 9.1 k.Da (Figure 3.2, lane No. 2).
Two of these protein bands with molecular weight of 146 k.Da and 142 k.Da
were absent from the soluble extract which contained 37 proteins (Figure 3.2,
lane No. 3). Otherwise both extracts had similar banding patterns with high
molecular weight components in the range of 158.6 k.Da - 125.1 k.Da, showed
the lowest staining intensities.
Of the 39 bands in the whole extract only 32 polypeptide bands were
visible by Coomassie blue staining of the trypsinised trypanosomes extract in
the size range of 96 k.Da to 9.1 k.Da (Figure 3.2, lane No. 4). Seven of the
protein bands present in the whole trypanosomal extract, were absent from the
trypsinised trypanosomes extract. Five of these bands were in the high
molecular weight part of the gel (158.6 - 125 k.Da) with the other two at 58.6
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and 52 k.Da. Furthermore only few proteins dominated by a 42 k.Da
component showed a similar staining intensity to that in the other two extracts.
The staining intensity of the other proteins in the trypsinised trypanosomes
extract appeared to be lower than that of the other two extracts despite
equivalent amounts of trypanosomes.
3. 3. 4. Immunological characterisation of T. evansi proteins (Table 3. 2):
Reactivity of infection serum:
Pooled serum collected from the infected rabbit for up to 21 days after
infection recognised a total of seventeen antigenic components ranging in
molecular size between 172 k.Da to 21.2 k.Da (Figure 3. 3. lane No. 1 and
table 3. 2.) in the three trypanosomal preparations used in this study. Of the 39
protein components present in the whole trypanosome extract 16 reacted with
the infection serum. Twelve of these antigens were also recognised by this
serum in the soluble extract. Five antigens of 65.5, 58.6, 31.5, 30 and 21.2
k.Da present in the whole extract were absent from the soluble extract with
one 44 k.Da component present only in the soluble extract. The serum
recognised 7 components in the trypsinised trypanosome extract with
corresponding antigens in both whole and soluble extracts while a 65.5 k.Da
component was common to the trypsinised and whole trypanosomes extract.
Reaction of hyperimmune serum:
Serum raised to T. evansi soluble extract recognised a total of twenty
protein components in the three trypanosomal preparations used in this study
with a molecular weight ranging from 166.1 k.Da to 26.6 k.Da (Figure 3. 3.
lane No. 2 and table 3. 2). Ten antigens recognised during 21 days of infection
were also recognised by the hyperimmune serum. The majority of the antigens
recognised by hyperimune serum were present in the soluble extract with 16
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components recognised by the serum. Seven of these 16 antigens were also
present in the whole cell extract and one 58.6 k.Da component was present
only in the whole extract. The serum recognised 4 of the above 16 components
in the trypsinised trypanosome extract which also contained two additional
components of 54.7 and 26.6 k.Da.
Reactivity of trypsinised trypanosomes antiserum:
Serum raised to the trypsinised trypanosomes did not recognise any




Total protein profile of J! evara7(TREU 2165) fractionated on SDS-PAGE and
stained with Coomassie Blue.
1. Molecular weight markers.
2. Whole cells extract.
3. Soluble extract.




T. evam/(TREU 2165) proteins identified by polyclonal polyspecific antisera
raised in rabbits against intact living trypanosomes, tiypsin-treated
trypanosomes and soluble extract and probed by western immunoblotting.
MM. Molecular weight marker.
1. Serum raised against intact living trypanosomes.
2. Serum raised against soluble extract.
3. Serum raised against trypsin-treated trypanosomes.
a- Soluble extract.
b- Trypsin-treated trypanosomes extract,






















T. evansi antigens recognised by infection serum and hyperimmune serum to
T. evansi soluble extract.
Antigenic during infection when Antigenic as soluble extract when
tested against tested against
M.wt Whole Soluble Trypsinised Whole Soluble Trypsinised
in parasite extract whole parasite parasite extract whole parasite
k.Da extract extract extract extract.
1 172 Yes Yes No No No No
2 139 Yes Yes No No Yes No
3 90 Yes Yes Yes No No No
4 83.7 Yes Yes Yes No No No
5 70.1 Yes Yes Yes Yes Yes Yes
6 65.5 Yes No Yes No No No
7 63.3 Yes Yes Yes Yes No Yes
8 60.0 Yes Yes Yes No Yes Yes
9 58.6 Yes No No Yes No No
10 52 Yes Yes No No Yes No
11 46.4 Yes Yes Yes No Yes No
12 44 No Yes No No No No
13 42 Yes Yes Yes Yes Yes Yes
14 33.2 Yes Yes No No No No
15 31.5 Yes No No Yes Yes No
16 30.0 Yes No No No Yes No
17 21.2 Yes No No No No No
Total bands 16 12 8 5 8 4
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Table 3. 2 continued
T. Evansi antigens recognised by infection serum and hyperimmune serum to
T. evansi soluble extract.
Antigenic during infection when Antigenic as soluble extract when
tested against tested against
M.wt whole cell soluble trypsin wc whole cell soluble trypsin wc
k.Da extract extract extract extract extract extract.
1 166.1 No No No No Yes No
2 104 No No No No Yes No
3 80.8 No No No Yes Yes No |
4 54.7 No No No No No Yes
5 47.8 No No No Yes Yes No
6 41.8 No No No No Yes No
7 38.9 No No No Yes Yes No
8 38.1 No No No No Yes No
9 28.1 No No No No Yes No
10 26.6 No No No No No Yes
Total bands 0 0 0 3 8 2
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3. 3. 5. Antibody response measured by ELISA:
The rabbit immunised with trypsinised trypanosomes did not show a
measurable antibody response by ELISA. Absorbance values of the serum
collected from this rabbit post-inoculation did not exceed that of the pre-
inoculation serum when tested against the soluble extracts of the trypsin-
treated and untreated trypanosomes (Figure 3. 4). Sera from the infected rabbit
and rabbit immunised with the soluble extract of the intact parasite, however,
reacted with the trypsin-treated trypanosomes when they were used as antigen
in a similar way to their reaction with the untreated trypanosome extract.
Absorbance values with trypsinised trypanosomes as antigen were, however,




The whole trypanosomes extract contained the largest number of the
parasite proteins compared to the other two trypanosomal preparations used in
this study. A total of 39 proteins were revealed by the Coomassie stain in this
extract. Two of these proteins were not released by aqueous solubilisation as
they were absent from the soluble extract and contained 37 proteins. The
resistance of these proteins to aqueous solubilisation and their release from the
parasite by SDS detergent lysis indicates a possible membrane association as
detergent lysis is known to solubilise the membrane proteins by replacement of
the lipid bilayer with a micelle of detergent (Goding, 1986). The trypsinised
trypanosomes extract contained the lowest number of the parasite proteins,
with seven bands absent from the trypsinised extract compared to that in the
whole trypanosomes extract. Although trypsin digestion is reputed to cleave
mainly the VSG from the parasite surface (Cross, 1975), other proteins were
reported to be cleaved during trypsinisation (Frommel et al, 1988). Possibly, in
the present study, these molecules possessed trypsin sensitive sites, arginine
and lysine (Stryer, 1988), and were released from the parasite together with
the surface coat during the process of trypsinisation. Of the proteins absent
after trypsinisation, two of 58.6 and 52 k.Da fall within the 53 to 63 k.Da
range reported for VSG molecules of T. evansi ( Richards, 1984) and the 53 to
65 k.Da range for T. bmcei (Cross, 1975, Johnson and Cross, 1977,
Hoeijmakers et al, 1980).
Twenty seven components of T. evansi were found to be antigenic in
the present study depending on the extraction procedure. Seventeen of these
components were recognised as antigens during infection as revealed by their
reaction with the infection serum collected for up to 21 days after infection.
The number of the parasite antigens recognised during the infection in the
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present study was less than that reported by Uche (1989) who reported up to
25 antigenic components after 28 days infection with T. evansi in rabbits. This
difference could be due to the difference in the duration of the infection as
after 28 days the animal could be expected to be exposed to wider range of
antigens than at 21 days.
The molecular weights of the T. evansi antigens identified in the present
study ranged from 172 k.Da to 21.2 k.Da although the upper molecular weight
limit of the parasite proteins revealed by Coomassie Blue Stain was 158.6
k.Da. This difference is possibly due to the fact that Western immunoblotting
is a more sensitive detection system than Coomassie Blue. Coomassie Blue
has a detection limit of 1 p.g protein (Harlow and Lane, 1988), while as little
as 100 pg of protein can be detected by the immunoblotting (Towbin et al,
1979).
Most of the antigens recognised during the course of infection were
also immunogens when presented as a soluble extract as they reacted with both
the infection serum and the serum raised against the parasite soluble extract
Differences were, however, detected in the antigenicity of the parasite
components released during infection and by physical disruption. Some of the
parasite components which were not antigenic during the course of infection
acted as antigens when presented to the host in soluble extract. This difference
in the antigenicity of these parasite materials could be accounted for by
difference in the way they were released from the parasite (Barriga, 1981) and
the way in which they were presentated to the host eg immunogenicity of
those incorporated with adjuvant will be increased due to their presentation in
an aggregated form (Goding, 1986).
Twelve of the antigenic components of T. evansi recognised by the host
during the 21 days of infection in the present study were soluble proteins as
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recognised by the infection serum in the soluble extract, while only 5 were
insoluble proteins possibly of membrane origin as they were present only in
the whole trypanosome extract prepared by the detergent lysis. Nine of the 17
antigens recognised by the infection serum were sensitive to trypsin as they
were absent from the bypsinised trypanosomes extract. This finding suggests
that these antigens possess trypsin sensitive sites and are present in the surface
of the parasite as the trypanosomes were viable and motile after the
tiypsinisation. Surface antigens other than the VSG have been reported in the
trypanosomes (reviewed in Overath et al, 1994).
Trypanosome infectivity was completely abolished when mice were
inoculated with motile trypsin-treated trypanosomes after incubation with
trypsin for periods greater than one hour The loss of the trypanosomes
infectivity following trypsin digestion reported in the present study is in
agreement with that reported by Cross (1975). This had been attributed to the
activation of complement by the alternative pathway caused by the exposure of
the plasma membrane of the parasite following the removal of the surface coat
(Ferrante and Allison, 1983). When the trypanosomes are covered with C3b
they are phagocytosed by macrophages (Newton, 1981), suggesting the surface
coat had been removed. Electron microscopy of the trypanosomes after 75
minutes incubation (Figure, 3. la) in the present study showed a uniform
removal of the surface coat. This period of incubation was chosen as an
optimum incubation period for the release of the surface coat of TREU 2165,
since shorter periods did not completely remove the parasite coat as indicated
by infectivity to mice, longer periods of incubation, on the other hand, might
lead to lysis of the parasite (Cross and Johnson, 1976).
Trypsin-treated trypanosomes did not stimulate antibody responses
when injected into a rabbit. Serum raised against these trypsinised
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trypanosomes in the present study did not recognise any antigenic components
of the parasites in the immunoblots. This was supported by the results from the
antibody-ELISA where serum samples collected from the rabbit immunised
with the trypsinised trypanosomes did not react with the freezed-thawed
trypsin-treated or untreated tiypanosomes when used as antigen.. However
serum collected on day 63 post-inoculation with trypsinised tiypanosomes
showed a slight rise in absorbance level of the antigen-antibody reaction but
was still within the negative control level. The reactivity of the ffeeze-thaw,
trypsin-treated trypanosomes with serum raised against the intact living
trypanosomes and the soluble extract was lower compared to that of the
untreated trypanosomes. This could be accounted for by difference in the
antigen composition in the two trypanosomal preparations with the trypsinised
trypanosomes lacking the surface coat antigen which is the the most abundant
trypanosome antigen (Cross, 1990).
The lack of antibody response to trypsin-treated trypanosomes suggests
that, the surface coat antigen might be important in the initiation of the
humoral immune response against the non-surface antigens This might take
place through direct activation of B lymphocytes without the involvment of
antigen-presenting cells such as macrophages. The role of macrophages in the
presentation of the trypanosomes antigens has been reported as negligible
(Paulnock et al, 1988). Alternatively, the trypsinised trypanosomes,unlike the
intact trypanosomes, did not replicate within the host body as indicated by
their absence in the circulation of the rabbit and mice inoculated with these
trypsinised trypanosomes. This would limit the amount of antigens released
from these trypsinised trypanosomes compared to the continuous stimulation
of the immune system in animals infected with the intact trypanosomes.
(De Raadt, 1974, Shapiro and Murray, 1982, Uche, 1989).
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The present study has identified a number of T. evansi components
which acted as antigens during the first 21 days of infection, the majority of
which were soluble proteins. Some of these antigens were trypsin-sensitive in
the intact organism suggesting a surface association. Two soluble antigens
were selected for further study - a trypsin sensitive 52 k.Da and a 42 k.Da
antigen which was recognised as a strong antigen in the three T. evansi
preparations investigated in this study. Both antigens were also good
immunogens when administered as soluble extracts making them suitable for
use in a range of purification methods.
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CHAPTER FOUR
PRODUCTION OF POLYCLONAL ANTIBODIES
TO A 42 AND 52 K.DA T. EVANSI ANTIGENS
THE AIM
The aim of this section was to raise specific antibodies to two soluble T.
evansi antigens, the 52 k.Da and the 42 k.Da antigens identified in section
three as major components in the immune response to T. evansi infection. The
antibodies will then be used in assays for the detection of the corresponding
antigen.
4. 1. INTRODUCTION:
Individual antigens purified to homogeneity is the principal requirement
for the production of the highly specific antisera needed for use in
immunoassays as the sensitivity of these assays is dependent on the specific
activity and high avidity of the antibody.
Prior to purification of individual parasite components, the organism
has to be obtained in a pure form separated from host materials. Unlike many
haemoflagelates, trypanosomes can be easily separated from host blood by
ion-exchange chromatography using DEAE cellulose (Lanham and Godfrey,
1970). The trypanosomes themselves like all protozoa consist of a mixture of
chemical components. The initial separation of individual antigens from this
complex mixture is usually based on differences in physicochemical properties
of the individual antigens. Trypanosomes antigens are predominantly proteins
(Shapiro and Murray, 1982, Muller et al, 1992, Authie et al, 1993) or
glycoproteins and classified as either surface (reviewed by Turner, 1982,
Cross, 1990 and Overath et al, 1994) or non-surface (Strickler et al, 1978,
Frommel and Balber, 1987). The majority of studies carried out on the
purification of trypanosomal antigens has concentrated on the major surface
glycoprotein - the variant specific glycoprotein. This is probably due to VSG's
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high degree of immunogenicity, its role in protecting animals against
reinfection (Wellde el al, 1981, Hall and Esser, 1984), its abundance as it
represents 10% of total parasite protein (Cross, 1990) and the relative ease
with which it can be purified from other parasite components. Most of the
purification methods involve some form of chromatographic separation
including ion-exchange chromatography (Clarke et al, 1984), size exclusion
chromatography (Down el al, 1991) and, to a lesser extent, affinity
chromatography using lectins (Johnson and Cross, 1977, Strickler et al, 1978,
Reinwald et al, 1979, Turner, 1982) or antibodies (Pearson and Anderson,
1980).
Although many of the above purification methods can be applied
equally to the non-variant protein antigens, their number and heterogeneity
necessitates the development of different methodologies for each antigen and
possibly in combination. One relatively simple method for purification of
antigens is based on their separation by SDS-polyaciylamide gel
electrophoresis (Harlow and Lane, 1988) in which proteins are separated
according to their molecular size and subsequently eluted from the gel. This
method however, is only usable if the polypeptides of interest can be resolved
as unique bands on such gels. This method has the overall advantage of speed
and avoids the breakdown of antigens by exposure to different pH and salt
concentration as in chromatographic methods. Sample preparation for SDS-
PAGE, however, involves the use of a strong ionic detergent and reagents such
as DTT that can lead to denaturation and changes in epitopes. Nevertheless,
SDS-denatured antigens often retain their antigenicity and induce good
antibody responses (Stumph et al, 1974) and this method has been used to
analyse the immune response to a wide range of organisms (Strauss et al,
1975, Carrol et al, 1978, Boulard and Lecroisey, 1982).
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A crucial part of using SDS-PAGE for antigen isolation is the efficient
localisation of the target antigen in the gel while avoiding any further
denaturation that can be caused by conventional staining. Localisation
methods include, the use of a separate reference lane which is stained and used
to localise the band of interest in rest of the gel. This method however, is only
suitable for purification of proteins that are well separated from each other
under condition of SDS-PAGE (Harlow and Lane, 1988) as small errors in
aligning the reference lane and the rest of the gel can lead to contamination of
the excised gel band. Alternative localisation methods involve whole gel
staining with Coomassie blue, sodium acetate or copper chloride to locate the
bands of interest. This method ensures the unequivocal identification of the
target component with a minimum risk of contamination from nearby bands,
but runs the risk of altering epitopes due to combination with stain.
For raising antibodies to the target antigen the excised gel containing
the antigen can be fragmented by repeated passage through a syringe and then
injected into animals for production of antibodies. Fragmentation of high
acrylamide concentration gels is difficult and the technique does not allow for
an accurate quantification of the protein injected into the animal during
immunisation or incorporation with adjuvants Another disadvantage of this
method is that the release of antigens from the acrylamide is sometimes too
slow to allow sufficient stimulation of the immune system (Goding 1986).
More effectively proteins trapped in the gel can be made to migrate out of the
gel under the influence of an electric field and the electrophoretically eluted
protein can then be used for immunisation (Harlow and Lane, 1988). Up to
90% of the amount of protein contained in the excised gel can be obtained by
this method (Goding, 1986). A major advantage of this method is that, the
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concentration of the eluted protein can be measured and the antigen can be
incorporated with an adjuvant before injection into animals.
The immunisation regime and the animal species influence greatly the
type of response and antibody characteristics. Sustained high levels of high
affinity antibodies are usually produced by repeated injection of animals with
the same antigen. Soluble protein antigens in their native state are often poorly
immunogenic (Dresser, 1962) and require incorporation with an adjuvant at an
early stage of immunisation which presents them in an aggregated form, thus,
enhancing their immunogenicity. The most popular adjuvants include
aluminium salts or mineral oils (Freund's adjuvant) both of which act by
lowering the rate of elimination of the immunogen by forming depots. This
results in a prolonged persistence of the immunogen in tissues and thus a
continuous stimulation of the immune system (Tijssen, 1985). The intervals
between booster injections should be timed to ensure that rapid clearance of
the antigen by the circulating antibodies does not occur. Hyperimmune sera
produced this way usually contain high levels of IgG of specific antibody with
high affinity to the immunogen due to maturation of the immune response
(Harlow and Lane, 1988). This makes them particularly suitable for use in
immunoassays which require high affinity antibodies.
In the present study a number of methods were investigated for the
purification of two T. evansi antigens including SDS-PAGE and several
chromatographic methods.
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4. 2. MATERIALS AND METHODS:
4. 2. 1. Trypanosomes:
Three populations of T. evansi (TREU 2165, 2222 and 2257)
representing two stocks of the parasite, one stock of T. bmcei (TREU 2185)
and one stock of T. vivax (TREU 2130) were used in this part of the study.
The history of T. evansi stocks is presented in section 2.1. T. brucei was
acquired by C.T.V.M. from the East African Trypanosomiasis Research
Organisation (E.A.T.R.O.) in 1964 and T. vivax as the rodent adapted
Wellcome strain of T. vivax acquired by C.T.V.M. in 1964.
4. 2. 2. preparative gel electrophoresis:
A total of ten SDS-PAGE gels (160 mm x 180 mm x 1.5 mm) were
used to provide the materials for immunisation. A T. evansi soluble extract
was prepared for SDS-PAGE as described in section 3.2.2. and separated on 7-
20% gradient SDS-PAGE gels. 100 p.1 samples of the soluble extract were
loaded in each of the 14 wells cast into the gel and electrophoresis was
performed as described in section 2.7. After electrophoresis and Coomassie
blue staining of the whole gel the 42 and 52 k.Da T. evansi proteins were
located in the gel by reference to a molecular weight standard lane (Molecular
weight markers, Pharmacia) electrophoresed in the same gel. Portions of
acrylamide containing the 42 and 52 k.Da proteins were cut with a scalpel
from each gel and placed in the glass tubes of an electro-elution device (Model
422 Electro-Eluter, Bio Rad, USA) set up according to the manufacturers
instructions as described in section 2.7.2. The proteins were then
electrophoretically eluted from each excised gel portion at a constant current
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of 10 mA per glass tube for 5 hours. A total of 600 pi containing the
appropriate protein was collected from the collection capsule of each tube. The
homogeneity and purity of proteins eluted from each portion was assessed by
SDS-PAGE using 10% homogeneous acrylamide mini-gels (8 x 10 cm, 0.75
mm thick; Mini-ProteinR II, Bio-Rad, USA) prepared according to
manufacturer's instructions. Proteins were detected in these gels with a silver
stain kit (Silver Stain Plus kit, Bio-Rad, USA) following the manufacturer's
instructions.
For each antigen, all electro-eluates were pooled, transferred to dialysis
tubes (molecular weight cut-off 12,000 daltons; Sigma chemical Co. St. Louis,
USA) and dialysed overnight against PBS. The total protein concentration of
the dialysed proteins was measured using a BCAR test kit (Pierce, USA). The
42 and 52 k.Da proteins were then concentrated approximately 6-fold using a
Centrifugal Ultrafiltration System (Sartorius Ltd., Germany) in which 2.5 ml
of eluate were placed in an outer centrifuge tube (92 x 14 mm. Centrisart L,
Sartorius Ltd.). An inner tube (floater) with a cellulose triacetate ultrafilter
(molecular weight cut-off of 5000 daltons) sealed to its base was then slipped
into the outer polystyrene tube. The sample was then centrifuged at 2500 g for
30 minutes at 4°C. After removing the inner tube containing the ultrafiltrate,
the concentrated protein in 380 pi PBS was collected and stored at - 20°C
until needed.
4. 2. 3. Separation of antigens by High performance liquid chromatography
3x10** column separated and washed T. evansi (TREU 2165)
tiypanosomes were suspended in 4 ml of ice-cold 0.015M phosphate buffer,
pH 8.0 (Appendix 14) containing N-CBZ-L-Phenylalanine Chloromethyl
Ketone (ZPCK, 0.4 mg/ml). Four milligrams of n-Octyl P-D- Glucopyranoside
(OGP) was then added directly to the trypanosomes suspension, mixed gently
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for 2 minutes and then centrifuged at 20,000 g for 35 minutes at 10°C in a
Beckman ultracentrifuge (L8-M, Beckman, USA) using a fixed head 65K
rotor. The supernatant was carefully removed and subjected to fractionation by
ion-exchange high performance liquid chromatography (HPLC).
Ion-exchange HPLC of the detergent solublised fraction was carried out
using a 75 x 7.5 mm Spherogel TSK DEAE-5 PW column (Beckman, USA).
One ml of the solublised trypanosome materials was injected onto the column
in 20 mM tris buffer, pH 7.0 (buffer A, Appendix 15) using a 1 ml sample
loop. Proteins were eluted from the column using a continuous gradient
generated using two buffers (a 20 mM tris, pH 7.0 start buffer and a high salt
buffer containing 20 mM tris buffer pH 7.0 with 240 mM NaCl, Appendix 16)
at a flow rate of 1 ml/minute over a period of 30 minutes. The absorbance of
the column eluate was monitored continuously at 280 nm and the eluate
collected into 1.7 ml microcentrifuge tubes at one minute intervals.
Five fractions representing the major ion-exchange elution peak
collected during the first 3-7 minutes were analysed using a 8-25% gradient
Phast gel (Pharmacia, USA) SDS-PAGE system. Samples from each fraction
were diluted with twice their volume in SDS-sample buffer (Appendix 12),
heated to 100°C and centrifuged at lOOOOg for 5 minutes. Four pi of each
sample were then applied to the gel and electrophoresis carried out at 250 V
for a total of 80 volts hour at 15°C, for 45 minutes. After electrophoresis the
gel was removed from the apparatus and the separated proteins were visualised
by silver staining in the development chamber of the Phast unit. This staining
process consisted of the gel being incubated with a solution of 50% ethanol
and 10% acetic acid for 2 minutes at 50°C, proteins were then fixed with 8.3%
gluteraldehyde for 6 minutes at 50°C and washed twice in 18 Mohm water
each for 2 minutes. The proteins were then incubated with 0.25% silver nitrate
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for 13 minutes at 40°C and washed twice in the 18 Mohm water for 0.5
minutes each at 30°C. The reacted proteins were then incubated with
developer solution for periods of 0.5 minute and 4 minutes respectively at
30°C; developer solution contained 12.5 g of sodium carbonate and 0.2 ml
formaldehyde in 500 ml water. Silver stained gels were then incubated for 2
minutes at 50°C with 5% acetic acid, and finally for 3 minutes with a mixture
of 10% acetic acid and 10% glycerol. Stained gels were air dried for one hour
before photography.
4. 2. 4. Size exclusion chromatography of the ion-exchange fractions:
The 5 fractions collected from the HPLC ion-exchange column were
pooled together and re-fractionated according to molecular size by size
exclusion HPLC (Welling and Welling-Wester, 1989). One ml of the pooled
sample was applied in 0.1 M Na2S04, 0.1 M KH2PO4, 0.001 M NaN3, pH
7.0 buffer (Appendix 17) to a 300 x 7.5 mm Biosep-SEC-S 300 column
(Phenomenex, UK) using a 1 ml sample loop. Samples were eluted from the
column over a period of 30 minutes using a flow rate of 0.65 ml/min. The
absorbance of the column eluate was monitored continuously at 280 nm and
the eluate fractions collected into 1.7 ml microcentrifuge tubes at one minute
intervals. Nine fractions were collected between 12 and 20 minutes of the
chromatography run representing the major elution peak. These fractions were
analysed by SDS-PAGE using a homogenous 15% acrylamide mini-gel (8x10
cm, 0.75 mm thick, Mini-ProteinR II, Bio-Rad, USA) prepared and run
according to manufacturer's instructions. Proteins were detected in the gel
with a silver stain kit (Silver Stain Plus kit, Bio-Rad, USA) following the
manufacturer's instructions.
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4. 2. 5. Lectin-afTinity chromatography:
The pool of 5 fractions eluted from the HPLC ion-exchange column
was subjected to lectin affinity chromatography using Concanavalin A
sepharose 4B (Con A sepharose, Sigma Ltd. UK). Prior to chromatography 4
ml of the Con A-sepharose gel was equilibrated with 10 ml Con A binding
buffer (Appendix 18). The sample (3 ml) was mixed with 7 ml of binding
buffer and then allowed to pass through a column prepared from 4 ml of Con
A-sepharose. The column eluate was passed back through the column a total of
5 times. The material bound to the Con A column was then eluted from the
column by passing 7 ml elution buffer (Appendix 19) through the column; the
eluate was collected as 7 x 1 ml fractions. All fractions were analysed by SDS-
PAGE using the Phast system.
4. 2. 6. Immunisation regime:
Antibodies were raised in rabbits to the 42 and 52 k.Da antigens which
had been separated by SDS-PAGE and eluted by electro-elution described in
section 4.2.2. The eluates were emulsified in Freund's adjuvant at a ratio of
antigen to adjuvant of 1:2 (v/v) using two 5 ml glass syringes connected
through a luer fitting. The antigen solution was first injected into the adjuvant
and the mixture was then passed repeatedly between the syringes until the
emulsion became thick and creamy. The stability of the emulsion was tested
by allowing a drop to fall onto the surface of a beaker of water. When the drop
stayed intact the emulsion is considered ready for injection (Goding, 1986,
Harlow and Lane, 1988). Two rabbits were immunised with each antigen.
Each rabbit was injected intramuscularly (i.m) in a thigh muscle, using 25-
gauge needle, with 100 pg of each antigen emulsified in Freund's Complete
adjuvant (FCA). This was repeated 14 days later in the other hind limb. The
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rabbits were then boosted three times by subcutaneous injection with 50 jag
emulsified in Freund's Incomplete adjuvant (FIA) on days 49 and 77 and again
with 25 jag of antigens in FIA on day 196. Five ml blood samples were
collected on days -1, 24, 56, 84, 203 and a final 40 ml blood sample was
collected on day 210 post primary injection for the preparation of serum.
Monitoring antibody production:
An antibody-ELISA was used to measure the amount of antibody in the
sera collected from the four rabbits on days 24, 56, 84 and 203 post primary
injection of the antigens. The assay was also used to determine the titre of the
antibodies in the final serum collected on day 210 post-injection. Each serum
was tested against a 1/80 dilution of a freeze-thawed soluble extract of the
homologous T. evansi population as antigen. Sera were evaluated over a 2-fold
dilution range from 1/250 to 1/8000 for the sera collected 24-203 days and
over a 10-fold dilution range from 1/10^ to 1/10^ for the final serum collected
at 210 days. In each case pre-immunisation serum at a similar dilution range
was included as a negative control. All serum samples were tested in duplicate
and the assay was performed as described in section 2.8. The antibody titre
was taken as the last dilution that continued to show an absorbance of at least
twice that of the negative control.
4. 2. 7. Specificity of the antibodies in day 210 sera:
Specificity and reactivity by antibody-ELISA:
The reactivity of the 210 day serum collected from rabbits immunised
with either 42 or 52 k.Da antigens was examined by ELISA testing against
freeze-thawed soluble extracts of homologous (TREU 2165) and heterologous
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(TREU 2222 and 2257) T. evansi populations coated at a dilution of 1/80.
Serum raised to the 52 k.Da antigen was also tested against freeze-thawed
soluble extracts of T. brucei (TREU 2185) and T. vivax (TREU 2130) coated
at a dilution of 1/80. All sera were tested at a dilution of 1/1000. Pre-
immunisation serum at a dilution of 1/1000 and PBS/Tween wells were also
included on each plate as controls. The assay was performed as described in
section 2.8. and test samples showing optical density (O.D) values of greater
than twice that of the pre-immunisation serum were considered as antibody
positive to that antigen.
Specificity and reactivity by western immunoblotting:
This was used to examine the specificity and ability of the antibodies to
react in this type of assay system. The antiserum raised to each antigen was
tested by immunoblotting against whole trypanosomes extract, prepared by
boiling in SDS sample buffer (section 3.2.3), from homologous (TREU 2165)
and heterologous (TREU 2222 and 2257) T. evansi populations. 50 pl/well of
the appropriate trypanosomes extract were subjected to SDS-PAGE (section
2.7) and electrophoretically transferred to nitrocellulose membrane as
described in section 2.7.1. The membranes were incubated with blocking
buffer (Appendix 7) for one hour at room temperature before incubation with
appropriate serum samples diluted to 1/50 in blocking buffer. Unreacted serum
was removed by washing as described in section 2.7.1. Peroxidase-labelled
donkey anti-rabbit whole IgG molecule (Scottish Antibody Production Unit,
Carluke, Lanarkshire) at a dilution of 1/500 in blocking buffer was then added
to the membrane and any antigen-antibody binding was visualised by
incubation with 4-chloro-l-a-naphthol substrate as described in section 2.7.1.
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Reactivity by indirect fluorescent antibody test (IFAT):
This assay was used to provide information on the location of both the
42 and 52 k.Da antigens within T. evansi by testing the antisera against
homologous (TREU 2165) and two heterologous (TREU 2222 and 2257) T.
evansi populations. Parasitaemic whole blood obtained from mice infected
with the appropriate T. evansi population was fixed either as smears in acetone
(section 2.10.2.) or in suspension using formalin (section 2.10.1.) was used as
antigen. In both cases reaction zones were marked on the microscope slides
bearing the fixed trypanosomes as described in section 2.10.1.
For immunofluorescence testing 50 pi of each antiserum was diluted to
1/50 in PBS and added to the reaction zones marked on the microscope slide
bearing the antigen. Serum collected on day 21 from rabbit infected with T.
evansi (TREU 2165), pre-immunisation serum and PBS were included on each
slide as positive and negative controls respectively. FITC-labelled donkey anti-
rabbit IgG (Scottish Antibody Production Unit, Carluke, Lanarkshire) at a
dilution of 1/40 was used as conjugate and the tests were performed as
described in section 2.10.3.
Agglutination test:
The variant specificity and agglutinating properties of antibodies in
each antiserum was examined by agglutination testing against homologous
(TREU 2165) and heterologous (TREU 2222 and 2257) T. evansi populations.
The serum was tested over a 2-fold dilution range from 1/2 to 1/1024 and the
test was performed in micro well plate as described in section 2.9.
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4. 3. RESULTS:
4. 3. 1. Preparative gel electrophoresis:
The eluate of the gel slices from both the 42 and 52 k.Da region from
the gel showed a single band of the appropriate molecular size when
subsequently analysed by SDS-PAGE. A similar amount of protein was
obtained for each antigen following electro-elution from the 10 gels with
671 mg/ml protein for the 42 k.Da and 625pg/ml of the 52 k.Da protein after
ultrafiltration concentration.
4. 3. 2. Chromatographic Purification Of Antigens:
The five fractions representing the major elution peak of the HPLC ion-
exchange column (Figure 4. 1) showed multiple protein bands when analysed
by SDS-PAGE Phast gel (Figure 4.2). Three to nine protein bands per fraction
were detected by electrophoresis with molecular weights ranging from
approximately 14 k.Da to 94 k.Da. The first four fractions included the 42 and
52 k.Da target proteins (Figure 4.2, lanes 2-5), while the fifth fraction included
the 52 k.Da (Figure 4.2, lane 6).
After fractionation of the pooled ionex fractions 3-7 by size exclusion
chromatography nine fractions were obtained that constituted the major elution
peak (Figure 4. 3). After analysis by SDS-PAGE one to three protein bands per
fraction were identified (Figure 4.4, lanes 4-10) with a molecular size of
approximately 66, 87 and 94 k.Da.
When the major ion-exchange peak (pooled fractions 3-7) was
subjected to lectin affinity chromatography using a Con A sepharose column,
the first six fractions eluted from the column with elution buffer all contained
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multiple bands when analysed by SDS-PAGE using the Phast system (Figure
4.5, lanes 2-7). Five protein bands were identified in each fraction with
molecular weights of approximately 15, 30, 62, 66 and 94 k.Da. The seventh
eluate fraction from this column (Figure 4.5, lane 8) did not contain any
protein material resolvable by SDS-PAGE.
4. 3. 3. Antibody Response In The Immunised Rabbits:
Serum from test bleeds collected from the immunised rabbits 10 days
following each injection of the antigen showed a progressive increase in
absorbance values when tested by ELISA against a soluble extract of the
homologous population (Figure 4. 6 and 4. 7). At a serum dilution of 1/250 a
3-fold increase in the absorbance value from day 24 to day 203 post-primary
injection was observed. Anti-serum to the 42 k.Da antigen showed an
absorbance value of 0.773 at day 24 which increased to 2.028 at day 203
(Figure 4.6). That of the 52 k.Da showed an absorbance value of 0.517 at day
24 which increased to 1.470 at day 203 post-primary injection (Figure 4.7).
The antibody titre of the final serum raised to the 42 k.Da antigen
collected on day 210 post-immunisation was 1/100000 as defined by antibody-
ELISA against the homologous soluble extract (Fig. 4. 8). The final serum to
the 52 k.Da antigen had an antibody titre of 1/10000 when analysed by
antibody-ELISA (Figure 4. 9).
4. 3. 4. Characterisation of the 210 day Anti-sera Raised To Each Antigen:
Anti-serum raised to the 42 k.Da antigen:
This serum was tested for reactivity against soluble extracts of the
homologous and heterologous T. evansi populations using an ELISA test, and
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reacted only with the homologous population of T. evansi giving an
absorbance value of more than 9 x that of the pre-immunisation serum (Figure
4.10). In the case of the heterologous populations TREU 2222 and TREU
2257 absorbance values of less than twice that of the pre-immunisation serum
were obtained when the serum was tested against the soluble extr acts of these
populations (Figure 4. 10).
Western immunoblotting of the whole cell extract with the antiserum
raised to the 42 k.Da antigen recognised four faintly stained protein bands of
molecular weight of approximately 65, 35, 29 and 26 k.Da and a strong 42
k.Da band in the homologous population of T. evansi (TREU 2165) (Fig. 4.11
lane No. 3). The serum did not recognise any antigenic components in the
heterologous populations TREU 2222 and TREU 2257 (Figure 4. 12 lane No.
1A and IB).
Fluorescent trypanosomes were detected in both formalin and acetone-
fixed preparations of the homologous population (TREU 2165) when serum
raised to the 42 k.Da antigen was tested against this population by IFAT. A
strong green fluorescence was observed over the entire outline of both
formalin and acetone-fixed trypanosomes. No fluorescent trypanosomes were
detected with the heterologous populations TREU 2222 and TREU 2257 of T.
evansi.
The serum to the 42 k.Da antigen did not agglutinate either homologous
or heterologous T. evansi populations.
Anti-serum raised to the 52 k.Da antigen:
This anti-serum reacted with both the homologous (TREU 2165) and
heterologous (TREU 2222 and 2257) populations of T. evansi as well as T.
brucei and T. vivax populations (Fig. 4. 13) by ELISA. Each of the soluble
trypanosome extracts showed absorbance levels greater than twice that of the
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negative control serum. The T. vivax antigens showed the highest absorbance
(1.028) followed by the T. evansi heterologous population TREU 2222 (0.717)
and TREU 2257 (0.668). The homologous population of T. evansi (TREU
2165) showed an absorbance value of 0.630 and the absorbance value obtained
with the T. brucei antigens was 0.481.
The serum recognised a single protein band of molecular weight of ~52
k.Da in the homologous population of T. evansi (TREU 2165) (Fig. 4.11 lane
No. 2) by western immunoblotting. While in the heterologous population of T.
evansi (TREU 2222 and 2257) two components were recognised - a major
component with a molecular weight of approximately 52k.Da and a minor 33
k.Da component (Figure 4. 12 lane No. 2A and 2B).
No fluorescent trypanosomes were seen with either formalin or
acetone-fixed parasites of the homologous (TREU 2165) or heterologous
(TREU 2222 and 2257) T. evansi populations.




Protein profile of the HPLC ion-exchange eluates: Silver staining on 8-25%
gradient acrylamide Phast gel.
Lanes 1 and 7: Molecular weight markers.
Lanes 2-6: Fractions 3 to 7 representing the elution peak.
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Figure 4. 3








































Protein profile of fractions separated by HPLC size exclusion column. Silver
staining on 15% acrylamide mini-gel.
Lane 1 : Molecular weight markers.




Protein profile of Concanavalin A column eluates: Silver staining on 8-25%
gradient acrylamide Phast gel.
Lane 1: Molecular weight markers.
Lanes 2-8: Fractions 1-7 from the column eluate.
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Figure 4. 6
Antibody response in rabbits immunised with the 42 k.Da T. evansi antigen.
Antibody-ELISA against the homologous T. evansi population.
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Antibody response in rabbits immunised with the 52 k.Da T. evansi antigen.
Antibody-ELISA against the homologous T. evansi population.




Titration of antibodies in the final serum collected from the rabbits immunised





Titration of antibodies in the final serum collected from the rabbits immunised





Reactivity of anti-serum to the 42 k.Da antigen with homologous and
heterologous-T.<?va/w/ populations by ELISA.
TR2165: T. evansi homologous population (TREU 2165).
TR2222 & TR2257: T. evansi heterologous populations (TREU 2222 & 2257).
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Figure 4. 11
Results of western immunoblotting of homologous T. evansi population
(TREU 2165) against sera to the 42 and 52 k.Da antigens.
Lane 1: Molecular weight markers.
Lane 2: Antiserum to 52 k.Da antigen.




Results of western immunoblotting of heterologous T. evansi population
(TREU 2222 and 2257) against sera to the 42 and 52 k.Da antigens.
Lane 1: Antiserum to 42 k.Da antigen.
Lane 2: Antiserum to 52 k.Da antigen.
Lane 3: Molecular weight markers,
a = T. evansi TREU 2222.




Reactivity of antiserum to the 52 k.Da antigen by ELISA against homologous
and heterologous T. evansi populations, and T. brucei and T. vivax.
TR2165: T. evansi homologous population (TREU 2165).
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4. 4. DISCUSSION:
Immunisation of rabbits with the T. evansi antigens eluted from
Coomassie stained polyacrylamide gels in the present study elicited strong
antibody responses to the 52 k.Da and 42 k.Da antigens by immunoblotting
and ELISA. This result indicates that both antigens retained their
immunogenicity and confirms the usefulness of the SDS-PAGE for the
purification of antigens for immunisation as reported by previous workers
(Stumph et al, 1974, Harlow and Lane, 1988).
The 52 k.Da antigen was found to be conserved between different
populations and stocks of T. evansi as well as across species in T. brucei and
T. vivax. Anti-serum raised against this antigen in the present study recognised
antigens in a heterologous T. evansi population of the same stock (TREU
2222) and a different stock (TREU 2257) as well as in stocks of T. brucei and
T. vivax . Immunoblotting with the serum recognised the target antigen as a
single component in the homologous population but as two components of 52
and 33 k.Da in the heterologous T. evansi population. This 33 k.Da component
might be a breakdown product or another component only present in the
hetereologous population carrying similar epitopes to the 52 k.Da
These findings indicate that the 52 k.Da represents an invariant antigen as
invariant antigens of molecular size ranging from 20 to 300 k.Da had been
reported from different species and populations of trypanosomes. Some of
these invariant antigens have been shown to be located on the surface of the
parasite (reviewed by Overath et al, 1994), while others are non-surface
associated antigens (Shapiro and Murray, 1982, Stieger and Seebeck, 1986,
Frommel and Balber, 1987, Muller et al, 1992). Evidence from the present
study suggests that the 52 k.Da antigen is not surface-associated as serum
raised to it did not react by IFAT or agglutination. Although IFAT can detect
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both surface and non-surface antigens, it prossibly biased towards surface
antigens as formalin fixation is reputed to preserve the surface coat
antigenicity (Nantulya and Doyle, 1977).
The 42 k.Da antigen in contrast to the 52 k.Da appeared to be a
population-specific antigen as serum raised against this antigen only
recognised antigenic materials in the homologous T. evansi population (TREU
2165) by immunoblotting, ELISA and IFAT. Results from immunoblotting,
however, showed that the serum recognised five protein bands in the
homologous population of the parasite although dominated by the 42 k.Da
protein. Such multiple recognition could be due to contamination of the
original gel slice or breakdown products arising from protease activity during
preparation of extracts. Contamination from the nearby bands during excision
of the antigen from gels is unlikely since the contaminants have large
molecular size range. The 65 k.Da contaminant is clearly not a breakdown
product of the 42 k.Da although the 42k.Da component might be a breakdown
product of the 65 K.Da component in the extracts used for SDS-PAGE.
Similarly, the other components could be breakdown product of either the 65
or 42 k.Da components.
One of the heterologous populations of T. evansi used in the present study was
derived from the same stock as the homologous population (section 2.1) and is
known to be antigenically different from the homologous population (T. W.
Jones, personal communication). This suggests that the 42 k.Da antigen
complex is variant-specific although the molecular weight all but the 65K.Da
component is lower than that reported for T. evansi VSG (65-67 k.Da, Uche,
1989).. Although there is evidence that the 42 k.Da is surface-associated from
the overall green fluorescence seen by IFAT, the anti-serum to this antigen did
not agglutinate the homologous population of the parasite. This suggests that if
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surface-associated, the 42 k.Da is not present in enough sites to cross-link for
agglutination formation. It is possible, however,that drying and fixation of the
trypanosomes during antigen preparation could have exposed the antigen to the
serum in IFAT making it appear to be surface-associated.
Results (not presented) from densitometric measurements on Coomassie Blue-
stained SDS-PAGE gels indicate that the 42k.Da antigen is present in greater
amount in the parasite materials than the 52 k.Da). This might also explain the
reaction of its antiserum in IFAT. Another explanation of the reaction of the
anti-42 k.Da serum in IFAT is that the antigen is possibly sharing an identical
epitope with the surface coat antigen. This hypothesis will also explain the
importance of the variant-specificity of the 42 k.Da antigen, as after switching
from one VSG to another the previous VSG will be only be gradually diluted
during succeeding divisions (Overath et al, 1994) and the presence of the 42
k.Da will possibly lower the chances of VSG-specific antibodies to bind to the
surface of the trypanosomes, thereby, allowing the switching process to
succeed.
None of the HPLC chromatographic procedures produced either the 42
or 52 k.Da antigens from T. evansi lysates in sufficient purity for further study.
Other systems such as reverse-phase high-performance liquid chromatography
might have produced better separation of these parasite antigens and have been
used for the purification of T. brucei VSG (Clarke et al, 1984). The organic
solvents used with this method however, might degrade the proteins reducing
their immunogenicity.
Despite the overall failure of the HPLC to separate the antigens, it did
provide additional information on the characteristics of these two antigens.
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1. The isoelectric point (pl).of both antigens is probably close to 7.0 as they
were eluted during the early stages of ion-exchange chromatography
indicating that they were not tightly bound to the column at pH 7.0
2. The smallest component resolved by size exclusion chromatography was
66k. Da. This would be in keeping with the failure to isolate either the 42 or
the 52 k.Da antigens by this method under these conditions.
3. Neither 42 nor the 52 k.Da antigens possesed any of the sugar residues that
are known to bind Con A such as a-linked D-mannosyl, D-glucosyl and N-
acetyl-D-glucosaminoyl (Lis and Sharon, 1973, Rautenberg et al, 1980,
Frommel and Balber, 1987) as neither bound to Concanavalin A.
The present study has, therefore,confirmed the usefulness of SDS-
PAGE separated proteins as a mean of producing highly-specific, high titred
antisera to individual trypanosomes proteins and highlighted the problems
associated with chromatographic separation of complex mixtures of proteins
with similar physico-chemical properties.. The antibodies produced in this part
of the study will be used to develop immunoassays for the detection of the two
antigens in serum and tissues of infected animals.
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CHAPTER FIVE
PRODUCTION OF MONOCLONAL ANTIBODIES
TO TRYPANOSOMA EVANSI (TREU 2165)
5. 1. AIM:
To develop monoclonal antibodies (McAbs) to T. evansi antigens for
use in detecting antigens in the circulation and tissues of infected animals.
5. 2. INTRODUCTION:
Monoclonal antibodies (McAbs) are highly selective reagents that can
be used in the identification and isolation of individual antigens from
trypanosomes. Unlike polyclonal mono-specific antibodies, a pure antigen is
not required for immunisation of animals for monoclonal antibody production
due to cloning and selection during production.
The introduction of a cell fusion technique by Kohler and Milstein
(1975) enabled the routine growth of populations of antibody-secreting cells in
vitro. In this technique an in vivo produced antibody-secreting cell is fused
with a myeloma cell to produce a hybridoma which can then multiply in an
appropriate tissue culture system. Such hybridomas can produce unlimited
quantities of antibodies with defined specificity. Hybridomas can also be
propagated in vivo in histocompatible animals and produce ascites fluid
containing up to 5-20 mg/ml of antibodies (Goding, 1986, Liddell and Cryer,
1991).
As with polyclonal antibody production, the immunisation regime used
in McAb work greatly influences the type of response in the animals from
which antibody-secreting cells will be isolated. Various immunisation methods
have been successfully used for the production of McAbs to trypanosomes, the
100
majority of which have been directed at variant-specific surface antigens. A
common approach in these methods involves infection of the host followed by
drug-treatment to arrest the development of new populations of trypanosomes
and to prevent the infected animal dying. Purified VSGs have been used in
immunisation regimes for production of McAbs (Myler et al, 1985; Masterson
et al, 1988). Unfortunately McAbs to purified VSGs do not usually recognise
the VSG molecule on living trypanosomes probably due to alteration of the
antigen during the initial purification process. The duration of the
immunisation protocol determines the class of antibody produced. IgM
antibodies are usually produced with a short period of immunisation and a
single infection (Theodos et al, 1990). IgG antibodies are generally produced
by longer immunisation protocols involving multiple inoculations of living
trypanosomes (Masterson et al, 1988) and boosting with soluble trypanosome
extracts (Theodos et al, 1990, Alves et al, 1983).
Similar approaches employing multiple inoculations with living
trypanosomes have been used to produce McAbs to invariant surface antigens
(Burgess and Jerrells, 1985). Infection and boosting protocols have also been
used to produce McAbs to non-surface antigens such as the cell membrane of
T. congolense, T. vivax (Nantulya el al, 1987) and T. brucei (Nantulya et al,
1987, Colmerauer et al, 1989, Turner et al, 1989) procyclic trypanosomes. As
in the case of VSG, purified non-surface antigens were used for McAbs
production (Stieger and Seebeck, 1986, Gallo and Schrevel, 1985).
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5. 3. DETERMINATION OF IMMUNISATION PROTOCOLS:
Two immunisation protocols previously used to produce McAbs to
trypanosomes were compared in this pilot study; a short immunisation
protocol as described by Theodos et al (1990) and a long protocol as described
by Masterson et al, (1988).
5. 3. 1. Materials and Methods:
Trypanosomes
The history of T. evansi TREU 2165 the parasite stock used in this study is
presented in section 2. 1.
Immunisation protocols:
Two groups of 5 mice were used for this study. One group (A) was
infected i.p. with 2.6x10^ T. evansi trypanosomes per mouse and treated at a
dose rate of 335 fig Berenil / mouse for 3 consecutive days starting three days
post-infection according to Theodos et al (1990). The mice in the second
group (B) were infected as above but treated two days later with a single dose
of 5 mg Berenil / Kg body weight. Group B was boosted 30 days post¬
infection with 2.6x10^ trypanosomes per mouse and was then treated on the
next day with Berenil at a dose rate of 5 mg/kg.
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For individual mice in the two groups 100 pi tail blood was collected
for serum on days 4, 6, 10, 17, 23, 37, 42 and 45 post infection and tested for
antibody.
Monitoring antibody response:
Indirect fluorescent antibody test (IFAT): Living trypanosomes as antigen:
Sera collected from both groups of mice on days 4, 6, 10, 17, 23, 37, 42
and 45 were tested by IFAT for antibody response to surface antigens using
live tiypanosomes as antigen as described by Doyle et al (1980). Column
separated trypanosomes (section 2.3) were resuspended in PSG to a
concentration of 1 x 10^/ml. 100 pi of the trypanosome suspension was
incubated in a microcentrifuge tube for 30 minutes at 4°C with an equal
volume of mouse serum previously diluted to 1/10 in PBS. The trypanosomes
were then washed 3 times in PSG by centrifugation at 3000 r.p.m. for 5
minutes at 4°C and resuspended in 100 pi of fluorescein isothiocyanate
(FITC)-labelled sheep anti-mouse IgM or IgG (The Binding Site Ltd,
Birmingham, U.K) diluted to 1/20 in PBS. After incubation for 30 minutes at
4°C the trypanosomes were washed as before and then resuspended in 10 pi of
tris-buffered glycerol, pH 9.5, containing 2% (v/v) gluteraldehyde. Each
preparation was mounted under a cover-slip on a microscope slide and
examined by combination of phase-contrast and incident fluorescence
microscopy using a Diaplan fluorescence microscope (see section 2.1.0.3), At
least 50 parasites were examined per sample and the number of fluorescent
trypanosomes recorded as a percentage of the total number of tiypanosomes.
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IFAT using formalin-fixed trypanosomes:
Immunofluorescence utilising formalin-fixed, air-dried T. evansi
(TREU 2165) trypanosomes was used to monitor the IgG response to the
parasite in the group B mice following challenge with 2.6 x 10^ homologous
trypanosomes. Serum collected from group B mice on days 37, 42 and 45 post¬
infection diluted 1/10 in PBS, and FITC-labelled sheep anti-mouse IgG diluted
1/20 in PBS were used in this test. Details of the test are described in section
2.10.3.
Agglutination test:
Serum collected from both groups of mice on days 4, 6, 10 and 23 post¬
infection was tested for agglutinating antibodies over a 2-fold dilution range
from 1/2 to 1/1024 by incubation with the homologous T. evansi population
(TREU 2165). Details of the test are described in section 2.9.
5. 3. 2. RESULTS:
Antibody response in mice of the short immunisation protocol (group a):
The anti-IgM conjugate labelled 16% of the live trypanosomes 4 days
after infection, with a peak labelling of 85% at day 6 but fell to an
undetectable level by 37 days after infection (Table 5.1).
The anti-IgG conjugate did not label any trypanosomes until 17 days
after infection when 75% of the living trypanosomes were labelled. This
reached 100% labelling 6 days later with a slight fall thereafter but maintained
a high level up to day 45 after infection (Table 5.1).
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Agglutinating antibody levels in the immunised mice were similar in
pattern to IgM levels with peak levels occuring at day 10. Levels of
agglutinating antibodies fell to 1/64 by day 23 after infection (Table 5.1).
Antibody response in Group B mice:
Using living trypanosomes as IFAT antigen, the IgM response in this
group was similar to that seen in group A. The peak activity of anti-IgM
conjugate was detected on day 6 then gradually fell to undetectable levels 37
days after infection (Table 5.2).
The action of IgG conjugate was detected slightly earlier in this group
by day 10 after infection. The activity increased reaching 100% labelling of
the living trypanosomes by 42 days a level that was maintained until the end of
the experiment on day 45(Table 5. 2).
When formalin-fixed trypanosomes were used as the IFAT antigen
100% labelling was detected with all sera collected from group B following
challenge with trypanosomes on day 30 (Table 5.2).
Agglutinating antibodies in group B were not detected before day 6
post-infection, but a higher level of these antibodies was maintained compared
to group A animals (Table 5.2).
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Table 5. 1
The percentages of labelled trypanosomes by the anti-IgM and IgG conjugates









4 16.4 1/32 0
6 85.5 1/128 0
10 78.2 1/256 0
17 45 - 75
23 40 1/64 100
37 0 - 90
42 0 - 92
45 0 - 98
106
Table 5. 2
The percentages of labelled tiypanosomes by the anti-IgM and IgG conjugates
and the agglutination antibodies in the second group of mice (B) infected with
T. evansi, treated with 5 mg Berenil/kg body weight two days later,














4 20 0 0 -
6 95.5 1/512 0 -
10 90.9 1/1024 9.1 -
17 50 - 70.5 -
23 40 1/1024 85 -
37 0 - 92 100
42 0 - 100 100
45 0 - 100 100
107
5. 3. 3. DISCUSSION:
Both immunisation protocols produced IgM and IgG responses in the
mice. Similar patterns of antibody developed in both groups A and B mice, an
initial IgM response which was later replaced by an IgG response. The overall
pattern of the IgM response was, similar in both immunisation protocols in that
it was first detected on day four, reached a peak level on day 6 and declined
thereafter until it disappeared on day 37 post-infection. The gradual increase in
the number of labelled trypanosomes could either be attributed to the
differences in antigenicity of the trypanosomes used in the test or more likely
to a gradual maturation of epitope recognition by these antibodies since new
variable antigen types (VAT) usually arise at 4 to 5 days intervals (Gray,
1965) and the trypanosomes used in the present test were grown in mice for
three days only.
Little difference was observed in the pattern of the IgG response
elicited by both immunisation protocols. The IgG response in group A mice
was detected later than in group B and reached a peak on day 23 post¬
infection. Group B mice showed a steady increase in the level of the IgG over
the course of the experiment. The challenge of group B on day 30 post¬
infection appears to have boosted the IgG in this group as would be expected .
following a challenge with the same antigen (Harlow and Lane, 1988).
Formalin-fixed trypanosomes were compared with living trypanosomes
as a source of antigen in the IFAT test. With live trypanosomes only the
surface antigens are exposed to the serum in the test. Although formalin
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fixation stabilises surface coat antigens while preserving their antigenicity
(Nantulya and Doyle, 1977), non-surface antigens will also be exposed
following drying and fixation of the parasites. A slight difference was
observed in the present study in the percentage of labelled trypanosomes by
the anti-IgG conjugate with 100% labelling observed on the formalin-fixed
trypanosomes. For subsequent studies IFAT using formalin-fixed
trypanosomes as an antigen source was chosen for screening the hybridomas
for McAbs production, since it should be able to detect both surface and non-
surface trypanosome antigens. It also has the additional advantage that fresh
tiypanosomes are not needed for performing the test, and that fixed
trypanosomes can be kept for long periods without affecting the antigenicity of
the trypanosome components (Nantulya and Doyle, 1977). The latter feature is
an important criteria when large numbers of hybrid supernatant have to be
tested as occurs in post-fusion screening.
For further studies the immunisation protocol used for the mice in
group B was selected for the production of monoclonal antibodies to T. evansi.
This choice was based on a number of criteria. First the IgG response was
elicited earlier by this group than by the mice in group A. Second challenging
with tiypanosomes will activate more B lymphocytes which will improve the
efficiency of the fusion of spleen cells with myeloma cells. Fusion usually
requires recently activated B cells (Goding, 1980) and fusion is recommended
on day 3 after the final immunisation (Oi et al, 1978). To bias class-specific
antibodies, IgG antibodies were chosen because they contain high level of
specific antibodies and are of high affinity to the immunogen (Harlow and
Lane, 1988) an important criteria to consider when the antibodies are to be
used in immunoassays.
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Agglutination tests were carried out in this study to confirm the IgM
response since these antibodies are known to be efficient agglutinators
compared to IgG antibodies (Bellanti, 1985). Results obtained with this test
generally confirm those of the IgM response.
The immunoglobulin response reported in this study is similar to those
reported in other hosts for trypanosomes infection. The persistence of IgM
antibodies up to 3 weeks post-infection as indicated by the level of
agglutinating antibodies is similar to the findings of Seed et al (1969) and
Zahalsky and Weinberg (1976) who reported a predominantly IgM response
during the period of primary infection in rabbits infected with T. b. gambiense
and rats or cattle infected with T. b. briicei. The predominantly high level of
IgG antibodies from 17 days post-infection compared to the level of IgM
antibodies occured regardless of the second challenge with trypanosomes and
is in agreement with the predominant IgG response during primary infection
reported by Campbell et al (1978), Nantulya et al (1979) and Uche (1989), for
T. b. rhodesiense, T. b. brucei and T. evansi infections respectively.
5. 4. MONOCLONAL ANTIBODIES TO T. EVANSI (TREU 2165)
5. 4. 1. Materials and Methods:
Experimental animals:
Balb/C mice (Bantin and Kingman, U.K.), 6-8 weeks old, were used as
source of sensitised lymphocytes and for ascites production.
Trypanosomes:
A T, evansi population (TREU 2165) was used for the immunisation of
the Balb/C mice. Two other populations of T. evansi (TREU No's 2222 and
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2257) representing two stocks of the parasite were used to characterise the
antibodies. The history of these trypanosome populations is presented in
section 2.1.
Immunisation protocol:
Cryopreserved T. evansi (TREU 2165) trypanosomes were expanded in
cyclophosphamide treated mice (300 mg/Kg body weight, 24 hours before
infection) and separated from the host blood using DE52 column
chromatography, washed by centrifugation with PSG and counted by
haemocytometry. The immunisation protocol described in section 5.3 was used
with 4 Balb/C mice injected i.p. with 5x10^ tiypanosomes per mouse and
treated i.p. two days later with a single dose of 5 mg Berenil / Kg body weight.
The mice were then boosted with the same number of trypanosomes on day 30
post-infection and then treated again with Berenil at a dose rate of 5 mg / Kg
one day later. Tail blood was collected from the mice for serum on day 32.
Two days later the spleen was removed from the mouse showing the highest
level of antibodies and used to prepare cells for the first fusion. The remaining
mice were boosted with 5x10^ trypanosomes on day 50 and treated with
Berenil at a dose rate of 5 mg / Kg body weight one day later. Tail blood was
collected from these mice for serum on day 52 and examined for antibody by
ELISA. Two days later the spleen was removed from the mouse showing the
highest level of antibodies and used to prepare cells for a second fusion.
Monoclonal antibody production:
Preparation of myeloma cells:
Mouse myeloma cell line NSO/1, a non-immunoglobulin-producing cell
line (Galfre and Milstein, 1981), was resuscitated from storage in liquid
nitrogen ten days prior to the day of fusion. The myeloma cells were passaged
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in complete medium (Appendix 20) in 75 and 150 cm^ tissue culture flasks
(Gibco) at logarithmic phase of growth by subculturing every 48 hours. The
myeloma cells were harvested for fusion by washing once in RPMI 1640
without FCS (in incomplete medium) at 1000 r.p.m. for 5 minutes and
resuspension in 10 ml fresh incomplete medium. The viability of the cells was
estimated by counting after staining with 0.2% trypan blue (Appendix 23).
Preparation of feeder cell layer:
An uninfected Balb/C mouse was killed by cervical dislocation. The
spleen was removed in an aseptic manner, cut into small fragments and a cell
suspension made by squashing the tissues with a blunt edge of a forsceps in a
coarse sieve over a Petri-dish containing about 5 ml incomplete medium. The
suspension was then frequently pipetted with sterile plastic pipette to disrupt
the clumps of the spleen cells before 15 ml incomplete medium was added and
the suspension transferred to a 50 ml centrifuge tube. After standing for
several minutes the suspension was centrifuged at 1000 r.p.m. for 5 minutes.
The pellet was suspended in 7 ml HAT medium (Appendix 21) containing 100
units/mg per ml of penicillin/streptomycin (Appendix 22) before counting the
number of cells in an aliquot diluted in white blood cell counting fluid
(Appendix 23). The cells were taken for irradiation for 98 seconds with 1500
rads using Caesium 137 to arrest cell growth. The irradiated suspension was
made up to 36 ml with HAT medium and the cells pipetted out into 6 x 96 well
flat bottomed microtitre plates (Gibco) with each well receiving 100 pi. Sixty
wells were used per plate to minimise accidental loss and the plates were
incubated in a humidified 37°C incubator in 5% CO2 in air.
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Preparation of mouse spleen cells for fusion:
One of the immunised Balb/C mice was killed by cervical dislocation.
A spleen cell suspension was prepared as described previously and centrifuged
at 1000 r.p.m. for 5 minutes. The pellet was then washed once in incomplete
medium before suspending in 10 ml fresh incomplete medium and the number
of cells counted after dilution in white blood cell counting fluid (Appendix
23).
Fusion of myeloma and spleen cells:
Myeloma and spleen cells were mixed together in a conical 50 ml tube
at a ratio of 1:10 and centrifuged at 1000 r.p.m. for 5 minutes. The supernatant
was poured off and a pipette used to remove the last few drops of the
remaining supernatant. Over a period of 3 minutes, 1 ml of pre-warmed
(37°C) polyethylene glycol (PEG, Boehringer) was added to the combined cell
pellet with mixing between drops, and the final suspension was then incubated
at 37°C for 2 minutes. The PEG enriched mixture was then diluted slowly by
adding 1 ml, 5 ml and then 10 ml of incomplete medium dropwise over a
period of 7 minutes while mixing by shaking the tube continuously. The
suspension was centrifuged at 900 r.p.m. for 5 minutes, supernatant discarded
and the pellet suspended in 36 ml HAT medium. The cells were then pipetted
out into the plates previously coated with feeder cells, each well receiving 100
pi of cell suspension, and the plates were incubated in a humidified 37°C
incubator in 5% CO2 in air.
Post fusion protocol and initial antibody screening:
Seven days after the fusion, the microtitre plates were first examined
for evidence of contamination. Wells showing turbidity and yellow medium
colour were emptied and rinsed four times with 70% ethanol. The remaining
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wells in the plates were then examined for cell growth using an inverted
microscope (Diavert, Leitz, Wetzlar). Wells which showed definite focal
colonies growth were marked for subsequent examination. At the same time
partial medium supplement was made by adding 50 p.1 fresh warmed HAT
medium to each well in the plates.
On day 10 after the fusion, the plates were again screened for cell
growth and any overlapped hybrids were released by carefully sucking them
up and down with a pipette. Next day, hybridoma culture supernatants were
harvested from wells marked as showing good cell growth on day 10 by
removing 100 p.1 from each marked well and replacing it with 100 pi fresh
HAT medium. Parameters used to indicate that the time was appropriate for
antibody screening included cell growth covering at least 70% of the microtitre
well bottom and medium colour change towards yellow.
Harvested undiluted supernatants were subjected to an initial IFAT
screen against formalin fixed T. evansi trypanosomes utilising FITC-labelled
sheep anti-mouse IgG (The Binding Site Ltd, Birmingham, U.K) as a
conjugate as described in section 2.10.3.
Expansion of hybridoma cultures:
Cultures from which the supernatants gave positive reaction by IFAT in
the initial screen were expanded into 2 cm^ wells (24 well plates, Gibco). For
this the microtitre well contents were resuspended and transferred to a 2 cm2
well containing 1 ml HAT medium. The original microtitre well culture
continued to be maintained by regular addition of fresh medium until the cell
cultures derived from it were established in the larger vessels and
cryopreserved. Culture supernatants from hybridoma cells growing in the 2
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cm2 wells, were tested for antibody activity against T. evansi by IFAT. Cells
from positively reacting wells were then cloned, cryopreserved and expanded
further. This expansion involved the transfer of the 2 cm^ well containing
cloned cells to 25 cm^ tissue culture flasks and thence to 75 and 150 cm^
flasks. At all stages cultures in the original wells were maintained and culture
supematants were tested for antibody activity by IFAT at regular intervals.
Cloning of hybridoma cultures:
Cloning was achieved by limiting dilution (Oi and Herzenberg, 1980) in
96 well microtitre plates. The cultures from 2 cm^ wells from 3 cell lines were
selected for cloning based on their reaction in IFAT. Cells were resuspended
and the cell concentration and viability determined using trypan blue and
haemocytometer counting of cells. Dilutions of the cells were then prepared to
a potential 5 cells per ml in HAT medium. The dilutions were then plated out
as follows as 100 plAvell, in plates previously coated with feeder cell layer at a
concentration of 5x10^ cells/ml:
20 wells @ 50 cells/ml i.e. 5 cells/well.
20 wells @ 10 cells/ml i.e. 1 cell/well.
20 wells @ 5 cells/ml i.e. 0.5 cells/well.
Seven days after cloning, microtitre plates were screened for growth
using an inverted microscope. Wells containing cloned colonies deriving from
a single cell were marked and the cells were fed by addition of 100 pi HAT
medium. When the cells were near to confluence the culture supernatants were
removed and tested for antibody activity by IFAT against formalin-fixed T.
evansi trypanosomes. Antibody-positive cloned cultures were maintained in
115
HAT medium until transfer to 2 cm^ wells. Thereafter, the medium was
gradually changed to HT medium. Passages were carried out every 2-3 days
and the HT medium was gradually changed to complete medium and the
cloned cultures were finally grown in complete medium. The cloning was
performed at least twice on the same culture using the above procedure.
Cryopreservation of hybridoma cultures:
Cells from confluent cultures were centrifuged for 5 minutes at 1000
r.p.m. The pelleted cells were then suspended in ice-cold freezing medium
(10% dimethyl sulphoxide in foetal calf serum) and cryopreserved in 1 ml
aliquots in cryotubes (Gibco) pre-cooled at -20°C. The tubes were placed in a
foam-insulated box and stored for 24 hours at -70°C and then transferred to a
liquid nitrogen bank for long term storage.
Resuscitation of hybridoma cultures:
Cryopreserved hybridoma cells were thawed in a 37°C water bath and
immediately after thawing a few drops of complete medium were added to the
cell suspension over a period of 1 - 2 minutes. The contents were then made
up to 10 ml with complete medium, mixed and transferred to 25 cm^ tissue
culture flask and incubated in a humidified 37°C incubator in atmosphere of
5% C02.
Harvesting monoclonal antibodies:
McAbs were produced in hybridoma culture supernatants or in ascites
fluids obtained from hybridomas grown in syngeneic Balb/C mice. Culture
supernatants were collected from the 75 or 150 cm^ flasks in 15-25 ml
volumes during passage after either 48 or 72 hours cell growth. The culture
supernatant was centrifuged at 2500 r.p.m. at 4°C and then stored at -20°C.
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For ascites production, mice were given i.p. injections of 0.5 ml
pristane (2,6,10,14-tetramethylpentadecane, Sigma) one week before
inoculation i.p. with 5x10^ live hybridoma cells in complete medium obtained
from cultures in the exponential phase of growth. The hybridoma was allowed
to grow in the mice for 1 - 4 weeks. A puncture was made in the peritoneal
cavity of the mice using a 21-gauge needle and drops of the ascitic fluid were
collected in small tubes. 2-3 ml of ascitic fluid were collected per mouse and
was centrifuged at 3000 r.p.m. for 10 minutes at 4°C and stored at - 20°C.
Nomenclature of hybridoma:
Parent cell lines were named after the original fusion plate and wells
from which they were selected, e.g. 2D5. Clones names include parent line




ELISA was used to test the reactivity of the McAbs against the soluble
T. evansi antigens and to determine the antibody titre in the serum collected
before fusion. The microtitre plates were coated overnight with a soluble
extract of the homologous T. evansi population (TREU 2165) at a dilution of
1/80 and processed as in section 2.8. The ascites and hybridoma culture
supernatants containing the McAbs at a 2-fold dilution range from 1/10 to
1/320 or the test and normal mouse serum diluted from 1/640 to 1/20480 were
then added to the plates, incubated and washed as described in section 2.8. A
peroxidase-labelled goat anti-mouse IgG (Pierce, USA) diluted to 1/5000 in
PBS/Tween was then added, incubated and washed as above before the TMB
substrate solution was added and incubated for 15 minutes at 37°C. The
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substrate reaction was stopped with 2M sulphuric acid and the optical density
of the wells read at 450 nm using an ELISA plate reading photometer.
Immunoblotting:
Western immunoblotting was used to determine the molecular nature
of the antigen recognised by the McAbs in the whole trypanosome antigen
preparation of the homologous T. evansi population (TREU 2165). One
McAb, 2D5/E2/C6/C7, was also tested against two heterologous populations
of T. evansi (TREU 2222 and TREU 2257). Soluble extracts of the
trypanosomes were fractionated by SDS-PAGE (section 2.7) and then
electrophoretically transferred to a nitrocellulose membrane ( section 2.7.1.).
The proteins bound to the nitrocellulose membrane were probed with ascites,
for each McAb, at a dilution of 1/20 or hybridoma culture supernatant diluted
to 1/2. The pre-fusion serum from the mouse at a dilution of 1/20 was also
included in the assay as a positive control. The procedure of western
immunoblotting was performed as described in section 2.7.1.
Agglutination Test:
The agglutinating ability of the McAbs was investigated against the
homologous population, TREU 2165 and two heterologous populations TREU
2222 and TREU 2257 of T. evansi. The ascites and culture supernatants were
tested over a 2-fold dilution range ranging from 1/2 to 1/1024. Details of the
test are described in section 2.9.
5. 4, 2. RESULTS:
The pre-fusion serum from the mouse that supplied the spleen had high
levels of IgG antibodies with an ELISA titre of 1/20000 when tested against
the homologous antigen.
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Primary screen of the hybridoma cultures and production of McAbs
Seven days after the first fusion the hybridoma cultures in all plates
were found to be contaminated and were discarded. A second fusion was
performed 13 days later.
Ten days after the second fusion, 268 of the 360 microtitre wells that
received fused cells contained distinct colonies. Forty five of these colonies
were positive for anti-7'. evansi antibody when the culture supernatants were
tested by IFAT using formalin-fixed T. evansi (TREU 2165) trypanosomes.
Subsequently the 45 antibody-secreting hybridomas were expanded and
cryopreserved. Three lines were produced from these hybridomas and cloned.
Finally 4 stable cloned hybridoma cell lines (2D5/B10/C7, 2D5/B10/E4,
2D5/E2/C6 and 2D5/E2/C7) were established as secreting antibodies to the
homologous T. evansi population by IFAT.
Characterisation results:
Culture supernatant from 4 clones showed an absorbance value similar
to that of PBS against the homologous population of T. evansi in antibody-
ELISA. The ascitic fluid produced from these cells reacted with the
homologous population of T. evansi in ELISA (Table 5.3). The McAb
2D5/E2/C7 showed the strongest reaction as defined by the absorbance of the
antigen-antibody reaction followed by 2D5/B10/C7, 2D5/B10/E4 and
2D5/E2/C6 (Table 5. 3)
The ascites of each of the four McAbs recognised a single antigenic
component of molecular weight of 72 k.Da in the homologous population of T.
evansi (TREU 2165) when tested by immunoblotting (Figure 5.1 and Table
5.3). The McAb 2D5/E2/C7 showed the strongest reaction with this
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component as determined by the staining intensity of the protein band (Figure
5.1 Lane 7), while the other 3 antibodies showed a reaction of low staining
intensity. The hybridoma culture supernatant of the 4 McAbs did not show any
reaction by immunoblotting (Figure 5.1). The McAb 2D5/E2/C7 recognised
the same antigenic component in a heterologous variant of T. evansi (TREU
2222) but not in the heterologous stock TREU 2257 (Figure 5. 2).
A low agglutination of titre of 1/16 was obtained only with the
homologous T. evansi population (TREU 2165) when the ascites containing
the McAb 2D5/E2/C7 was analysed by the agglutination test. No agglutination
was detected when either of the other three monoclonals were analysed by this
method (Table 5. 3). The heterologous populations of the parasites were not
agglutinated by any of the 4 antibodies.
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Table 5. 3
Reaction of the four McAbs with the homologous T. evansi population
Hybridoma Reactivity in
number ELISA Immunoblottine Agglutination
A S A S A S
2D5/E2/C7: 0.710 0.071 72 k.Da - 1/16
2D5/B10/C7: 0.681 0.066 72 k.Da - -
2D5/B10/E4: 0.462 0.068 72 k.Da - -
2D5/E2/C6: 0.320 0.067 72 k.Da - -
A = Ascites.
S = Supernatant.
- = Negative reaction.
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Figure 5. 1
Reaction of the four McAbs with the homologous population of T. evansi in
immunoblotting
Lane 1: 2D5/B10/E4 ascitic fluid.
Lane 2: 2D5/B10/E4 culture supernatant.
Lane 3: 2D5/B10/C7 ascitic fluid.
Lane 4: 2D5/B10/C7 culture supernatant.
Lane 5: 2D5/E2/C6 ascitic fluid.
Lane 6: 2D5/E2/C6 culture supernatant.
Lane 7: 2D5/E2/C7 ascitic fluid.
Lane 8: 2D5/E2/C7 culture supernatant.
Lane 9: Pre-fusion serum.




McAb 2D5/E2/C7: Antibody specificity probed by immunoblotting against the
homologous population of T. evansi (TREU 2165) and the heterologous
populations (TREU 2222 and TREU 2257) fractionated by SDS-PAGE on a
10% acrylamide.
Lane 1: Normal mouse serum.
Lane 2: TREU 2257 (heterologous stock).
Lane 3: TREU 2222 (heterologous variant).
Lane 4: TREU 2265 (homologous population).
Lane 5: Molecular weight markers.
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5. 4. 3. DISCUSSION:
The immunisation regime used for the Balb/C mice in the present study
elicited a high level (ELISA titre of 1/20000) of IgG antibodies to T. evansi in
the serum collected before fusion. Immunisation protocols employing
infection, treatment and boosting with living trypanosomes have previously
been successfully used to produce McAbs to variant and invariant
trypanosome antigens (Masterson et al, 1988, Burgess and Jerrells, 1985). The
immunisation regime used for the production of McAbs to T. evansi in the
present study was slightly longer than that used in the pilot study as the first
fusion performed was contaminated and a second fusion had to be undertaken.
The second fusion was successful and a high proportion of fused cells
secreting antibodies to T. evansi was produced with a minimum of
contamination. Four anti-71. evansi monoclonal antibodies were finally
established from this fusion. This low number was obtained despite the fact
that 3 parent cultures were cloned and is a reflection of the technical
difficulties in handling many secreting lines. Many cultures previously
identified as anti-T. evansi antibody secretors either stopped secreting
antibodies or ceased to grow before they could be preserved. Other workers
have reported similar numbers of 2-5 McAbs per fusion from trypanosomes
(Masterson et al, 1988, Turner et al, 1989). The loss of antibody secreting
ability prior to cloning is a well established phenomenon often resulting from
overgrowth of secretors by non-secreting hybridomas especially as antibody
production, by its use of cell resources, makes a secreting hybridoma cell line
less able to compete for growth with non-secretors (Goding, 1980). Early
cloning as practised in the past can prevent this, but cessation of secretion is
still a frequent occurrence as in present study. Loss of chromosomal materials
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(Goding, 1980) or instability in gene expression in hybridoma cells (Pearson et
al, 1980; Galfre and Milstein, 1981) attributed to loss of antibody secreting
ability in a cloned cell line.
The four McAbs produced recognised a similar antigenic component of
72 k.Da by immunoblotting in the homologous population of T. evansi. This
antigenic component was also recognised in a heterologous variant of the same
T. evansi stock indicating that these McAbs recognise stock-specific antigen.
In the IFAT used to screen the hybridomas an overall green fluorescence was
observed on the formalin-fixed trypanosomes suggesting that the antigen
recognised by these McAbs may be located on the surface of the parasite since
formalin-fixation is reputed to stabilise the surface antigens (Nantulya and
Doyle, 1977). It could, however, also be of a non-surface origin since internal
antigens would also be exposed following fixation and drying of the
trypanosomes and in this case the antigen is dispensed in the cytoplasm and
not localised in organelles during IFAT screening. The non-agglutinating
ability of these McAbs observed in this study also suggest that this 72 k.Da
antigen is not exposed on the surface of the parasite or it is present in small
amount that could not induce agglutinating antibodies. A 72 k.Da antigen was
also recognised by the 21 days serum raised in rabbits against the homologous
population of T. evansi in earlier part of the study (see section 3) and by the
pre-fusion serum in the present study (Figure 5. 1) indicating that this
component is recognised by the infected hosts as an antigen during the course
of infection. The 72 k.Da antigen described in section three suggest that it is a
soluble antigen which is insensitive to trypsin again indicating that this antigen
is possibly not located on the surface of the parasite or do not posses arginine
and lysine residues that are sensitive to trypsin digestion.
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The hybridoma culture supernatants collected from the cloned cultures
did not react in either ELISA or immunoblotting possibly due to the low
concentration of antibodies in these supernatants as the cells were grown in
large volumes of medium.
The present study produced McAbs to a stock-specific 72 k.Da antigen
of T. evansi that is antigenic during the course of infection, hence these
antibodies are valuable reagents for the diagnosis of infection and
epidemiological studies of this stock of T. evansi. The antibody produced will
be used to develop immunoassays for the detection of the 72 k.Da antigen in
serum and tissues of infected animals.
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CHAPTER SIX
PRODUCTION OF LABELLED ANTIBODIES TO
T. EVANSI
6. 1. INTRODUCTION:
The efficiency of an immunoassays is directly related to the purity of
the antibodies used (Tijssen, 1985). Serum, ascitic fluid and hybridoma culture
supernatants can contain a wide range of proteinaceous substances in addition
to immunoglobulins, and are not usually suitable for direct use in
immunoassays for antigen detection. In practice, therefore, the antigen-specific
immunoglobulins must be purified from these materials. This is particularly
important if the antibodies have to be labelled because it reduces the amount
of the label required by as much as 10-fold (Tijssen, 1985).
IgG is the immunoglobulin class most commonly used in immunoassays
as most IgG antibodies are of higher affinity to the immunogen than IgM
(Harlow and Lane, 1988). High-affinity antibodies bind large amounts of
antigen and consequently produce a strong signal in a short period of time in
immunoassays (Harlow and Lane, 1988). Low affinity-antibodies bind only a
small proportion of the antigen and therefore require a longer period of time to
develop a detectable signal. The affinity of the antibody also has an effect on
the avidity of the antigen-antibody complex because antibodies with a high
affinity increase the stability of the antigen-antibody complex during washings
(Tijssen, 1985), therefore increasing the final signal strength.
IgG is much easier to purify compared to IgM, IgA, IgD and IgE
(Goding, 1986). A number of methods have been developed for the
purification of IgG usually governed by the intended application of the
purified antibody, the animal species in which the antibody was raised and
whether the starting material is serum, ascites or tissue culture supernatant
(Harlow and Lane, 1988). Simple methods such as ammonium sulphate
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precipitation and DEAE chromatography are capable of separating antibodies
from a wide range of sources but do not yield pure IgG (Harlow and Lane,
1988). Affinity chromatography using IgG-specific ligands such as protein A
or G coupled to sepharose beads can produce pure IgG in high yield (Tijssen,
1985, Harlow and Lane, 1988). A disadvantage of this method, however, is
that IgG from different species and individual IgG subclasses differ in their
affinity to these ligands (Tijssen, 1985), with subsequent differences in yield
and purity of the IgG. To some extent this problem can be solved by increasing
the salt concentration of the binding buffer which increases the affinity of
these IgG for protein A (Harlow and Lane, 1988). This phenomemon has been K
/
exploited in commercially available kits for IgG preparation such as those
produced by the Pierce Chemical Company who have developed a custom
system of buffers. These are claimed to enhance the binding of IgG to
immobilised protein A from a wide range of sources including ascitices fluid
and serum from different species.
After purification from contaminating proteins, the antibodies for use in
immunoassays usually require to be labelled with an easily detected tag so that
any antigen-antibody complex can be detected. The label for such complexing
can be placed either directly onto the antibody or indirectly by first coupling
the antibody to small chemical group such as biotin which, in turn, can be
detected by a labelled ligand such as avidin. Different types of labelling
systems are available depending on the proposed assay. Fluorochromes, such
as fluorescein isothiocyanate (FITC) and tetramethyl rhodamine isothiocyanate
(TRITC) are generally suitable for immunohistochemistiy and flow cytometry
(Johnstone and Thorpe, 1982). Radioisotopes such as iodine (125I) are used in
radioimmunoassays (Liddell and Cryer, 1991), while enzymes are used for
increasingly popular enzyme-immunoassays.
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Conjugation of the antibody to the label without impairing the activity
of either molecule is vital. The active site of most enzymes usually occupies a
relatively small part of the enzyme which means that the remaining portion is
available for conjugation to the antibody without affecting the catalytic
activity of the enzyme. Enzymes have achieved a high degree of popularity in
immunoassays mainly because of their high specificity for the substrate which
can be converted to coloured products that can be either soluble or insoluble.
Soluble products are needed for use in ELISA-type assays and insoluble
products are for immunoblotting and immunohistochemistry. Enzymes also
have the advantage over other labels in that they are readily available,
inexpensive and have high specific activity (Tijssen, 1985). The most
commonly used enzymes include horseradish peroxidase (HRP), alkaline
phosphatase (AP) and P-galactosidase (P-G) (Harlow and Lane, 1988).
Overall, HRP conjugates are considered to be superior to AP and P-G
conjugates due to the higher specific enzyme activity and immunological
reactivity of HRP conjugates (Porstmann et al, 1985). The reaction products of
HRP are easily detectable, while that of AP and P-G are less strongly coloured
(Liddell and Cryer, 1991).
There are a number of methods used to couple HRP to
immunoglobulin, however, the periodate method (Wilson and Nakane, 1978)
is the most commonly used. This method is popular because it couples the
antibody to HRP through the carbohydrate portion of each molecule as shown
in the diagram below and, since this is not usually involved in the active site of
the antibody or the enzyme, the method is less likely to reduce the
immunoreactivity.
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Another popular method of conjugating antibody to HRP is the two-
step gluteraldehyde method developed by Avrameas and Ternynck (1971).
This method links the amino groups of lysine residues [Antibody - N = C'-
(CH2)3 - C' = N - enzyme] and although simple to perform is considered
inferior to the periodate method in terms of yield (Voller et al, 1979) and titre
of conjugates (Nygren, 1982).
The indirect method of labelling depends on the antibodies being
modified by the addition a small molecule such as biotin. This molecule can
then be detected by either of the biotin-binding proteins, avidin or streptavidin,
which have themselves been labelled with HRP, AP or P~G (Harlow and Lane,
1988). In this way a larger number of labelled molecules can be attached to the
antibody than is possible by direct labelling which greatly improves the
efficiency of the assay (Tijssen, 1985). Avidin has a high affinity for biotin
and the bond formation between them is very stable (Tijssen, 1985), and hence
will not be released during immunoassay washing cycles. A number of biotin
derivatives are commercially available for biotinylating antibodies. In this
study Biotin-HPDP derivative a sulfhydryl specific reagent was used because
it preserve the antigen binding site of the immunoglobulin since it couples
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through the sulfhydryls at the hinge region of the reduced immunoglobulin as
shown in the diagrams below.
Biotinylation of IgG
(1) Reduction of antibody using mercaptoethylamine (MEA):
\VsV/.,. VH + HS //MEA
EDTA
(2) Addition of biotin-HPDP to the reduced antibody results in the linkage
of biotin to the antibody via the sulfhydryl groups in the hinge region.
HN
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The present study investigated the affinity chromatographic purification
of IgG molecules from rabbit serum and ascitic fluid using Protein A
chromatography along with methods for the labelling of the purified IgG with
HRP or biotin.
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6. 2. MATERIALS AND METHODS:
6. 2. 1. Purification of Antibodies from Serum and Ascites fluid:
The antibodies from the serum raised in rabbits against the T. evansi 42
k.Da and 52 k.Da antigens (section 4.2.6) and the ascitic fluid containing the
72 k.Da monoclonal antibody 2D5/E2/C7 were purified using the
commercially available ImmunoPureR IgG kit (Pierce Chemical Company,
USA). The method utilised 1.0 ml columns of immobilised protein A
covalently coupled to 6%, crosslinked, beaded agarose (Protein A afflnityPak
™ columns).
In this method 2.5 ml of the serum sample or ascites fluid were diluted
with 2.5 ml of ImmunoPureR IgG binding buffer, pH 8.0. The Protein A
affinityPak™ column was equilibrated with 5 ml of ImmunoPureR IgG binding
buffer before the diluted sample was applied to the column. The sample was
allowed to flow completely into the column before washing it with 15 ml of
ImmunoPureR IgG binding buffer. The IgG bound to the column was eluted in
5x1 ml fractions of ImmunoPureR IgG elution buffer, pH 2.8. The elution was
monitored by measuring the absorbance of each fraction at 280 nm. Fractions
eluted from the Protein A affinityPak™ column that showed absorbance values
greater than 0.5 at 280 nm were each dialysed against PBS and then stored at -
20°C. Three fractions were collected from the anti-42 k.Da and anti-52 k.Da
serum and a single fraction from the monoclonal antibody.
Antibody reactivity:
The dialysed fractions from the protein A affinityPak™ columns were
each tested against freeze-thawed antigens from the homologous T. evansi
population by ELISA. The antigen was used at a dilution of 1/80. The anti-42
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and 52 k.Da fractions were tested at six 2-fold dilutions from 1/400 to
1/12800. The anti-72 k.Da fractions were tested at six 2-fold dilutions 1/10 to
1/320. The antigen-antibody complex was detected by peroxidase-labelled
donkey anti-rabbit IgG or goat anti-mouse IgG at a dilution of 1/5000 and the
reaction was visualised by TMB substrate as described in section 2.8.
6. 2. 2. Labelling of antibodies:
For all three antibodies, the second fraction eluted from the Protein A
affinityPak™ column had both the highest absorbance value at 280 nm and
greatest antibody reactivity when tested against the freeze-thawed T. evansi
antigens by ELISA. These fractions were, therefore, chosen for labelling
studies. Before labelling the selected IgG fractions were concentrated by
freeze-drying. Prior to this each fraction was dialysed with slow stirring
overnight against several changes of distilled water at 4°C. The dialysed
fractions were frozen onto the sides of 5 ml bijoux in a bath of methanol
cooled with solid CO2 and then freeze-dried overnight using a Virtis freeze-
diyer (Medicell International Ltd.).
Labelling of IgG with horseradish peroxidase (HRP):
The modified periodate method:
The modified periodate method (Wilson and Nakane, 1978) was used to
conjugate HRP to antibodies to the three antigens. In this method, 50 pi of a
38.5 mg/ml solution of sodium periodate (NaKXj) was added to 4 mg of HRP
(Type VI, activity 250-330 units/mg, Sigma Ltd. UK) dissolved in 1 ml
distilled water. The mixture was stirred for 20 minutes at room temperature to
oxidise the carbohydrate residues of the HRP and then dialysed at 4°C
overnight against 1 mM sodium acetate buffer, pH 4.4. The activated HRP was
transferred to a 10x75 mm test tube, and 20 pi of 0.2M sodium carbonate
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buffer, pH 9.5 was added followed immediately by 10 mg of the relevant
lyophilised antibody fraction dissolved in 0.01M sodium carbonate buffer, pH
9.5. The reaction mixture was stirred for 2 hours at room temperature and then
40 mg of lysine was added to block any remaining unreacted aldehyde groups.
100 pi of freshly prepared sodium borohydride (NaBFLp 4 mg /ml distilled
water) was then added and the mixture incubated for a further 2 hours at 4°C.
The resulting IgG-HRP conjugate was dialysed overnight against PBS at 4°C.
Prior to storage an equal volume of glycerol was added to the conjugate which
was then stored at -20°C until needed.
ImmunoPureR activated peroxidase kit
The ImmunoPureR activated peroxidase kit (Pierce, USA) was used to
conjugate the anti-42 k.Da immunoglobulins to HRP. In this method 0.3 mg
lyophilised antibody was dissolved in 100 pi of coupling buffer (0.1 M
NaHC03, 0.9% NaCl, pH 9.5) and added to 1 mg of the HRP previously
dissolved in 100 pi distilled water. After incubation overnight at 4°C, the
reaction was stopped by the addition of 40 mg lysine followed by a 2 hour
incubation at room temperature. The reaction mixture was then mixed with an
equal volume of immunoPureR gentle binding buffer, pH 8.0 (Pierce, USA)
and applied to a column containing a mixture of immobilised protein A and
protein G which had been pre-equilibrated with 5 ml of the immunoPureR
gentle binding buffer. The column was then washed with immunoPureR gentle
binding buffer and 15 x 1 ml fractions collected. The absorbance of the
column fractions was monitored at 280 nm to ensure that a stable base line
was reached. The reaction of these 15 x 1 ml fractions to the substrate TMB
was also monitored by adding a 100 pi aliquot of each fraction to 100 pi of the
TMB substrate (section 2.8). The HRP-conjugated IgG bound to the column
was then eluted with immunoPureR gentle elution buffer; 10 x 1 ml fractions
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were collected and the elution of the conjugate from the column was
monitored at 280 nm. The conjugate fractions were then dialysed against 50
mM Tris buffer, pH 7.5 containing 0.9% NaCl, 0.2% thimerosal; 10 mg of
BSA was added to the dialysed conjugate as a stabiliser.
Conjugate immunoreactivity test:
Antibodies conjugated to HRP through the modified periodate method
and the 10 fractions of the anti-42 k.Da antibodies conjugated by the Pierce
immunoPureR activated peroxidase kit were tested against the ffeeze-thawed
antigens of the homologous T. evansi population at a dilution of 1/80 using
direct ELISA. The conjugated antibodies were tested at 2-fold dilutions (table
6.1) and the reaction was visualised using TMB substrate as described in
section 2.8.
Table 6. 1
Dilutions of the HRP-labelled antibodies used in the immunoreactivity test
Conjugates dilutions
Labelling method 42 k.Da 52 k.Da 72 k.Da
Modified periodate method 1/500-1/6400 1/50-1/3200 1/10-1/320
Activated peroxidase kit 1/10-1/320
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Labelling IgG with biotin:
The 42 k.Da and 52 k.Da IgG molecules were coupled to biotin using
N-[6-(Biotinamido)hexyl]-3/-(2/-pyridyldithio) proionamide(biotin-HPDP
derivative Pierce Chemical Company, USA). In this method 10 mg lyophilised
IgG was dissolved in 0.5 ml of 0.1M sodium phosphate buffer, pH 6.0
containing 5 mM EDTA. The IgG was then reduced by mixing with 3.5 mg of
2-mercaptoethylamine HC1 and incubating for 90 minutes at 37°C. The
solution was cooled to room temperature and excess mercaptoethylamine was
removed by a desalting column. The reaction mixture was applied to a 5 ml
desalting column (Excellulose prepacked GF-5 desalting column, Pierce,
USA) that had been pre-equilibrated with PBS-EDTA buffer, pH 7.4 (20 mM
sodium phosphate, 150 mM NaCl, 1 mM EDTA). The column eluate was
discarded. The column was then washed with 0.5 ml PBS-EDTA. A 1.25 ml
volume of PBS-EDTA was then added to the column and the eluate, which
contained the reduced IgG was collected in a single fraction.
A 4 mM biotin-HPDP stock solution was prepared by dissolving 2.2 mg
biotin-HPDP in 1 ml dimethylformamide. To 50 pi of this stock solution 1 ml
(8 mg) of the reduced IgG was added, the mixture vortexed and then incubated
for 90 minutes at room temperature. The progress of the reaction was
monitored by following the change in absorbance at 343 nm for 15 minutes
due to the release of Pyridine-2-thione as a result of the reaction between
biotin and the reduced IgG. The resulting biotinylated IgG was then purified
by applying the mixture to a GF-5 desalting column as described above. The
column was washed with 1 ml PBS-EDTA; a 2.5 ml volume of PBS-EDTA
buffer was then added and the eluate, which contained the biotinylated IgG
was collected in a single fraction and stored at - 20°C.
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Biotinylated antibodies immunoreactivity test:
The biotinylated anti-42 and 52 k.Da IgG were tested against the
freeze-thawed antigen of the homologous T. evansi population at a dilution of
1/80 using a direct ELISA. The biotinylated IgGs were tested at eight 2-fold
dilutions from 1/10 to 1/1280. The antigen-biotinylated IgG complex was
detected using avidin coupled to HRP (Pierce, USA) at a dilution of 1/10000.
The reaction was visualised using TMB substrate as described in section 2.8.
6. 3. RESULTS:
6. 3. 1. Purification of Antibodies:
The 280 nm absorbance values of the fractions collected from the
protein A affinityPak™ columns are shown in table 6. 2. For the anti-42 k.Da
antibodies the major antibody peak in the column elution occured in the
second eluate fraction with an absorbance value of 2.472 at 280 nm. The first
and the third fractions showed lower absorbance values and the elution of
antibody was considered to be completed by the third fraction. A similar
elution pattern was seen with the anti-52 k.Da antibodies and the anti- 72 k.Da
antibodies with major antibody peaks seen in fraction 2 with an absorbance of
2.458 and 2.180 at 280 nm respectivly.
The first three fractions from the anti 42 and 52 K.Da serum and the




Purification of T. evansi antibodies using protein A affinityPak™ columns
(Pierce Chemical Company, USA)
Absorbance at 280 nm
anti-42 k.Da anti-52 k.Da anti-72 k.Da
Fraction 1: 0.656 0.965 0.010
Fraction 2: 2.472 2.458 2.180
Fraction 3: 1.723 1.204 0.097
Fraction 4: 0.086 0.034 0.000
Fraction 5: 0.000 0.000 0.000
Antibody reactivity:
The ELISA absorbance values of the three fractions of the anti-42 k.Da
antibody decreased with increasing dilutions of the antibody when titrated
against soluble extract of the homologous T. evansi population. The highest
activity was seen in the second eluate fraction with an absorbance of more
than 1.0 at a dilution of 1/1600 (Table 6.3). The first and the third fractions
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showed much lower antibody activity with an absorbance values of 0.149 and
0.132 respectivly at a dilution of 1/1600 (Table 6.3).
Similarly, the greatest antibody activity of the anti-52 k.Da preparation
was seen in the second fraction (Table 6.3) with an absorbance value of more
than 1.0 but only at a dilution of 1/400. Again the first and third fractions
showed much lower absorbance values (0.241 and 0.302 respectively) at this
dilution.
As in the case of the other two preparation the second fraction collected
from the anti-72 k.Da antibody showed highest activity against the
homologous T. evansi population with an absorbance value of 0.962 at a
dilution of 1/10 (Table 6.3).
Consequently the second fraction from each antibody preparation was
selected for further study.
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Table 6. 3: T. evansi antibodies purified by protein A affinityPak™ columns
(Pierce, USA): Reaction of eluate fractions with the homologous T. evansi
population in ELISA.
Antibody dilutions
1/400 1/800 1/1600 1/3200 1/6400 1/12800
Anti-42 k.Da:
Fraction 1 0.315 0.201 0.149 0.127 0.101 0.097
Fraction 2 1.898 1.379 1.001 0.645 0.355 0.239
Fraction 3 0.242 0.165 0.132 0.129 0.102 0.120
Anti-52 k.Da:
Fraction 1 0.241 0.167 0.115 0.079 0.067 0.069
Fraction 2 1.199 0.994 0.660 0.422 0.247 0.172
Fraction 3 0.302 0.217 0.131 0.092 0.071 0.062
Anti-72 k.Da dilution: 1/10 1/20 1/40 1/80 1/160 1/320
Fraction 2 0.962 0.596 0.445 0.264 0.198 0.182
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6. 3. 2. Antibody-labelling:
HRP labelling by the modified periodate method:
HRP conjugates produced by the modified periodate method reacted
with the homologous T. evansi antigens when tested by a direct ELISA which
titrated out with increasing conjugate dilution (Figure 6. 1). The absorbance
values obtained with the anti-42 k.Da conjugate ranged from 1.803 at a
dilution of 1/500 to 0.079 at 1/64000 (Figure 6.1A) while values with the anti-
52 k.Da preparation ranged from 1.713 at a dilution of 1/50 to 0.105 at a
dilution of 1/3200 (Figure 6. IB). Absorbance values with the anti-72 k.Da
conjugate ranged from 1.981 to 0.288 but over a lesser dilution range of 1/10
to 1/320 (Figure 6.1C).
The anti-42 k.Da conjugate showed an estimated titre of 1/2000 at an
absorbance value of 1.0 while the anti-52 k.Da conjugate had an estimated titre
of 1/200 for similar absorbance value (Table 6.4). The anti-72 k.Da McAb
conjugate had an estimated titre of 1/80 at an absorbance value of 1.0 (Table













42 k.Da 1/500 1.803 1000-2000 2:3
52 k.Da 1/50 1.713 100-200 2:3
72 k.Da 1/10 1.981 40-80 2:3
HRP labelling by activated peroxidase kit:
The anti-42 k.Da antibodies conjugated to HRP using the
iminunoPureR activated peroxidase kit (Pierce, USA) did not react with the
homologous T. evansi antigens when tested by ELISA. No colour change was
observed in any of the wells reacted with the conjugated antibodies that
exceeded that seen in the control wells containing only PBS/Tween (Table
6.5).
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Table 6.5: ELISA absorbance values elicited by HRP-labelled anti-42 k.Da
antibodies conjugated by the Pierce ImmunoPure^ activated peroxidase kit.
Conjugate dilutions
1/10 1/20 1/40 1/80 1/160 1/320
Fraction 1 0.039 0.032 0.040 0.040 0.041 0.040
Fraction 2 0.039 0.039 0.043 0.044 0.450 0.047
Fraction 3 0.042 0.038 0.044 0.039 0.051 0.043
Fraction 4 0.044 0.042 0.045 0.043 0.041 0.043
Fraction 5 0.044 0.044 0.047 0.045 0.044 0.043
Fraction 6 0.043 0.043 0.043 0.043 0.042 0.048
Fraction 7 0.043 0.050 0.044 0.041 0.043 0.046
Fraction 8 0.049 0.046 0.049 0.046 0.047 0.045
Fraction 9 0.040 0.039 0.040 0.040 0.041 0.041
Fraction 10 0.041 0.039 0.041 0.045 0.040 0.044 '
PBS/T (0.046)
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Figure 6. 1: HRP-labelled T. evansi antibodies coupled through the modified
periodate method: Reaction to the homologous T. evansi population using
direct ELISA.
Antigen dilution 1/80.
A: anti-42 k.Da antibodies.
B: anti-52 k.Da antibodies.






1:500 1:1000 1:2000 1:4000 1:8000 1:16000 1:32000 1:64000
Biotinylated antibodies:
Biotinylated anti-42 and 52 k.Da IgG reacted with the homologous T.
evansi antigen when tested by direct ELISA using an avidin-HRP conjugate. A
gradual decrease was seen in the absorbance values with increasing dilution of
the biotinylated antibodies (Figure 6. 2). Absorbance values obtained with the
anti-42 k.Da biotinylated antibodies ranged from 2.711 at a dilution of 1/10 to
0.354 at a dilution of 1/1280 while those with the anti-52 k.Da biotinylated
antibodies ranged from 2.252 to 0.165 over the same dilution range.
The biotinylated anti-42 k.Da antibodies showed an ELISA absorbance
value of 1.0 at an estimated titre of 1/320 while the biotinylated anti-52 k.Da
antibodies had an estimated titre of 1/160 for the same absorbance value













42 k.Da 1/10 2.711 1/320 1:4
52 k.Da 1/10 2.252 1/80-1/160 1:4
Figure 6. 2
T. evansi biotinylated antibodies: Reaction to the homologous T. evansi




T. evansi antibodies in the present study were successfully separated
from serum and ascitic fluid using affinity chromatography on protein A
columns. The method is a well established means for the purification of IgG
molecules (Tijssen, 1985, Harlow and Lane, 1988) although IgM antibodies
from some species have been reported to bind to protein A (Tijssen, 1985).
The conditions used in the present study, however, were likely to produce
predominantly IgG antibodies particularly the high salt buffer conditions under
which over 80% of IgM molecules are reported to be removed from the
column with the washing buffer (Tijssen, 1985). The second eluate fraction of
each antibodies in the present study contained the highest concentration of
antibodies as judged by its ability to recognise the ffeeze-thawed T. evansi
antigens in ELISA. This form of assay was selected to reflect the ways in
which the reagents would ultimately be used for detection of antigen in serum
and tissues.
The purified antibodies were successfully labelled with horseradish
peroxidase using the modified periodate method (Wilson and Nakane, 1978).
This is a well-established method for conjugation of the enzyme which
preserves antibody reactivity by coupling to the carbohydrate portion of the
enzyme and antibody molecule which is not usually involved in the antigen
binding (Liddell and Cryer, 1991). Conjugates produced by this method also
usually have higher activities than those produced by the two-step
gluteraldehyde method with Nygren (1982) reporting five fold higher
detectabilities in spot-ELISA with periodate conjugates compared with those
produced with the two-step gluteraldehyde method.
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The conjugates prepared from the antibodies to the42 k.Da antigen
showed the highest reactivity with the T. evartsi soluble antigen preparation.
This could be due either to the greater abundance of this antigen in the soluble
extract from the parasite or because the antibodies themselves were of higher
affinity than those to the 52 k.Da antigen. The anti-72 k.Da McAb conjugates
showed the the lowest activity of the three preparations by direct ELISA test
possibly due to difference in the performance characteristics of the monoclonal
and polyclonal systems (Liddell and Cryer, 1991) or differences in affinity.
Each antibody preparation was also successfully biotinylated and used
in an ELISA to detect T. evansi antigens in association with HRP-labelled
avidin. The biotin derivative used in the present study - Biotin-HPDP, has a
sulfhydryl specific reactivity which preserves the immunological activity of
the antibody molecule. The conjugation processes includes reduction of the
immunoglobulin under mild conditions using mercaptoethylamine which
cleaves the disulphides between the IgG heavy chains while preserving the
disulphide linkages between the heavy and light chains. This ensures that the
biotinylation site is restricted to the hinge region of the antibody leaving the
antigen binding site unaffected.
The anti-42 k.Da antibodies that were directly labelled with HRP had a
higher title compared to when they were coupled to biotin. This might be due
to the low proportion of antibody labelled by the biotin as the manufacturer
(Pierce Chemical Company) estimates that only 57% of the IgG molecules are
likely to be biotinylated using the protocol used in the present study. In the
case of the anti-52 k.Da antibodies, however, no difference was observed
between direct and indirect labelling, suggesting that factors other than those
considered above affect binding efficiency with this form of biotin.
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The Pierce immunoPureR activated peroxidase kit failed to produce a
functionally-labelled HRP conjugate with the anti-42 k.Da antibodies in that
resulting preparation was not able to recognise the homologous T. evansi
antigen. This failure might be due to the 10:1 enzyme:antibody ratio used in
the present study. Although this ratio is within that recommended by the kit
manufacturer other workers have shown that under conditions of 4 to 8-fold
excess of activated enzyme the majority of antibodies remain unlabelled
(Nygren, 1982). Furthermore, the amount of antibody recommended in the kit
was 0.3 mg/conjugation which, depending on the purity of the antibody
preparation might not be enough to recognise the antigen.
In the present study the usefulness of Protein A affinity
chromatography for the separation of IgG from serum and ascitic fluid was
confirmed. The resulting IgG after conjugation to HRP or biotin retained its
activity and could be used in antigen-trapping ELISAs at high working
dilutions for use in subsequent studies monitoring the presence of the






This chapter developed immunoassays and used them to investigate the
dynamics of the 42, 52, and 72 k.Da T. evansi antigens during the course of
infections in mice and rats
7. 1. INTRODUCTION:
A lot of information is known about the interaction between the host
and the intact trypanosomes, in terms of the parasites distribution within the
host, its infectivity and the pathology of the disease. The dynamic aspects and
the fate of individual trypanosome components during infection are, however,
not well understood. Such information might provide better insights into the
host-parasite interaction and provide indicators of infection, progress of the
disease and effectiveness of the chemotherapy. Most of the information on the
behaviour of the trypanosome components during infection has come from
studies designed to produce antigen detection diagnostic tests. Soluble
products of trypanosomal origin have been detected in the circulation of
infected animals using an antigen-capture ELISA based on a polyclonal
antiserum raised against crude trypanosomal antigens (Rae and Luckins,
1984). Nantulya and Lindqvist (1989) in developing antigen-ELISA for
diagnosis of bovine trypanosomiasis using monoclonal antibodies to
membrane antigens of procyclic trypanosomes, detected differences in the
dynamics of circulating trypanosome antigens. T. vivax and T. congolense
antigens were detectable between 10 - 12 days following tsetse challenge,
while T. brucei antigens were detectable between 8 and 14 days. Following
treatment of the infected cattle with Berenil, T. vivax and T. congolense
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antigens were cleared from the circulation within two weeks but the rate of
clearance of T. brucei antigens was slower compared to the other two species.
The host species has also been found to influence the dynamics of the
trypanosome antigens. El Amin et al (1993) during an evaluation of antigen-
ELISA for the diagnosis of T. evansi infection using the above anti-brucei
group-specific antigen detected the antigens in camels 2-4 days after
infection. In goats the parasite antigens were detected after 7 days of infection.
Two types of ELISA, competitive and non-competitive, are suitable for
the detection of parasite components in body fluids (WHO, 1976, Kemeny,
1992). One form of competitive assay involves immobilising antigen onto a
solid matrix and allowing it to compete with antigen present in the test sample
for an enzyme labelled antibody specific to the test antigen which is added
along with the test sample. If the corresponding antigen is present in the test
sample, the labelled antibody is prevented from binding to the immobilised
antigen and a reduced absorbance value is obtained. A disadvantage of the
immobilised antigen method is that, a precise, limiting quantity of the antigen
has to be immobilised. Also any dissociated antigen will compete for the
labelled antibody (Kemeny, 1992). An alternative assay configuration consists
of immobilised antibody and an enzyme-labelled antigen competes with any
unlabelled antigen in the sample for the immobilised antibody. A disadvantage
of this immobilised antibody method is that the antigen may be altered by
conjugation to the enzyme and the antibody may not be able to detect it. The
competitive methods are useful for quantitation of antigen present in test
samples (Tijssen, 1985, Kemeny, 1992).
In non-competitive assays specific antibody is immobilised onto the
solid phase before the addition of test sample suspected of containing the
corresponding antigen. Any antigen binding to the antibody is detected with a
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conjugate consisting of the enzyme-labelled primary antibody used to coat the
plate. Detectability of such assays can be increased by using a linked avidin-
biotin system (Tijssen, 1985, Liddell and Cryer, 1991).
In addition to circulating in the blood trypanosome materials are also
expected to be present in the tissues of the infected host and indeed they are
known to inhabit extravascular sites throughout the host body (Seed and
Effron, 1973, Seed et al, 1984, Sudarto et al, 1990). Enzyme immunoassays
have been successfully applied to the localisation of antigens in cells or tissue
sections both at the light and electron microscope level in studies on the
function, development and processing of antigens in cells or tissues (Iwamasa
et al, 1982, Leppi et al, 1982, Naritoku and Taylor, 1982, Mwangi et al,
1990,Sudarto et al, 1990). These methods can be used with paraffin sections
from fixed tissues or cryostat sections of fresh or fixed tissues (Tijssen, 1985).
A disadvantage of paraffin sections is that they do not preserve many antigens,
while ciyostat sections are reputed to preserve the antigens and cell structures
(Harlow and Lane, 1988). The successful detection of antigens in tissue
sections is influenced by three major factors. First the local antigen
concentration at time of collection; second the type of tissue ^fixation, and third
the nature of the assay (Harlow and Lane, 1988). Antigens need to be present
at a high concentration for successful detection. Soluble antigens are often
difficult to distinguish from background signal even when present at high
concentration as they tend to diffuse in the tissues. Insoluble antigens such as
membrane antigens are easy to detect because they have characteristic
structures and many identical antibody-binding sites. Depending on their
chemical composition antigens may be extracted or denatured by particular
fixative agents such as methanol or acetone. These solvents are suitable for
large proteins, but may extract some antigens. Formaldehyde denatures large
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proteins and is generally more suitable for smaller antigens (Tijssen, 1985).
The assay method also influences the detection of the antigens. Methods using
enzyme-labelled antibodies have a higher sensitivity than the
immunofluorescent methods particularly when certain procedures are used
such as peroxidase anti-peroxidase (PAP) method or avidin-biotin-peroxidase
complex (ABC) (Tijssen, 1985). Detection methods based on fluorochrome-
labelled antibodies, however, offer a better resolution (Harlow and Lane,
1988).
The studies in this chapter describe the development and application of
assays to detect T. evansi antigens in blood and tissues
7. 2. ASSAY DEVELOPMENT FOR T. EVANSI ANTIGENS
SERUM AND TISSUE EXTRACTS:
7. 2. 1. BASIC ASSAY PROCEDURE: (antigen-ELISA)
A basic test procedure consisted of coating ELISA microtitre plates
with an IgG preparation to either the 42 or 52 k.Da antigens. The plates were
coated with a 100 pl/well of a 2-fold dilution of IgG from 1/50-1/6400,
incubated overnight at 4°C and washed as described in section 2.8. Each
coating dilution was then reacted with 100 pl/well of either a freezed-thawed
T. evansi extract or normal rabbit serum using a 2-fold dilution series from
1/50-1/400. The remaining area of the plate was incubated with 100 pl/well
PBS/Tween. After incubation at 37°C and washing (section 2.8), 100 pl/well
of the anti-42 or 52 k.Da IgG preparations labelled with either horseradish
peroxidase or biotin was added to each well
The peroxidase-labelled anti-42 and anti-52 k.Da IgG were diluted to
1/200 in PBS/Tween before use in the assay. Plates were incubated at 37°C
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for 30 minutes with the conjugate and then washed before adding 100 pl/well
of the TMB substrate system (section 2.8). After incubation for 15 minutes the
reaction was stopped by the addition of 50fil/well of 2M sulphuric acid. The
optical densities of each well was read at 450 nm using an ELISA plate
reading photometer (MultiskanR Plus, Labsystems Finland).
The biotinylated IgG conjugates were used at a dilution of 1/160 in
PBS/Tween, incubated for 1 hour at 37°C before washing. The bound
conjugate was detected with either HRP-labelled avidin at a dilution of
1/10000 in PBS/Tween using the TMB substrate system, or with alkaline
phosphatase-labelled avidin at a dilution of 1/5000 using 2.5 mM p-
nitrophenyl phosphate (PNPP) substrate in 10 mM diethanolamine and 0.5
mM MgCl2. The resulting absorbance values were read at 405 nm.
A similar assay procedure was used to establish the working dilution for
the unlabelled McAb to the 72 k.Da antigen by coating the plates with
unlabelled IgG in a 2-fold dilution series ranging from 1/10 to 1/1280. As
before each coating dilution in 2/3 of the plate was then reacted with a 2-fold
dilution series ranging from 1/10-1/1280 of the standard soluble T. evansi
extract. The remaining third of the microtitre plate was incubated with
PBS/Tween only. Antigen binding was assayed using a peroxidase labelled
anti-72 k.Da IgG preparation at a dilution of 1/40. The assay was performed as
described for the HRP system above.
RESULTS:
Neither the peroxidase-labelled or biotinylated antibodies to the 42 or
52 k.Da antigen gave a sufficiently strong signal that differentiated between
the T. evansi soluble extract and normal rabbit serum (Table 7. 1).
156
Table 7.1 Comparison of the reaction of peroxidase-labelled and biotinylated
anti-42 k.Da antibodies with T. evansi antigen and normal rabbit serum in
antigen-ELISA
coating antibody dilutions
1/50 1/100 1/200 1/400 1/800 1/1600 1/3200 1/6400
HRP-Labelled (1/200)
antigen (1/50) 0.569 0.494 0.475 0.433 0.408 0.303 0.259 0.207
NRS (1/50) 0.560 0.457 0.450 0.450 0.416 0.310 0.213 0.172
PBS/T 0.623 0.576 0.560 0.524 0.496 0.391 0.287 0.220
Biotinylated (1/160): (avidin-HRP)
antigen (1/50) 0.538 0.500 0.488 0.484 0.483 0.462 0.332 0.254
NRS (1/50) 0.589 0.561 0.546 0.512 0.475 0.450 0.417 0.301
PBS/T 0.544 0.534 0.528 0.514 0.489 0.446 0.392 0.297
Biotinlated (1/160): (avidin-AP)
antigen (1/50) 0.187 0.120 0.113 0.110 0.096 0.050 0.050 0.045
NRS (1/50) 0.162 0.117 0.112 0.112 0.089 0.054 0.050 0.041
PBS/T (1/50) 0.158 0,115 0,110 0,107 0,083 0,061 0,049 0,044
The peroxidase labelled anti-72 k.Da McAb detected the homologous T.
evansi antigen at a dilution of up to 1/320. A working dilution of up to 1/640
for the unlabelled IgG was able to react with the homologous antigen at a
dilution of 1/80 (Table 7. 2).
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Table 7. 2
Determination of working dilution of unlabelled McAb
coating antibody dilutions
1/10 1/20 1/40 1/80 1/160 1/320 1/640 1/1280
Antigen dilution:
1/10 1.198 1.068 1.106 1.113 1.175 1.074 1.127 1.062
1/20 0.890 0.745 0.705 0.764 0.737 0.678 0.708 0.643
1/40 0.629 0.561 0.516 0.533 0.484 0.456 0.445 0.384
1/80 0.481 0.533 0.425 0.379 0.327 0.285 0.332 0.265
1/160 0.429 0.419 0.339 0.319 0.263 0.246 0.257 0.246
1/320 0.337 0.320 0.299 0.328 0.259 0.247 0.229 0.190
1/640 0.331 0.381 0.340 0.292 0.262 0.224 0.207 0.186




The basic ELISA using anti-72 k.da McAb conjugates effectively
discriminated between soluble T.evansi antigen and the control wells
containing PBS/Tween. However, neither the anti-42 or 52 k.Da conjugates
could differentiate between the T. evansi antigen and normal rabbit serum as
similar absorbance values were obtained with antigen, normal rabbit serum
and PBS/Tween irrespective of dilution of antibody or antigen.
Evidence had been previously obtained that each unlabelled antibody
preparation was active against the parasite antigen under such assay conditions
(see section six). The conjugated preparations were also active as evidence by
its reaction with the substrate in the present basic assay and the soluble
trypanosome extract should have contained enough of both the 42 and 52 k.Da
antigens to be detected by the antibodies.
The failure of this particular assay system is attributed to high
absorbance values with the negative control system rather than lack of
reactivity with the target antigen. Such results could arise from the binding of
normal rabbit serum to the unlabelled IgG or the binding of the conjugate to
the unlabelled IgG. Such non-specific reactions are known to increase
background levels in the such assays and adversely affect its discriminatory
power (Tijssen, 1985). These non-specific reactions can be due to a number of
mechanisms (Tijssen, 1985, Tsang et al, 1985) and number of different
approaches have been used to reduce their impact on assays. These include
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a)Adsorption of labelled antibody to the solid matrix that can result in high
background levels. This can be eliminated or reduced by blocking the
remaining binding sites of the matrix using blocking agents such as bovine
serum albumin (Towbin et al, 1979, Aubertin et al, 1983), b)The presence of
auto-antibodies (rheumatoid factors) in the assay complex (Tijssen, 1985)
which react specifically with IgG or IgM of the same species giving rise to
false-positive reactions. The reaction of the normal rabbit serum with the
unlabelled IgG and that of the labelled and unlabelled IgG in the present study
could possibly be due to these rheumatoid factors. Since the Fc fragment of
antibody is the only part of the molecule that carries receptors for rheumatoid
factors (Stanworth and Turner, 1978), a number of approaches have been used
to reduce or eliminate interference by rheumatoid factors such as the use of
conjugates based on the F(ab)2 fragment (Tijssen, 1985). Rheumatoid factors
can also be removed with an excess of Fc fragments (Tijssen, 1985) or more
easily by pre-incubation with small amount (1-2%) of normal serum from the
same species (Kemeny, 1992).
Further studies were, therefore, carried out to determine the source of
the non-specific reactions obtained with the basic assay procedure in an —
attempt to improve the overall performance of the antigen-trapping system.
7. 2. 2. Improving the basic assay:
A number of factors influencing the assay system were investigated
with the aim of improving the discriminating power of the assay. These were
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all carried out initially with anti-42 k.Da IgG preparation and promising
modifications applied to the anti-52k.Da preparation.
(a) Blocking the binding sites of the plate with bovine serum albumin (BSA):
A blocking step in which 100 pi per well of 1% BSA (w/v) was
introduced in the above basic assay with the aim of blocking any remaining
binding sites on the microtitre plates after incubation with the unlabelled IgG.
The remainder of the assay was performed as previously described for the
peroxidase-labelled IgG and TMB system.
(b) Incorporation of normal rabbit serum (NRS) in the conjugate dilution
buffer:
1% (v/v) normal rabbit serum was added to PBS/Tween that was used
for preparation of working dilution of the peroxidase-labelled or biotinylated
anti-42 IgG conjugates. In this study the plates were coated with the anti-42
IgG at a dilution of 1/50 in the carbonate/bicarbonate buffer, incubated and
washed as described previously. The soluble T. evansi antigens and NRS in
PBS were used at a two-fold dilution series ranging from 1/50 to 1/6400 and
the conjugated antibodies were used at a dilution range from 1/200 to 1/3200
in PBS/Tween containing 1% NRS.
The addition of 1% NRS to the conjugate dilution buffer was also
undertaken with the anti-52 k.Da antibodies. Dilution ranges investigated in
this case were as used in the basic assay described in section 7.2.1 with the
peroxidase-labelled and biotinylated anti-52 k.Da antibodies diluted in
PBS/Tween containing 1% (v/v) NRS.
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(c) Salt precipitation of immunoglobulins from serum:
Saturated ammonium sulphate (SAS) (1000 g / 1 litre of distilled water)
was used to precipitate the immunoglobulins in the serum raised against the 42
k.Da antigen. A two ml serum sample was diluted 1:2 in ice-cold PBS and
4.92 ml of SAS was added dropwise to give a final concentration of 45%
saturation (v/v). The mixture was stirred at 4°C for 30 minutes, and
centrifuged at 1000 g for 15 minutes at 4°C. The resulting precipitate was
washed by centrifugation with 45% SAS as above. It was then re-dissolved in
2 ml of PBS and centrifuged at 5000 g for 15 minutes at 4°C to remove any
insoluble materials. The immunoglobulin (Ig) in the supernatant was re-
precipitated as above using 1.34 ml of SAS to give a final concentration of
40% saturation and then centrifuged at 1000 g, 15 minutes, at 4°C. The
precipitate was redissolved in 0.5 ml PBS and dialysed against five litres PBS
overnight at 4°C. The dialysed Ig solution was finally centrifuged at 5000 g,
15 minutes, at 4°C to remove any insoluble materials. The protein content of
the Ig containing supernatant was measured spectrophotometrically at 280 nm
and the Ig solution was stored at -20°C.
The immunoglobulin preparation was then coupled to HRP using the
modified periodate method as described in section 6 .3.
The labelled and unlabelled SAS precipitated immunoglobulin
preparations were then used in the basic assay with the SAS precipitated
preparations replacing the protein A separated preparations.
(d) F(ab)2-HRP conjugate:
F(ab)2 fragment was prepared from the protein A separated anti-42
k.Da IgG using ImmunoPureR F(ab)2 Preparation Kit (Pierce, USA) and
following the manufacturers instructions involving pepsin digestion of the IgG
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molecule. This fragment was then coupled to HRP using the modified
periodate method as described in section 6.2.2.
The activity of the F(ab)2 preparation was tested in the basic assay by
coating the microtitre plates with the anti-42 k.Da F(ab)2 fragment at a
dilution of 1/50 in the carbonate /bicarbonate buffer. The T. evansi soluble
materials and normal rabbit serum in PBS were used at a two-fold dilution
range from 1/25 to 1/400. The antigen-antibody complex was detected with the
anti-42 k.Da F(ab)2~HRP conjugate at dilutions ranging from 1/50 to 1/6400 in
PBS/Tween.
RESULTS:
The introduction of a blocking step with 1% BSA did not improve the
performance of the basic assay as assay continued to fail to differentiate
between the antigen and NRS. Results for the antigen and NRS at 1/50
dilution is shown in table 7.3.
The inclusion of 1% normal rabbit serum in PBS/Tween, as a blocking
agent in the buffer used to dilute the HRP-labelled or biotinylated anti-42 k.Da
antibodies, however, substantially reduced the absorbance with the NRS and




The effect of a BSA blocking step, on assay performance
Coating antibody dilutions




0.570 0.559 0.553 0.540 0.398 0.359 0.319 0.323
0.609 0.587 0.576 0.560 0.406 0.324 0.377 0.310
0.523 0.525 0.517 0.508 0.467 0.371 0.311 0.315
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Table 7.4
The effect of using PBS/T containing 1% normal rabbit serum as a dilution
buffer for the antibody conjugates on the assay performance
Conjugated antibody dilutions
1/200 1/400 1/800 1/1600 1/3200
HRP-Labelled:
antigen (1/50) 1.048 0.577 0.400 0.306 0.136
NRS (1/50) 0.286 0.176 0.116 0.089 0.063
PBS/T 0.203 0.118 0.097 0.087 0.074
Biotinylated:
antigen (1/50) 1.231 0.858 0.624 0.392 0.265
NRS (1/50) 0.458 0.338 0.260 0.180 0.119
PBS/T 0.303 0.254 0.218 0.172 0.126
Similar results were also obtained with the 52 k.Da antibodies (Table
7.5).
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Table 7.5 Dilution of labelled anti-52 k.Da antibodies with PBS/Tween
containing 1%NRS
coating antibody dilutions
1/50 1/100 1/200 1/400 1/800 1/1600 1/3200 1/6400
HRP-Labelled (1/200)
antigen (1/50) 0.994 0.900 0.763 0.652 0.656 0.640 0.459 0.460
NRS (1/50) 0.294 0.247 0.178 0.159 0.142 0.134 0.106 0.103
PBS/T 0.290 0.288 0.179 0.151 0.126 0.138 0.105 0.117
Biotinylated (1/160): (avidin-HRP)
antigen (1/50) 1.723 1.536 1.543 1.714 1.599 1.542 0.561 0.573
NRS (1/50) 0.290 0.222 0.235 0.287 0.291 0.294 0.290 0.290
PBS/T 0.266 0.264 0.254 0.265 0.289 0.290 0.288 0.289
Immunoglobulin purified by salt precipitation produced reduced
absorbance readings with both antigen and NRS compared to those obtained
with the same antibody purified with protein A chromatography. The assay,
however, did not differentiate between the antigen and NRS (Table 7.6).
166
Table 7. 6 The effect of immunoglobulin purification method (SAS
precipitation) on the assay performance
Coating antibody dilutions
















The assay using HRP anti-42 k.Da F(ab)2 fragment produced
significant signal strength to differentiate between the antigen and NRS. A
binding ratio of 3.0 was obtained at a 1/100 dilution of F(ab)2 (Table 7.7).
Table 7, 7 The effect of F(ab)2-HRP on reduction of non-specific reaction
F(ab)2-HRP dilutions
1/50 1/100 1/200 1/400 1/800 1/1600 1/3200 1/6400
antigen (1/50) 1.108 0.732 0.392 0.192 0.119 0.077 0.060 0.048
NRS (1/50) 0.457 0.272 0.129 0.087 0.063 0.049 0.046 0.045
PBS/T 0.402 0.274 0.160 0.092 0.069 0.065 0.047 0.047
DISCUSSION:
In the present assay the addition of 1% normal rabbit serum to the
conjugate dilution buffer increased the binding ratio with the antigen
essentially by reducing the absorbance of the NRS control. Consequently, the
assay was able to discriminate between the antigen and NRS. The only other
modification to the assay that had a beneficial effect on the discriminatory
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power of the assay was the use of F(ab)2 fragments rather than whole IgG
molecule preparations. These results suggests that the presence of rheumatoid
factors causing cross-reactions between the labelled antibody and coating IgG
was the major cause of the failure of the basic assay to discriminate between
antigen and normal rabbit serum. This type of non-specific-reactions have
been shown to be neutralised by pre-incubation with small amount of serum
(1-2%) from the cross reacting species (Kemeny, 1992). 1% normal serum
have been used in corporation with PBS/T for dilution of antibody conjugates
to reduce or eliminate non-specific reaction in antigen-ELISAs (Nantulya el al,
1989; Nantulya and Lindqvist, 1989). The presence of normal serum in the
conjugate diluent should help to neutralise the effect of rheumatoid factors by
binding to the offending antibody. Similarity, the use of F(ab)2 fragment
reduced non-specific reactivity. This fragment does not carry receptors for
rheumatoid factors (Stanworth and Turner, 1978) hence the use of F(ab)2
fragment should eliminate the effect of these rheumatoid factors.
Both of the modifications used in this study that increased the
absorbance values of the antigen-antibody reaction, therefore, appeared to be
associated with rheumatoid-factor activity. The effect possibly arising from the
coating antibody competing with the antigen for the labelled antibody in the
assay in the absence of NRS or F(ab)2 fragment. These modifications probably
served to increase the number of labelled antibody molecules binding only to
the antigen with strong avidity compared to those with the coating IgG? hence
increasing the absorbance level in the antigen-containing wells. The reduction
in the absorbance values before the assay modification was possibly due to the
dissocciation of the bond between the conjugate and the coating IgG during
washing as these cross-reactants usually bind less avidly than the specific
antigens (Tijssen, 1985).
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The inclusion of a BSA blocking step in the assay did not improve the
discriminatory power of the basic assay. This result suggests that non-specific
binding of the antigen and/or the labelled antibody to the wells of the
microtitre plate was not responsible for the increased level of background.
This is probably linked to the presence of Tween 20 in PBS for all wash
solutions and diluents which is an effective a blocking agent that inactivates
the binding sites of the matrix (Mohammad and Esen, 1989).
Possible interactions between the IgG preparations arising from their
isolation using protein A matrix were discarded as the substitution of
ammonium sulphate precipitated immunoglobulins did not improve the
discriminating power of the assay.
Consequently, in all further studies 1% NRS was included in the diluent
for appropriate antibody conjugate.
7. 2. 3. Comparison of the Sensitivity of Different Conjugates for Antigen
Detection:
The sensitivity of both peroxidase-labelled and biotinylated anti-42 and
52 k.Da antibodies was compared using the modified antigen capture-ELISA
by titration against T. evansi soluble extract.
In this part of the study the basic ELISA assay as described in section
7.2.1 was performed in which microtitre plates were coated with unlabelled
IgG to the 42 or 52 k.Da antigen diluted to 1/50 or 1/200. The coated plates
were then titrated with the T. evansi soluble extract along with NRS as control
over a 2-fold dilution range from 1/50 to 1/6400 PBS. The equivalent labelled
IgG preparation was then added to all wells at a dilution of 1/200 in
PBS/Tween containing 1% (v/v) NRS.
Conjugates preparations tested in this way were a) HRP-labelled anti-
42 and 52 k.Da IgG, b) biotinylated IgG to 42 and 52 k.Da with avidin coupled
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to HRP or alkaline phosphatase. Results were expressed as an antigen titre,
equivalent to the last antigen dilution that showed an absorbance of at least
twice that of the NRS at the same dilution.
RESULTS:
The biotinylated anti-42 k.Da antibodies utilising the avidin-HRP
detection system produced the highest antigen end-point titre of 1/400 along
with the highest antigen binding ratios (Table 7.8). The peroxidase-labelled
antibodies had an slightly lower end-point titre (1/200) and antigen binding
ratios, while the lowest performance indicators were seen with the biotin-
avidin alkaline phosphatase system with an end-point titre of 1/50 and a
binding ratios close to 2.0 (Table 7.8). Similarly, in case of the 52 k.Da
antigen system the biotin-avidin HRP had the highest antigen end-point titre
and antigen binding ratios (Table 7.8).
Overall the anti-52 k.Da conjugates appeared to be able to detect the T.
evansi soluble extract at higher dilutions than the anti-42 k.Da conjugates.
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Table 7. 8
Comparison of sensitivity of the conjugated anti-42 and 52 k.Da antibodies
Antigen end-point titre Absorbance at end-point titre
Antigen NRS Antigen binding Ratio
Anti-42 k.Da conjugates:
Biotin-avidin-HRP: 1/400 0.985 0.271 3.6
Biotin-avidin-AP: 1/50 0.239 0.115 2.1
HRP conjugate: 1/200 0.419 0.160 2.6
Anti-52 k.Da antibodies:
Biotin-avidin-HRP: 1/800 1.238 0.385 3.2
Biotin-avidin-AP: 1/400 0.349 0.138 2.5
HRP conjugate: 1/400 0.534 0.246 2.2
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DISCUSSION:
The results from the present study have confirmed the ability of the
antibodies raised to the 42 or 52 k.Da antigens to detect their corresponding
antigens when the antibodies are coupled either directly to HRP or used in a
biotin-avidin system. In the present study the biotin-avidin system utilising
HRP as the enzyme conjugate was found to be the most sensitive detection
system as it could detect lower concentration of antigen as judged by the
results of end-point titration of antigen. This is probably related to the large
number of label molecules that are attached by to the antibody when compared
to the directly labelled systems and increases detectability (Liddell and Cryer,
1991, Tijssen, 1985, Johnstone and Thorpe, 1982).
The anti-52 k.Da antibodies in the present study detected the T. evansi
crude antigen at greater dilutions than those raised against the 42 k.Da antigen
although the concentration of the 52 k.Da antigen was lower than that of 42
k.Da as determined by densitometric analysis of SDS-PAGE preprations
(results not shown). This suggests that the 52 k.Da antibodies had a higher
affinity for the antigen than the equivalent ones to the 42 k.Da antigen.
The biotinylated antibodies to the 42 or 52 k.Da antigen utilising avidin
coupled to horseradish peroxidase were consequently chosen for the
development of assays for the detection of their corresponding antigens in
blood and tissues.
7. 2. 4. Evaluation of the developed assay and development of an
immunohistochemical test:
After the establishment of the modified ELISA assay under in vitro
conditions the assay was subsequently evaluated for its ability to detect the
antigens in vivo in rabbits and mice.
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[a] Evaluation of the ELISA test:
(i) Materials and Methods:
Two sources of antigen were utilised in this assay, serum and tissue
extracts.
(a) Serum:
A rabbit was inoculated intravenously with 10 mg of ffeeze-thawed T.
evansi soluble extract, and bled for serum one day before inoculation, at 0.5,
1, 2, 4, and 24 hours post-inoculation, and then daily until the end of the
experiment 6 days later. The serum was prepared as described in section 2.6.
(b) Tissue extracts:
Two mice were infected intraperitoneally with 1x10^ trypanosomes
TREU 2165. On day 4 post-infection, the organs of one of the infected mice as
well as a non-infected control mouse were perfused as described below and a
number of their organs collected and used for the preparation of tissue extracts
specifically, the organs collected were spleen, liver, kidneys, brain, heart, and
lungs. At the same time remaining infected mouse was treated with Berenil at
a dose rate of 75 pg/mouse and its organs was perfused 10 days later.
Organ perfusion was carried out according to the method of Mulumba
and Wery (1983) as modified by Turner et al (1986). In this method the
posterior and anterior venae cavae were cut, and heparinised PSG was injected
into the left ventricle. Perfusion was continued for a further 20 ml after the
kidneys became fully blanched.
The protocol used for the preparation of the tissue extracts was adapted
from that of Ekejindu et al (1986) and Dignam (1990). Briefly, tissue samples
from each organ were washed several times in cold PBS before they were cut
into small pieces in PBS using forceps and scissors. Further disruption of the
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tissues was achieved by pushing the tissue through a coarse sieve with the
blunt edge of the forceps. Large tissue particles were removed by
centrifugation at 15000 g for 30 minutes at 4°C and the supernatant was
carefully removed, aliquoted and stored at -20°C, or assayed directly,
(c) Assay procedure:
The basic assay was performed by coating ELISA microtitre plates
overnight at 4°C with the unlabelled anti-42, 52 or 72 k.Da antibodies at a
dilution of 1/50, 1/200 or 1/640 respectively. Each antibody was then reacted
with 100 pl/well of undiluted serum collected from the rabbit before and at
different times after inoculation with T. evansi soluble extract or tissue extract
from normal or infected mice diluted to 1/16 in PBS/T. Biotinylated anti-42 or
52 k.Da antibodies at a dilution of 1/200, or HRP-labelled anti-72 k.Da McAb
at a dilution of 1/40 were then added to each well and the assay was performed
as described previously (section 7.2.1). Serum samples and tissue extracts
showing absorbance values more than twice that of the pre-inoculation serum
from the rabbit or normal mouse tissues were considered positive for T. evansi
antigens.
[B] Immunohistochemical detection of antigens in tissues:
(i) Materials and Methods:
(a) Preparation of cryostat sections:
Samples of organs from the infected and control mice were frozen at -
70°C immediately after being taken from these animals. They were trimmed
frozen and mounted onto cold specimen holders using OCT embedding
compound (Tissue-Tek, Miles Labs., Ltd.) and 8 p.m thick sections were cut at
-42°C using a cryostat microtome (Bright Instrument Company Ltd.). The
sections were mounted on 8 well multispot slides (C.A. Hendley, (Essex),
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Ltd.) which had previously been dipped into a chrome alum gelatine solution
(Appendix 24) and dried overnight at 37°C.
The sections were allowed to dry for 2 - 3 hours at 37°C and were then
fixed in cold acetone at -20°C for 30 minutes and left to dry for 10 minutes.
The sections were rinsed once in PBS for 10 minutes, kept frozen or used
directly in the assay.
(b) Assay procedure:
Any endogenous peroxidase in the tissue sections was inactivated by
incubation for 10 minutes in 70% (v/v) ethanol, in methanol containing 1%
(v/v) hydrogen peroxide for 10 minutes, and for a further 10 minutes in 70%
ethanol. The sections were then dried and rinsed once in PBS for 15 minutes.
Sections from each organ were then incubated for one hour at room
temperature under moist conditions with 50 pi of the biotinylated antibodies to
the 42 or 52 k.Da antigen applied as a 2-fold dilution range from 1/10 - 1/40 or
peroxidase-labelled McAb to the 72 k.Da antigen applied over a 2-fold
dilution range from 1/5 to 1/20.
Unreacted antibodies were removed by washing the sections in three
changes of PBS of 5 minutes each, and excess buffer was removed with a
tissue paper around the edges of the slides. Each section containing the
biotinylated antibodies received 50 pi of avidin-HRP at a dilution of 1/200,
incubated and washed as above. 50 pi of S^-diaminobenzidine substrate
(Sigma Fast™ DAB tablets) dissolved in distilled water were then added to all
sections and incubated for 15 minutes. The sections were then washed as
before and counter-stained by dipping in aqueous hematoxylin for 10 seconds.
The sections were then washed in distilled water for 5 minutes and dehydrated
in graded concentrations of ethanol: twice in 70%, 90% and twice in 100%.
The sections were cleared twice in Histo-clear™ (National Diagnostics, New
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Jersey, USA), mounted in DPX and examined for the presence of antigen-
antibody complex under light microscope. The dehydration and clearing steps
were applied for 30 seconds each.
Controls for the specificity of the test include the replacement of the
conjugated anti-T. evansi antibodies with normal rabbit serum /or PBS, and
equivalent of tissues from uninfected mice.
RESULTS:
(i) T. evansi antigens in the circulation of the inoculated rabbit:
The anti-42 k.Da T. evansi antibodies detected antigens in the blood of
the rabbit by 2 hours after inoculation. Thereafter, there was a gradual decline
in the antigen titre which reached pre-inoculation level at 72 hours post-
inoculation (Figure 7. 1). Similarly, the 52 k.Da antigen was also detected at 2
hours after inoculation and gradually declined to the pre-inoculation level by
72 hours post-inoculation (Figure 7. 2). The 72 k.Da antigen, however,
reached a detection level at one hour post-inoculation and gradually declined
to pre-inoculation level 24 hours post-inoculation (Figure 7. 3).
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Figure 7. 1
The dynamics of the 42 k.Da antigen in the circulation of rabbit inoculated
with T. evansi crude soluble materials.
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Figure 7. 2
The dynamics of the 52 k.Da antigen in the circulation of rabbit inoculated





The dynamics of the 72 .k.Da antigen in the circulation of rabbit inoculated




(ii) T. evansi antigens in tissue extracts of infected mice:
The antibodies to 42 k.Da antigen detected the antigen in tissue extracts
collected from the spleen and brain of the infected mice at 4 days after
infection (Table 7. 11). By 14 days post-infection this antigen was only
detectable in the kidneys.
Evidence of the presence of 52 k.Da antigen was not detected in any of
the organs extracts at 4 days after infection (Table 7. 11), but by 14 days post¬
infection evidence of the antigen was found in tissue extracts from kidneys,
brain, heart and lungs (Table 7. 11).
The 72 k.Da antigen was not detected in any of the tissue extracts
examined (Table 7. 11).
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Table 7. 11
Absorbance values of T. evansi antigens in tissue extracts of the
experimentally infected mice.
42 k.Da 52 k.Da 72 k.Da
normal infected normal infected normal infected
At 4 davs:
spleen 0.261 1.024* 0.301 0.335 0.199 0.200
liver 0.809 0.991 0.805 0.824 0.233 0.391
kidney 0.245 0.411 0.242 0.301 0.165 0.181
lung 0.270 0.486 0.290 0.442 0.163 0.204
heart 0.261 0.513 0.270 0.380 0.172 0.183
brain 0.265 0.753* 0.267 0.421 0.178 0.195
At 14 davs:
spleen 0.251 0.488 0.303 0.564 0.196 0.203
liver 0.801 0.974 0.808 0.820 0.238 0.357
kidney 0.244 0.503* 0.240 0.569* 0.162 0.172
lung 0.262 0.440 0.286 0.645* 0.169 0.170
heart 0.259 0.378 0.274 0.550* 0.174 0.182
brain 0.267 0.457 0.265 0.575* 0.182 0.265
* s positive reaction (more than twice that of uninfected control),
(iii) T. evansi antigens on cryostat sections:
None of the three antigens were detected in the cryostat sections
prepared from the organs collected from the infected mice on day 4 or 14 post¬
infection (Table 7. 12).
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Table 7. 12
T. evansi antigens detected in tissue extracts and ciyostat sections from mice
experimentally infected with T. evansi
42 k.Da antigen 52 k.Da antigen 72 k.Da antigen
organ extract section extract section extract section
spleen + * _ _ _ _
liver _ _ _ _ _
kidney + ** _ -i- ** _ _
brain + * + ** _
heart _ + ** _ _ _
lung - - -1- ** - - -
N.B.
*: 4 days after infection.
* *: 14 days after infection.
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7. 2. 5. Antigen dynamics in T. evansi infected rats:
(i) Materials and Methods:
(a) Experimental animals:
Ten male Wistar rats (Bantin & Kingman Ltd. UK) were used in this
experiment, 4 of which served as un-infected controls.
(b) Infection protocol:
Six rats were infected intraperitoneally with 1x10^ T. evansi (TREU
2165) trypanosomes per rat. Parasitaemia was monitored daily until the end of
the experiment on day 17 post-infection using the microhaematocrit
centrifugation technique. Tail blood was collected daily from the infected and
control rats as a source of serum. All infected rats were treated with Berenil on
day 8 post-infection. On day 12 after infection one of the infected rats was
sacrificed, perfused as described previously and spleen, liver, kidney, lung,
heart and brain removed for preparation of tissue extracts and cryostat
sections. These materials were also prepared at the end of the study from
surviving infected and control rats.
(c) Detection of antigens in circulation and tissue extracts:
The antigen-ELISA developed in the previous section was used to
monitor levels of the 42, 52, and 72 k.Da antigens in the blood and tissues of
the infected rats. Pooled serum collected from the each infected or uninfected
rats was diluted to 1/3 before use in the assay, while tissue extracts were
diluted to 1/16 in PBS/T before use. Serum and tissue extracts samples
showing an absorbance value greater than twice that from uninfected control
animals were considered positive for the antigens.
(d) Detection of antigens on cryostat sections:
Cryostat sections prepared from the organs collected from both infected
and uninfected rats were examined for the presence of T. evansi antigens using
the immunohistochemical technique described in the previous section. The
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biotinylated antibodies to the 42 and 52 k.Da antigens were used at a dilution
of 1/20 and the HRP-labelled McAb to the 72 k.Da at a dilution of 1/10 and
the assay performed as described previously.
RESULTS:
(i) Parasitaemia:
The parasites were first detected in the tail blood of the rats at 4 days
after infection. Thereafter, their number increased reaching a peak on day 8
post-infection. Following treatment with Berenil on day 8, the parasites
disappeared from the circulation the next day and were not detected up to the
time that the experiment was terminated at 17 days post-infection (Table 7.
13).
(ii) Antigenaemia:
The antibodies to the 52 k.Da antigen detected the antigen in the blood
of the rats by day 6, reaching peak activity on day 8 post-infection. After
treatment on day 8 the activity declined reaching negative control level on day
11 post-infection and the rats remained antigen-negative until the end of the
experiment 17 days after infection (Table 7. 13).
The 42 k.Da antigen activity was first detected on day 7 after infection
reaching a peak activity on day 8 post-infection. After treatment on day 8,
there was a gradual decrease in the activity reaching negative control levels by
day 11 post-infection that was maintained until the end of the experiment 17
days after infection. (Table 7. 13).
The presence of the 72 k.Da antigen was first detected on day 8 post¬
infection. Again, after treatment, there was a sharp decline in the activity level
reaching negative control level by the next day that was maintained until the
end of experiment 17 days after infection.(Table 7. 13).
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[CJ Antigens in Tissues:
The 42 k.Da antigen was detected in the spleen and kidneys of the
infected rats when extracts of tissues collected at the end of the experiment 17
days after infection were examined by antigen-ELISA (Table 7. 14). This
antigen was not detected in any tissue extracts collected one day following the
disappearance of the antigen from the circulation. The 52 k.Da was detected
only in the spleen extract prepared 17 days after infection (Table 7. 14). The
72 k.Da antigen was not detected in any of the tissue extracts examined (Table
7. 14).
None of the antigens were detected in the sections prepared from the
infected rats one day after the disappearance of the antigens from the blood
circulation or at the end of the experiment 17 days post-infection.
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Table 7. 13
Parasitaemia and antigenaemia in the experimental rats
days tryps 42 control 52 control 72 control
after per 20 k.Da serum k.Da serum k.Da serum
infect. fields O.D* O.D* O.D* O.D* O.D* O.D*
1 0 0.212 0.210 0.257 0.189 0.154 0.150
2 0 0.360 0.216 0.286 0.249 0.149 0.140
3 0 0.379 0.209 0.249 0.220 0.150 0.144
4 10 0.350 0.260 0.286 0.215 0.146 0.131
5 22 0.344 0.242 0.283 0.231 0.150 0.148
6 41 0.551 0.291 0.562 0.255 0.174 0.141
7 85 0.586 0.292 0.894 0.259 0.294 0.153
8 200 1.151 0.301 1.346 0.265 0.492 0.192
9 0 1.004 0.211 1.078 0.212 0.267 0.190
10 0 0.919 0.258 1.159 0.234 0.280 0.176
11 0 0.486 0.263 0.407 0.239 0.251 0.183
12 0 0.350 0.280 0.401 0.234 0.231 0.173
13 0 0.397 0.225 0.432 0.238 0.242 0.164
14 0 0.361 0.220 0.417 0.212 0.248 0.191
15 0 0.357 0.262 0.421 0.221 0.297 0.190
16 0 0.354 0.216 0.397 0.207 0.260 0.186
17 0 0.264 0.205 0.292 0.209 0.281 0.188
* O.D. values represents a mean of 2 tests, and values more than double that of
the negative control were considered positive.
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Table 7. 14
Absorbance values of T. evansi antigens in tissue extracts of the
experimentally infected rats.
42 k.Da 52 k.Da 72 k.Da
uninfected infected uninfected infected uninfected infected
At 12 davs:
spleen 0.350 0.352 0.320 0.376 0.327 0.377
liver 0.702 0.794 0.520 0.543 0.605 0.611
kidney 0.215 0.289 0.274 0.399 0.404 0.441
lung 0.281 0.350 0.367 0.383 0.374 0.415
heart 0.298 0.306 0.345 0.388 0.401 0.418
brain 0.220 0.233 0.316 0.381 0.412 0.466
At 17 davs:
spleen 0.350 0.732* 0.320 0.673* 0.327 0.352
liver 0.702 0.774 0.520 0.551 0.605 0.624
kidney 0.215 0.456* 0.274 0.392 0.404 0.415
lung 0.281 0.292 0.367 0.374 0.374 0.395
heart 0.298 0.308 0.345 0.346 0.401 0.407
brain 0.220 0.259 0.316 0.373 0.412 0.421
*
= positive reaction (more than twice that of the uninfected control).
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DISCUSSION:
The results obtained in this part of the study have confirmed the ability
of the antigen capture-ELISA developed earlier to detect T. evansi antigens in
serum and tissues. When soluble extracts of the parasite were inoculated in an
aqueous form intravenously into a rabbit all three antigens were detected
between 1 to 2 hours post-inoculation due to their circulation with blood
throughout the animal body. Unaggregated protein antigens are known to
distribute evenly throughout the animabs blood before being cleared by the
phagocytic cells (Tizard, 1992). Thereafter, the level of the antigens declined
between 1 to 3 days after inoculation, either as result of dilution or as a result
of phagocytic clearence.
Of the three antigens included in the present study, the 52 k.Da antigen
was the first antigen to be detected in the circulation of T. evansi- infected
rats. Such early appearance might be allied with the antigen's surface-
association making it one of the first antigens that would be released from the
parasites early during infection. The 42 k.Da antigen was the next antigen to
be detected followed by the 72 k.Da fraction. Although the level of the 42
k.Da and the 52 k.Da antigens remained high for two days following treatment
a sharp decline was seen on the second day. Conversely, the 72 k.Da antigen
was rapidly cleared from the circulation following treatment. The rapid
clearance of these antigens from the circulation suggests that they could have
been circulating as antigen-antibody complexes. Such complexes are known to
be rapidly cleared from the circulation by phagocytic cells (Tizard, 1992) and
elimination of antigens from the circulation by these mononuclear phagocytic
cells is inefficient when antibodies have low affinity for the antigen (WHO,
1977).
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The peak level of antigenaemia generally coincided with the highest
levels of parasitaemia. It is likely that the ELISA result reflects the presence of
free target antigens in the circulation of the infected rats rather than antigen
appearing in the blood sample due to breakdown of parasites after blood
sampling. Previous studies had shown that trypanosomes at a concentrations of
approximately 1x10^ trypanosomes/ml would be needed in the blood sample
to reach the absorbance levels obtained with serum from the rats. These levels
were never reached during the course of infection in the present study.
In tissue extracts the 42 k.Da antigen was detected in the brain and
spleen of the infected mice during early infection, while the 52 and the 72
k.Da antigens were not detected in these tissues during early stages of
infection either due to their scarcity or differences in processing the individual
trypanosomes components. Following two weeks of infection, however, the 52
k.Da fraction was detected in extracts from the brain, heart, lungs and kidneys
of the infected mice. The 42 k.Da antigen was also detected in the kidneys of
the infected mice. In infected rats both the 42 k.Da and 52 k.Da antigens were
detected extravascularly in extracts of spleen and the 42 k.Da was also
detectable kidneys extracts 17 days after infection, although both antigens
were absent from the circulation. The variation in the fate of these antigens
within the host body and the difference in their extravascular location in mice
and rats suggests that the fate of individual trypanosome antigens is influenced
by both the antigen itself and the host species. The difference in the dynamics
and localisation of these trypanosome antigens warrants further investigation
and provides a better understanding of the host-parasite interaction.
Antigens investigated in the present study were not detected in any
cryostat sections examined. This might be due to their scarcity in these
sections or due to changes taking place during the processing of the sections,
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in particular the pre-fixation drying steps and the effect of acetone fixation on
these particular antigenic molecules.
The rapid clearance of all three T. evansi antigens from the circulation
after successful chemotherapy makes them good candidates for developing
serologically-based test for measuring the effectiveness of chemotherapy. The
52 k.Da also has the advantage over the other two antigens in that it is an
invariant antigen that appears early during infection and could also be a
candidate antigen for the diagnosis of infection, but only in areas where
diagnosis is not complicated by the presence of other salivarian trypanosomes
as the antigen is present in both T.brucei and T.vivax. Furthermore, the fact
that the 42 k.Da and 52 k.da antigens could be detected in tissue extracts of
some organs even after they had disappeared from the blood raises the
possibility of diagnosis of trypanosome infection based on such extracts,




Scientific endeavour over the past 100 years has yielded large amounts
of information on many aspects of the parasitic trypanosomes including
morphology, infectivity, behaviour of intact parasites and host/parasite
interaction and has been the subject of extensive reviews (Hoare, 1972,
Stephen, 1986, Urquhart and Holmes, 1987). Our knowledge on many aspects
of host/parasite interaction and immunology in particular, is mainly gleaned
from studies based only on whole parasite extracts . Such extracts consist of a
complex mixture of molecules each potentially capable of interacting with the
host in a particular way. A full understanding of the way in which
trypanosomes interact with the host must take into account the nature and
behaviour of individual parasite components and the way in which they
interact with the host. Recent developments in biotechnology have led to the
emergence of a number of sophisticated techniques such as SDS-PAGE and
immunoblotting (Towbin et al, 1979, Burnette, 1981) that are capable of
resolving individual parasite components from complex mixtures and assessing
their interaction with host components.
The discriminatory power of SDS-PAGE (Laemmli, 1970) has been
used extensively for the analysis of pathogenic organisms such as
trypanosomes. When combined with the technique of immunoblotting they
provide a powerful means for examining host/parasite interaction at the
molecular level. This combination of technique have been used in
trypanosomiasis research mainly for characterisation and identification of the
variant surface glycoprotein of trypanosomes (Cardoso de Almeida and
Turner, 1983, Gardiner et al, 1987), determination of the molecular nature of
invariant antigens in T. brucei rhodesiense (Burgess and Jerrells, 1985) and
studying antibody response to T. evansi antigens in experimentally infected
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A
rabbits (Uche, 1989). In the present study a similar combination of molecular
techniques was used to identify and antigenically characterise individual T.
evansi components using sera from experimentally infected rabbit and
hyperimmune serum to a range of the parasite soluble materials. Overall
twenty seven components were found to be antigenic but the number was
dependent on the way in which they were presented to the host. The majority
of these components acted as antigens during 21 days of infection. The others,
although not recognised as antigens during the infection were capable of
eliciting an antibody response when used as soluble extract. From those
recognised during infection two antigens of 42 k.Da and 52 k.Da identified as
major components in the immune response to T. evansi were selected for
further investigation into the dynamics of T. evansi antigens during the course
of infection.
For studies on the dynamics of the individual parasite antigens during
infection, an assay capable of sufficient sensitivity for detecting and tracing
these antigens in the host is needed. Antigen-capture ELISA is capable of
detecting antigens in host materials and have been used successfully to detect
circulating trypanosome antigens (Rae and Luckins, 1984; Nantulya ei al,
1989, Olaho-Mukani et al, 1989; Masake and Nantulya, 1991, El Amin et al,
1993, Olaho-Mukani et al, 1993, Sinyangwe and Munyama, 1993). The study
of the interaction of the antigens at tissue and cellular level is facilitated by the
development of immunohistochemical techniques. Attempts were made to
exploit both types of assays in the present study as a tool for studying the
dynamics of individual antigens of T. evansi.
A key element in these immunoassays is the availability of high specific
antibody to detect the target antigen as the sensitivity of these assays is
dependent on the specific activity and high avidity of the antibody (Tijssen,
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1985). Two types of antibodies can be utilised in these assays to detect the
target antigen polyclonal antibodies in hyperimmune serum raised to a single
antigen, and monoclonal antibodies. The hyperimmune serum usually contain
high proportion of high affinity antibodies with high ability to bind antigen
(Harlow and Lane, 1988). such high affinity and high sensitivity of polyclonal
antibodies makes them better reagents in immunoassays compared to
monoclonal antibodies which often has low affinity (Tijssen, 1985). However,
the successful production of polyclonal antibodies requires the availability of a
highly purified antigen so that the antibody produced will be able to detect the
target antigen in complex mixtures. The production of monoclonal antibodies
do not require pure antigen and are highly selective reagents that can be used
in the identification and isolation of individual antigens in complex mixtures
(Liddell and Cryer, 1991) as they usually recognise a single antigenic
determinant. Another advantage of monoclonal antibodies over the polyclonal
antibodies is that large quantities of identical antibodies can be generated. The
present study utilised both type of antibodies, polyclonal antibodies to the 42
k.Da and 52 k.Da T. evansi antigens and a monoclonal antibody recognising a
72 k.Da antigen of T. evansi. Characterisations of these antigens revealed the
42 k.Da antigen to be variant-specific antigen, while the 52 k.Da antigen was
common to different variants and stocks of T. evansi and to T. brucei and T.
vivax. The 72 k.Da was stock specific antigen common between different
variants of the same T. evansi stock.
In developing immunoassay for the detection of antigens purified
antibodies are usually required as the efficiency of these assays is directly
dependent on the purity of the antibody (Tijssen, 1985). Immunoglobulins
constitute about 10% of the total serum proteins of which 1 - 10% are usually
antibodies to the injected antigen (Kurstak, 1985). Enrichment of antibodies is
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a necessary step achieved by purification and consequently the amount of
enzyme needed to conjugate the antibody will be reduced. A number of
purification methods are available of which affinity chromatography with
protein A Sepharose is the most popular since it produces high yields of pure
antibody (Tijssen, 1985, Harlow and Lane, 1988). Antibodies produced in the
present study were purified using this method and the effect of purification on
their detectability was tested by antibody-ELISA. The purified antibodies were
then labelled with horseradish peroxidase and biotin before used to develop
the antigen-capture ELISA.
The performance of any immunoassay depends largely on optimisation
of the assay conditions (Kemeny, 1992). In order to optimise the conditions of
the antigen-capture assay and to test its capability of detecting the target
antigens in the present study the assay was first tested using crude T. evansi
extracts. After establishing appropriate working conditions the assay was then
evaluated against antigens in serum of a rabbit inoculated with a crude parasite
extract and tissue extracts from infected mice. Cryostat sections were also
prepared from these tissues and examined for the presence of the antigens.
Extracts from infected and perfused organs were used as a second approach to
tissue sections to determine the presence of the antigens in the extravascular
sites. The assay was then applied for studying the dynamics of the antigens
during the course of infection and after drug treatment in experimentally
infected rats.
The assays developed were sufficiently stable and sensitive in that they
were capable of detecting the target antigens in the blood and tissue.
Differences were seen in the dynamics of the three antigens investigated in the
present study. The 52 k.Da antigen reached a detectable level in the circulation
of the infected rats before the appearance of the other two antigens, while the
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72 k.Da antigen was the last to be detected. Following treatment of the
infected rats the 72 k.Da antigen was the first to disappear from the circulation
followed by the 42 k.Da and the 52 k.Da antigens two days later.
The antigen-capture ELISA used in the present study was also able to
detect the target antigens in the tissue extracts collected from infected mice
and rats. As in the circulation differences were seen in the location of the three
antigens in these extravascular sites. The 42 k.Da antigen was detected 4 days
after infection from the brain and spleen of the infected untreated mice
possibly due to the presence of trypanosomes in these organs. Extravascular
trypanosomes in the brain and spleen of infected animals have been reported
(Seed and Effron, 1973, Turner et al, 1986, Sudarto et al, 1990) and
considered as important sources of relapses after drug treatment. The 52 and
the 72 k.Da antigens were however not detected in these tissues at this time of
infection possibly due to their scarcity as they represent small proportion of
the parasite extract. Following treatment the 42 k.Da antigen was detectable
from the kidneys while the 52 k.Da was present in extracts from brain, heart,
lungs and kidneys indicating differences in the behaviour of these antigens. In
rats the antigens were detected in the tissues from 6 days following their
disappearance from the circulation. The 42 k.Da antigen was detected from the
kidney and spleen and the 52 k.Da antigen from the spleen. The 72 k.Da
antigen was, however not detected from any of the tissues examined. In both
infected mice and rats the clearance of the antigens appeared to be through the
spleen and the kidneys as indicated by the presence of the antigens in these
organs following their disappearance from the circulation.
The three antigens were not detected in the cryostat sections examined,
possibly due to alteration encountered during the processing of the sections
particularly the effect of the fixative used (acetone) (Tijssen, 1985).
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The detection of the parasite antigens in extracts of tissues from
perfused infected animals by the antigen-capture ELISA used in the present
study represents a useful application of this sensitive test to study
extravascular trypanosomes. The rapid clearance of the antigens from the
circulation following the destruction of the trypanosomes by chemotherapy is
a possible indicator of effective chemotherapy since their absence is indicative
of the disappearance of the parasites from the circulation. This contrasts with
other findings where antigens persisting in the circulation for periods of two
months after the destruction of the parasites by chemotherapy have been
reported in cattle (Sinyangwe and Munyama, 1993).
The release of internal antigens in the circulation depends on the
destruction of the tiypanosomes from the preceding parasitaemic wave and
usually do not reach detectable levels before the remission of the first
parasitaemia (Nantulya et al, 1986). The 52 k.Da antigen being a common
trypanosome antigen that can reach a detectable level in the circulation before
the remission of the first parasitaemic wave represent a possible candidate for
the diagnosis of infection particularly in areas where T. evansi is the only
trypanosome species present.
The differences in the behaviour and the fate of these antigens during
infection warrant further investigation in the dynamics of the other antigenic
components of the parasite using this approach. Also application of this
approach for the parasite components in the primary hosts might require the
use of more advanced techniques such as 2-dimensional electrophoresis which
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Phosphate buffered saline (PBS):
Sodium chloride 8.0 g.
Potassium chloride 0.2 g.
Disodium hydrogen phosphate, anhydrous 1.15 g.
Potassium dihydrogen phosphate 0.2 g.
Made up to one litre with distilled water.
pH 7.3
Appendix 2:
Phosphate saline glucose (PSG):
Disodium hydrogen phosphate, anhydrous 13.48 g.
Sodium dihydrogen phosphate 0.78 g.
Sodium chloride 4.25 g.
Made up to one litre with distilled water.
For use, the above solution was diluted in the ratio of 6:4 with distilled water
and glucose was added to give a 1% solution. PH 8.0
Appendix 3:
Gel solutions:
solution concentration of gel solution
required (in ml) 20% 15% 10% 7%
4.5%
stock acrylamide (40%) 100 75 50 35 11.25
x4 lower tris 50 50 50 50 —
x4 upper tris — — — — 25
grams of sucrose 30 30 — — —
distilled water 20 45 100 115 63.75
Total volume 200* 200* 200* 200* 100**
* stored at -20°C in 20 ml aliquots.
** stored at -20°C in 10 ml aliquots.
Appendix 4:













Electrode buffer (Appendix 4) 100 ml.
Methanol 100 ml.
Distilled water 300 ml.
Appendix 7:
Blocking buffer xlO:
Tris 60.5 g (50 mM).
Sodium chloride 87.0 g (150 mM).
EDTA 3.72 g (1 mM).
Nonidet P40 (NP40) 5.0 ml (0.05%).
Gelatin 25.0 ml (0.25%).
Thiomersal 2.0 g (0.02%).
Distilled water to 1000 ml.
pH adjusted to 7.4 with concentrated HC1. For use the buffer was diluted 1:10
with distilled water and 5% Marvel added.
Appendix 8:
Substrate solution (immunoblot):
(a) 60 mg 4-chloro-l-naphthol was dissolved in 20 ml ice-cold
methanol.
(b) Tris buffered saline (TBS)
Tris 4.85 g (20 mM).
Sodium chloride 58.48 g (500 mM).
Made up to 2 litre with distilled water and pH adjusted to 7.5
with concentrated HC1.
(c) Immediately before use, 60 pi ice-cold hydrogen peroxide was
added to 100 ml of TBS at room temperature, mixed with (a) and used in
the assay.
Appendix 9:
ELISA coating buffer:(carbonate/bicarbonate buffer). pH 9.6
Sodium carbonate 1.59 g
Sodium bicarbonate 2.93 g
Made up to one litre with distilled water
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Appendix 10:
ELISA washing buffer (PBS/Tween): pH 7.4
Sodium hydrogen orthophosphate 2.9 g
potassium dihydrogen orthophosphate 0.2 g
Sodium chloride 8.0 g
Potassium chloride 0.2 g
Tween 20 0.5 ml
Made up to one litre with distilled water.
Appendix 11:




Made up to 10 ml with distilled water
give a 1% solution.
Appendix 12:
SDS-sampIe buffer:





0.05% (w/v) Bromophenol Blue
Appendix 13:
Sodium cacodylate buffer:
Sodium cacodylate 2.14 g
made up to 500 ml with distilled water. pH adjusted to 7.3 with HC1 and
stored at 4°C. Before use the buffer is double diluted with distilled water to
make a single strength buffer. 12 ml of 25% EM grade gluteraldehyde is then
added to 88 ml of the single strength (0.1 M) cacodylate buffer, pH 7.3.
Appendix 14:
Phosphate buffer:(0.015M)
Disodium hydrogen phosphate (Na2HPC>4) 2.13 g
Made up to one litre with distilled water




0.096 g (0.03 M)
0.140 g (0.23 M)
0.087 g (0.15 M)
. For use glucose was added to
1.0 ml.
1.6 ml.










pH adjusted to 7.0 with HC1.
Appendix 17:
HPLC: Elution buffer (size exclusion fractionation):
Sodium phosphate 0.1 M
Potassium dihydrogen phosphate 0.1 M
Sodium nitrate 0.001 M
pH adjusted to 7.0 with HC1
Appendix 18:






Made up to 100 ml with distilled water
Appendix 19:
Con A elution buffer:
Methyl a-D-Mannopyranoside 1.94 g (0.1 M).









HAT and HT supplements:
Hypoxanthine-Aminopterin-Thymidine (HAT) and Hypoxanthine-
Thymidine (HT) supplements (Gibco) were supplied as sterile 50x
concentrated solutions containing:
Hypoxanthine 65 mg
Aminopterin (HAT only) 0.95 mg
0.8203 g (0.1 M)
2.922 g (0.5 M)
0.02033 g (0.001 M)
0.0147 g (0.001 M)













A stock solution (x 1000) containing 100,000 units per ml of sodium
benzylpenicillin (Crystapen, Glaxovet) and 100,000 pg per ml of streptomycin
sulphate (Glaxo) in purified water was stored in aliquots at -20°C. The
working concentration was 100 units/fig per ml solution.
Appendix 23:
Counting fluid:
[a] White blood cell counting fluid:
2% acetic acid (BDH)
[b] Trypan blue:
0.2% hypan blue (Sigma) in PBS pH 7.3.
Appendix 24:
Chrome alum gelatine solution:
gelatin (Oxoid) was dissolved in PBS to give a 0.5% solution.
Chromium alum was then dissolved in the gelatin solution to a final
concentration of 0.05%. the solution was stored at 4°C until needed.
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